第112回日本泌尿器科学会総会 JUA Abstracts

河原貴史{かわはらたかしKAWAHARATAKASHI}|上田崇{うえだたかしUEDATAKASHI}|鈴木敦人{すずきあつとSUZUKIATSUTO}|永原啓{ながはらあきらNAGAHARAAKIRA}____岸田健{きしだたけしKISHIDATAKESHI}|中村晃和{なかむらてるかずNAKAMURATERUKAZU}____岸田健{きしだたけしKISHIDATAKESHI}|中井川昇{なかいがわのぼるNAKAIGAWANOBORU}|垣本健一{かきもとけんいちKAKIMOTOKEN-ICHI}|川村憲彦{かわむらのりひこKAWAMURANORIHIKO}|中井康友{なかいやすともNAKAIYASUTOMO}|中山雅志{なかやままさしNAKAYAMAMASASHI}|西村和郎{にしむらかずおNISHIMURAKAZUO}____パネルディスカッション1難治性精巣腫瘍への挑戦____難治性胚細胞腫瘍 導入化学療法のみで寛解に持ち込めなかった症例|RPLNDによる大量出血防止対策としての腹部大動脈ステントグラフト内挿術(EVAP)の有用性の検討|精巣癌脳転移に対する集学的治療|進行性胚細胞腫瘍における集学的治療後晩期再発症例に対する適切な治療とは?

PD1

パネルディスカッション1
難治性精巣腫瘍への挑戦

河原崇司{かわはらたかしKAWAHARATAKASHI}|向井幹夫{むかいみきおMUKAIMIKIO}|泉浩二{いずみこうじIZUMIKOUJI}|塩田真己{しおたまさきSHIOTAMASAKI}____木村高弘{きむらたかひろKIMURATAKAHIRO}|上村博司{うえむらひろじUEMURAHIROJI}________シンポジウム1前立腺がんホルモン療法の功罪〜副作用を中心に____前立腺がんホルモン療法患者における骨折リスク評価と予防の重要性|前立腺がん患者に対するがん薬物療法に伴う心血管毒性|ADTの功罪 オーバービュー|GnRHアゴニストとGnRHアンタゴニストの有害事象プロファイル

SY1

シンポジウム1
前立腺がんホルモン療法の功罪〜副作用を中心に

西高辻信良{にしたかつじのぶよしNISHITAKATSUJINOBUYOSHI}____藤井靖久{ふじいやすひさFUJIIYASUHISA}________文化人講演1歴史を紡ぐ____歴史を紡ぐ

CL1

文化人講演1
歴史を紡ぐ

演者：西高辻 信良

牟田口淳{むたぐちじゅんMUTAGUCHIJUN}|諸岡健一{もろおかけんいちMOROOKAKEN'ICHI}|金子正大{かねこまさともKANEKOMASATOMO}|加藤浩晃{かとうひろあきKATOHIROAKI}____荒木元朗{あらきもとおARAKIMOTO}|土谷順彦{つちやのりひこTSUCHIYANORIHIKO}____諸岡健一{もろおかけんいちMOROOKAKEN'ICHI}|小田昌宏{おだまさひろODAMASAHIRO}|種子島時祥{たねがしまときよしTANEGASHIMATOKIYOSHI}|塚原茂大{つかはらしげひろTSUKAHARASHIGEHIRO}|後藤駿介{ごとうしゅんすけGOTOSHUNSUKE}|小林聡{こばやしさとしKOBAYASHISATOSHI}|松元崇{まつもとたかしMATSUMOTOTAKASHI}|塩田真己{しおたまさきSHIOTAMASAKI}|森健策{もりけんさくMORIKENSAKU}|江藤正俊{えとうまさとしETOMASATOSHI}|浮村理{うきむらおさむUKIMURAOSAMU}____総会校企画1次の100年に向けたAI____膀胱内視鏡とAI -これからの100年-|画像AIによる現在・未来の泌尿器科医療支援|尿細胞診診断支援AIが変える尿路上皮癌診療|2030年に向けた医療の大変革 ～AIの進化と医師の新たな役割～

SP1

総会校企画1
次の100年に向けたAI

【指導医教育コース】

*指導医教育コース認定プログラム

上村博司{うえむらひろじUEMURAHIROJI}|絹谷清剛{きぬやせいごKINUYASEIGO}|溝脇尚志{みぞわきたかしMIZOWAKITAKASHI}|三宅秀明{みやけひであきMIYAKEHIDEAKI}|木村高弘{きむらたかひろKIMURATAKAHIRO}|磯田拓郎{いそだたくろうISODATAKURO}____大家基嗣{おおやもとつぐOYAMOTOTSUGU}|細野眞{ほそのまことHOSONOMAKOTO}________総会校企画2いつ始める？新たな前立腺癌治療に備え、今日からすべきこと～核医学治療が切り拓くLu-PSMA-617治療～____Lu-PSMA-617 試験結果から見たｍCRPC治療の展望 |治療病室・特別措置病室－どうやって整備・運用すればいいの？|Lu-PSMA-617の実臨床導入時に予想される問題点|－

SP2

総会校企画2
いつ始める？新たな前立腺癌治療に備え、今日からすべきこと～核医学治療が切り拓くLu-PSMA-617治療～

TakumaKatou{KATOUTAKUMA}|KaiZhang{ZHANGKAI}|XinyanYang{YANGXINYAN}|Po-FanHsieh{HSIEHPO-FAN}|Tsu-ChenLin{LINTSU-CHEN}|MakotoKawase{KAWASEMAKOTO}|Yu-HsiangHuang{HUANGYU-HSIANG}|TomokiTakeda{TAKEDATOMOKI}|MasahiroYamazaki{YAMAZAKIMASAHIRO}____ToshitakaShin{SHINTOSHITAKA}|SeongIlSeo{SeoSeongIl}____TohruYoneyama{YONEYAMATOHRU}|ShingoHatakeyama{HATAKEYAMASHINGO}|TakumaSato{SATOTAKUMA}|RhujiMatsumoto{MATSUMOTORHUJI}|KeiichiroMori{MORIKEIICHIRO}|ToshikiTanikawa{TANIKAWATOSHIKI}|YouichiroTohi{TOHIYOUICHIRO}|ShinichiSakamoto{SAKAMOTOSHINICHI}|MasaharuInoue{INOUEMASAHARU}|HiroshiFukuhara{FUKUHARAHIROSHI}|ChikaraOoyama{OOYAMACHIKARA}|MikioSugimoto{SUGIMOTOMIKIO}|JeremyTeoh{TEOHJEREMY}|PilarLaguna{LAGUNAPILAR}|JoseDominguez-Escrig{DOMINGUEZ-ESCRIGJOSE}|Chi-FaiNg{NGCHI-FAI}|JeanDeLaRosette{DELAROSETTEJEAN}|YuGuangTan{TANYUGUANG}|FreddySim{SIMFREDDY}|KennethChen{CHENKENNETH}|JohnYuen{YUENJOHN}|ChristopherCheng{CHENGCHRISTOPHER}|HenryHo{HOHENRY}|MelvinChua{CHUAMELVIN}|TuanJeffrey{JEFFREYTUAN}|RavindranKanesvaran{KANESVARANRAVINDRAN}|NyeThaneNgo{NGONYETHANE}|YanMeeLaw{LAWYANMEE}|KaeJackTay{TAYKAEJACK}|SunaoShoji{SHOJISUNAO}|Kuan-YuLin{LINKUAN-YU}|Ruei-JeChang{CHANGRUEI-JE}|Chung-LinLee{LEECHUNG-LIN}|Liang-KangHuang{HUANGLIANG-KANG}|Hung-ChengKan{KANHUNG-CHENG}|I-HungShao{SHAOI-HUNG}|Po-HungLin{LINPO-HUNG}|Chun-TeWu{WUCHUN-TE}|Cheng-KengChuang{CHUANGCHENG-KENG}|See-TongPang{PANGSEE-TONG}|Kai-JieYu{YUKAI-JIE}|HitomiMatsubara{MATSUBARAHITOMI}|ShinichiTakeuchi{TAKEUCHISHINICHI}|MasayukiTomioka{TOMIOKAMASAYUKI}|TomokiTaniguchi{TANIGUCHITOMOKI}|KotaKawase{KAWASEKOTA}|KojiIinuma{IINUMAKOJI}|KeitaNakane{NAKANEKEITA}|YukiTobisawa{TOBISAWAYUKI}|KikuGoto{GOTOKIKU}|TakuyaKoie{KOIETAKUYA}|JonathanYjChen{CHENJONATHANYJ}|ShuzoHamamoto{HAMAMOTOSHUZO}|KengoKawase{KAWASEKENGO}|TomokiOkada{OKADATOMOKI}|ReiUnno{UNNOREI}|ShoichiroIwatsuki{IWATSUKISHOICHIRO}|ToshikiEtani{ETANITOSHIKI}|AtsushiOkada{OKADAATSUSHI}|YukihiroUmemoto{UMEMOTOYUKIHIRO}|TakahiroYasui{YASUITAKAHIRO}|HiroshiKawahira{KAWAHIRAHIROSHI}|YoshitakaMaeda{MAEDAYOSHITAKA}|KosukeOiwa{OIWAKOSUKE}|HirotakaYokoyama{YOKOYAMAHIROTAKA}|TomohiroKameda{KAMEDATOMOHIRO}|JunKamei{KAMEIJUN}|ToruSugihara{SUGIHARATORU}|SatoshiAndo{ANDOSATOSHI}|TetsuyaFujimura{FUJIMURATETSUYA}____Selected Oral 1Prostate cancer 1____S2,3PSA% is a significant predictor of reclassification of 1st-year protocol biopsy on active surveillance for early-stage prostate cancer|Short-Mid-term oncological results of Irreversible Electroporation for the Ablation of Localized Prostate Cancer: A Multi-Center Randomized Study|Early oncological and patient reported outcomes of an extended observational cohort of a Phase II clinical Trial in Focal Cryotherapy|The Diagnostic value of MRI for Persistent Prostate Cancer following Irreversible Electroporation Focal Therapy: Results from a Randomized Controlled Trial|Combining percentage PSA reduction and mpMRI to reduce unnecessary biopsy after focal therapy of prostate cancer|Efficacy and Safety of High-intensity Focused Ultrasound in Patients with Prostate Cancer|Efficacy of assessment and feedback in perioperative pelvic floor muscle exercises by physiotherapists for urinary incontinence after radical prostatectomy|Cystopexy following anterior-approach robot-assisted radical prostatectomy enhances early continence recovery|Comparison of the surgical outcomes of robot-assisted radical prostatectomy using two different insufflators|Initial surgical performance in robot-assisted radical prostatectomy is associated with clinical outcomes and learning curves

SO-1

Selected Oral 1
Prostate cancer 1

JunyanChen{CHENJUNYAN}|ShenCheng-Huang{CHENG-HUANGSHEN}|Ting-YiChiang{CHIANGTING-YI}|RettaCatherinaSihotang{SIHOTANGRETTACATHERINA}|－|ErikaIkezoe{IKEZOEERIKA}|YiqunTian{TIANYIQUN}|DaiKoguchi{KOGUCHIDAI}|KevinA{AKEVIN}|MototakaSato{SATOMOTOTAKA}____ShusukeAkamatsu{AKAMATSUSHUSUKE}|RainyUmbas{UmbasRainy}____YutaoWang{WANGYUTAO}|ChangDeching{DECHINGCHANG}|ChouChih-Chieh{CHIH-CHIEHCHOU}|FangChiung-Yao{CHIUNG-YAOFANG}|FakhriRahman{RAHMANFAKHRI}|ChaidirArifMochtar{MOCHTARCHAIDIRARIF}|AgusRizalHamid{HAMIDAGUSRIZAL}|AkinoriNakayama{NAKAYAMAAKINORI}|YusukeHara{HARAYUSUKE}|HirokiTsujioka{TSUJIOKAHIROKI}|AsumiNirazuka{NIRAZUKAASUMI}|KintaroHasegawa{HASEGAWAKINTARO}|KeitaIzumi{IZUMIKEITA}|KiyoshiSetoguchi{SETOGUCHIKIYOSHI}|KazutakaSaito{SAITOKAZUTAKA}|XiaoyongZeng{ZENGXIAOYONG}|HideyasuTsumura{TSUMURAHIDEYASU}|Ken-IchiTabata{TABATAKEN-ICHI}|ShuheiHirano{HIRANOSHUHEI}|MasaomiIkeda{IKEDAMASAOMI}|DaisukeIshii{ISHIIDAISUKE}|TakefumiSatoh{SATOHTAKEFUMI}|KazumasaMatsumoto{MATSUMOTOKAZUMASA}|LovekeshKumar{KUMARLOVEKESH}|BrusabhanuNayak{NAYAKBRUSABHANU}|PrabhjotSingh{SINGHPRABHJOT}|SatyavirYadav{YADAVSATYAVIR}|AmleshSeth{SETHAMLESH}|ShodaiSuzuki{SUZUKISHODAI}|TetsuyaMurakawa{MURAKAWATETSUYA}|ToshimitsuTanaka{TANAKATOSHIMITSU}|ShunUmeda{UMEDASHUN}|NorihideTei{TEINORIHIDE}|OsamuMiyake{MIYAKEOSAMU}____Selected Oral 2Prostate cancer 2____Integrating DNA methylome, transcriptome and proteome to identify potential therapeutic targets for prostate cancer in multi-ethnic populations|JC Virus-Like Particles (VLPs) Carrying a PSA Promoter-Driven Suicide Gene Suppress Metastatic Tumor Growth and Improve Survival in Mice model|Significance of incidental focal 18F-FDG PET/CT uptake in the prostate gland: A Systematic review and meta-analysis|The Microbiome Characteristics in Prostate Cancer: A Systematic Review|演題取り下げ|Timing of radiographic progression on prostate-specific antigen kinetics in metastatic castration-sensitive prostate cancer patients received upfront therapy|Prevalence and burden of prostate diseases from 1990 to 2021, a research involved 21 regions and 204 countries|Less aggressive metastatic pattern in high-volume castration-sensitive prostate cancer|Effect of androgen deprivation therapy on cardiovascular function in patients with advanced prostate carcinoma: A prospective cohort study|Impact of androgen deprivation therapy on lumbar spine bone health in patients with prostate cancer using quantitative computed tomography

SO-2

Selected Oral 2
Prostate cancer 2

SoroushRais-Bahrami{RAIS-BAHRAMISOROUSH}|MohummadMinhajSiddiqui{SIDDIQUIMOHUMMADMINHAJ}|FrancescoEsperto{ESPERTOFRANCESCO}|PavelNavratil{NAVRATILPAVEL}____YoshihikoTomita{TOMITAYOSHIHIKO}________Scholarship Forum - Postgraduate Lectures from AUA and EAU____MRI and/or PET imaging for the diagnosis and risk stratification of prostate cancer|The Development of Quality Measures for Improving Quality of Care in Urologic Oncology|New lasers in endourology|Radical Nephrectomy with Inferior Vena Caval Thrombectomy for Level I to IV Tumor Thrombus: Long-Term Single-Center Experience

SC

Scholarship Forum - Postgraduate Lectures from AUA and EAU

本郷文弥{ほんごうふみやHONGOFUMIYA}|五島悠介{ごとうゆうすけGOTOYUSUKE}|皆川倫範{みながわとものりMINAGAWATOMONORI}|澤田智史{さわだのりふみSAWADANORIFUMI}____浮村理{うきむらおさむUKIMURAOSAMU}________IJU Camp 2025____IJUの編集方針|IJU編集幹事（DE）の実際の業務について|論文を深く読み込もう|わたしの論文投稿経験と査読について

IJU_CAMP

IJU Camp 2025

JaspreetSandhu{SANDHUJASPREET}|NaokiTerada{TERADANAOKI}|DavidPenson{PENSONDAVID}|YoichiroTohi{TOHIYOICHIRO}|YasutakaYamada{YAMADAYASUTAKA}____TakahikoMitsui{MITSUITAKAHIKO}|JaspreetSandhu{SANDHUJASPREET}________JUA/AUA Joint Symposium____(Talk1) Urinary Adverse Events after Prostate Radiotherapy|(Talk2) Current status of localized, high-risk prostate cancer|(Talk3) Screening and detecting prostate cancer in 2025: a Brave New World or more of the same?|(Panel Discussion)Strategies of localized, high-risk prostate cancer

JUA_AUA

JUA/AUA Joint Symposium

【指導医教育コース】

*指導医教育コース認定プログラム

VipulR.Patel{PATELVIPULR.}____YoshihikoTomita{TOMITAYOSHIHIKO}________AUA Lecture 1____Telerobotic Surgery: A road to global healthcare equity

AUA1

AUA Lecture 1

Speaker：Vipul R. Patel

JaspreetSandhu{SANDHUJASPREET}____TakahikoMitsui{MITSUITAKAHIKO}________AUA Lecture 2____AUA Clinical Practice Guidelines development process

AUA2

AUA Lecture 2

Speaker：Jaspreet Sandhu

NobuhikoHata{HATANOBUHIKO}____HiroshiFukuhara{FUKUHARAHIROSHI}________Invited Lecture 1____Advancing Urology with Autonomous Robotics, AI, and Human-Robot Collaboration

IL01

Invited Lecture 1

Speaker：Nobuhiko Hata

DavidPenson{PENSONDAVID}____TetsuyaFujimura{FUJIMURATETSUYA}________Invited Lecture 2____What do we do with node-positive prostate cancer in 2025?

IL02

Invited Lecture 2

Speaker：David Penson

VipulR.Patel{PATELVIPULR.}____AtsushiTakenaka{TAKENAKAATSUSHI}________Invited Lecture 3____Robotic Radical Prostatectomy: The ongoing journey to 20,000 cases: Lessons learned

IL03

Invited Lecture 3

Speaker：Vipul R. Patel

JaspreetSandhu{SANDHUJASPREET}____YoshiyukiKojima{KOJIMAYOSHIYUKI}________Invited Lecture 4____Male Incontinence

IL04

Invited Lecture 4

Speaker：Jaspreet Sandhu

MartinGleave{GLEAVEMARTIN}____JunyaFurukawa{FURUKAWAJUNYA}________Invited Lecture 5____Multimodal Approaches to Optimize Surgical Outcomes in High Risk Localized Prostate Cancer

IL05

Invited Lecture 5

Speaker：Martin Gleave

BertrandTombal{TOMBALBERTRAND}____NorioNonomura{NONOMURANORIO}________Invited Lecture 6____Hormonal therapy of metastatic hormone-sensitive prostate cancer (mHSPC): Time for de-escalation?

IL06

Invited Lecture 6

Speaker：Bertrand Tombal

Jean-ChristopheBernhard{BERNHARDJEAN-CHRISTOPHE}____TsunenoriKondo{KONDOTSUNENORI}________Invited Lecture 7____Enhancing kidney cancer management with 3D models

IL07

Invited Lecture 7

Speaker：Jean-Christophe Bernhard

AlexanderTamalunas{TAMALUNASALEXANDER}|－|ShinroHata{HATASHINRO}|YumikoSaito{SAITOYUMIKO}|TomohiroMagari{MAGARITOMOHIRO}|MuhammadZulharyahyaDandyAP{ZULHARYAHYADANDYAPMUHAMMAD}|YuenChingKam{KAMYUENCHING}|TakaakiYokoyama{YOKOYAMATAKAAKI}____YoshiyukiAkiyama{AKIYAMAYOSHIYUKI}|TetsuyaFujimura{FUJIMURATETSUYA}____AminWendt{WENDTAMIN}|FlorianSpringer{SPRINGERFLORIAN}|RuHuang{HUANGRU}|RuixiaoWang{WANGRUIXIAO}|YuhanLiu{LIUYUHAN}|BeataRutz{RUTZBEATA}|AnnaCiotkowska{CIOTKOWSKAANNA}|StephanLedderose{LEDDEROSESTEPHAN}|GiuseppeMagistro{MAGISTROGIUSEPPE}|ElfriedeNoessner{NOESSNERELFRIEDE}|ChristianGStief{STIEFCHRISTIANG}|MartinHennenberg{HENNENBERGMARTIN}|VictorVigodski{VIGODSKIVICTOR}|NikolausEitelberger{EITELBERGERNIKOLAUS}|MoritzTrieb{TRIEBMORITZ}|MayukaShinohara{SHINOHARAMAYUKA}|HironoriKai{KAIHIRONORI}|HiromitsuMimata{MIMATAHIROMITSU}|ToshitakaShin{SHINTOSHITAKA}|AtsukoFujihara{FUJIHARAATSUKO}|MarinaKawahara{KAWAHARAMARINA}|MadokaMiyamoto{MIYAMOTOMADOKA}|OsamuUkimura{UKIMURAOSAMU}|KazumasaFukuda{FUKUDAKAZUMASA}|YosukeFuruya{FURUYAYOSUKE}|RyoOki{OKIRYO}|HaruyukiOgura{OGURAHARUYUKI}|KazutoIto{ITOKAZUTO}|IsaoKurosawa{KUROSAWAISAO}|MuhammadAsykarPalinrungi{ASYKARPALINRUNGIMUHAMMAD}|SyakriSyahrir{SYAHRIRSYAKRI}|SyarifSyarif{SYARIFSYARIF}|KhoirulKholis{KHOLISKHOIRUL}|AbdulAzis{AZISABDUL}|PuiChiChan{CHANPUICHI}|PuiYanHui{HUIPUIYAN}|HoiChuTo{TOHOICHU}|HiroakiKobayashi{KOBAYASHIHIROAKI}|TakehiroHanazawa{HANAZAWATAKEHIRO}|MasayukiShinchi{SHINCHIMASAYUKI}|YujiroTsujita{TSUJITAYUJIRO}|KenjiKuroda{KURODAKENJI}|AkioHoriguchi{HORIGUCHIAKIO}|KeiichiIto{ITOKEIICHI}____Selected Oral 3LUTS 1____Immuno-Modulatory Imide Drugs (IMiDs) Inhibit Human Bladder Smooth Muscle Contraction: a Novel Drug Class in LUTS?|Phospholipase C (PLC) is a Crucial Mediator of Agonist-induced Smooth Muscle Contraction in the Lower Urinary Tract|演題取り下げ|Morphological Changes in Mitochondria and Enhanced Mitophagy in the External Urethral Sphincter of Elderly Individuals|Changes in overactive bladder symptoms after robot-assisted laparoscopic sacrocolpopexy for pelvic organ prolapse|What factors are associated with changes in lower urinary tract dysfunction and ADL in cerebral infarction patients who underwent reperfusion therapy?|Sling Placement for Postoperative Urinary Incontinence After Martius Flap in Fistel Urethrovaginal: A Systematic Review|The role of percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder:a pilot study|Surgical and Patient-Reported Outcomes of Urethroplasty for Radiation-Induced Urethral Strictures Following Prostate Cancer Therapy

SO-3

Selected Oral 3
LUTS 1

WeiTu{TUWEI}|KuanYuChen{CHENKUANYU}|KiwahAndanniBangsawan{BANGSAWANKIWAHANDANNI}|YunChuChang{CHANGYUNCHU}|YuanLingCheng{CHENGYUANLING}|ShengMinTsai{TSAISHENGMIN}|KaLunLo{LOKALUN}|HaoEnChen{CHENHAOEN}|YusukeKimura{KIMURAYUSUKE}|RyoTanji{TANJIRYO}____SunaoShoji{SHOJISUNAO}|JunHyukHong{HONGJUNHYUK}____YungChiShih{SHIHYUNGCHI}|ShangJuHsieh{HSIEHSHANGJU}|ShiuDongChung{CHUNGSHIUDONG}|Sung-LangChen{CHENSUNG-LANG}|Shao-ChuanWang{WANGSHAO-CHUAN}|Min-HsinYang{YANGMIN-HSIN}|Wen-JungChen{CHENWEN-JUNG}|Tuzo-YiHsieh{HSIEHTUZO-YI}|Cheng-JuHo{HOCHENG-JU}|Wen-WeiSung{SUNGWEN-WEI}|AndikaAfriansyah{AFRIANSYAHANDIKA}|Yu-HuaFan{FANYU-HUA}|Jung-YaoHuang{HUANGJUNG-YAO}|Chi-WeiTsao{TSAOCHI-WEI}|EnMeng{MENGEN}|Sheng-TangWu{WUSHENG-TANG}|Tai-LungCha{CHATAI-LUNG}|Guang-HuanSun{SUNGUANG-HUAN}|Dah-ShyongYu{YUDAH-SHYONG}|Sun-YranChang{CHANGSUN-YRAN}|Hui-KungTing{TINGHUI-KUNG}|KauHanLee{LEEKAUHAN}|ChienLiangLee{LEECHIENLIANG}|ChiaChengSu{SUCHIACHENG}|Kuan-HuaHuang{HUANGKUAN-HUA}|BrianSiu{SIUBRIAN}|IvanKo{KOIVAN}|AlexLiu{LIUALEX}|JuliusWong{WONGJULIUS}|SteffiYuen{YUENSTEFFI}|MandyTam{TAMMANDY}|WilsonChan{CHANWILSON}|JeremyTeoh{TEOHJEREMY}|PeterChiu{CHIUPETER}|ChiHangYee{YEECHIHANG}|ChiKwokChan{CHANCHIKWOK}|ChiFaiNg{NGCHIFAI}|YuriKoyama{KOYAMAYURI}|JoTamura{TAMURAJO}|AtsushiYamamoto{YAMAMOTOATSUSHI}|HiroshiYamane{YAMANEHIROSHI}|RyutaroShimizu{SHIMIZURYUTARO}|NoriyaYamaguchi{YAMAGUCHINORIYA}|ShuichiMorizane{MORIZANESHUICHI}|KatsuyaHikita{HIKITAKATSUYA}|MasashiHonda{HONDAMASASHI}|AtsushiTakenaka{TAKENAKAATSUSHI}|TomohiroKawamata{KAWAMATATOMOHIRO}|KanakoGunji{GUNJIKANAKO}|YukiHarigane{HARIGANEYUKI}|AkihisaHasegawa{HASEGAWAAKIHISA}|AkihisaOnagi{ONAGIAKIHISA}|RurikoTakinami{TAKINAMIRURIKO}|SeijiHoshi{HOSHISEIJI}|JunyaHata{HATAJUNYA}|YuichiSato{SATOYUICHI}|SoichiroOgawa{OGAWASOICHIRO}|MotohideUemura{UEMURAMOTOHIDE}|YoshiyukiKojima{KOJIMAYOSHIYUKI}____Selected Oral 4LUTS 2____Application of local hemostatic matrix was associated with a reduction in bleeding complications related to transurethral resection of prostate surgery|Comparison of the outcomes after treatment of Urolift to Rezūm in BPH patients: results from a global multi-institutional database analysis|Efficacy and Safety of En-Bloc vs. Three-Lobe Enucleation Technique for the Management of Benign Prostatic Obstruction: A Systematic Review and Meta-analysis|Delayed-cut technique at the bladder neck during Thulium laser enucleation of the prostate protects small prostates from bladder neck contracture|Initial Experience with En-bloc Thulium Laser Enucleation of the prostate|Comparative Efficacy and Safety of Laser TUEP vs. TURP in Treating Large Volume Prostate: A Single-Center Retrospective Analysis|A pilot office-based same day discharge program of transurethral water vapour therapy on prostate with obstructive uropathy under pure local anesthesia|Prolonged Sterile Pyuria and Urge Urinary Incontinence Caused by Dystrophic Calcifications on Prostatic Fossa post Thulium Laser Enucleation of the Prostate|Analysis of Factors for de novo OAB Onset After Robotic-Assisted Radical Prostatectomy and theImpact of ARVUS|Prediction of overactive bladder after robot-assisted radical prostatectomy (RARP) based on preoperative male sexual function

SO-4

Selected Oral 4
LUTS 2

Chen-YuehWen{WENCHEN-YUEH}|－|KaiWuYang{YANGKAIWU}|NanHawChow{CHOWNANHAW}|LienPingChou{CHOULIENPING}____EijiKashiwagi{KASHIWAGIEIJI}____Hung-YuLin{LINHUNG-YU}|Shih-YingLin{LINSHIH-YING}|JungleChi-HsiangWu{WUJUNGLECHI-HSIANG}|Pei-LainChe{CHEPEI-LAIN}|Cheng-HuangShen{SHENCHENG-HUANG}|Yu-HsuanYeh{YEHYU-HSUAN}|Kun-CheLin{LINKUN-CHE}|Lien-PingChou{CHOULIEN-PING}|PiCheChen{CHENPICHE}|ChengHuangShen{SHENCHENGHUANG}|ChiaPingChang{CHANGCHIAPING}|ShuFenWu{WUSHUFEN}____一般口演001Urologic Tumors ①____Unveiling the role of ATAD3A in kidney renal clear cell carcinoma: a novel biomarker for prognosis and immunotherapy response|演題取り下げ|JCPyV Infection is Highly Prevalent in UTUC : Implications for Oncogenic Factors and Pathological Staging|Development of targeted therapy for urothelial carcinoma with trophoblastic differentiation|Immunosuppressive macrophages induced by tumor derived adiponectin in patients with upper urinary tract urothelial carcinoma

OP-001

一般口演001
Urologic Tumors ①

FaiyazKapasi{KAPASIFAIYAZ}|Yung-HaoLiu{LIUYUNG-HAO}|Ting-YiChiang{CHIANGTING-YI}|－____KoheiHashimoto{HASHIMOTOKOHEI}____AliciaGriffin{GRIFFINALICIA}|AtiqurRahman{RAHMANATIQUR}|TheoRaudsepp{RAUDSEPPTHEO}|Chi-WeiTsao{TSAOCHI-WEI}|EnMeng{MENGEN}|Sheng-TangWu{WUSHENG-TANG}|Tai-LungCha{CHATAI-LUNG}|Guang-HuanSun{SUNGUANG-HUAN}|Dah-ShyongYu{YUDAH-SHYONG}|Sun-YranChang{CHANGSUN-YRAN}|Hui-KungTing{TINGHUI-KUNG}____一般口演002Urologic Tumors ②____Multiparametric MRI of the prostate for early detection of Cancer: Accuracy, effectiveness and an evaluation of learning curve between urologist and radiologist|Detection of Prostate Cancer by En-bloc Thulium Laser Enucleation|Predictive Factors for Progression to mCRPC and Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Single-Center Retrospective Study|演題取り下げ

OP-002

一般口演002
Urologic Tumors ②

KaLunLo{LOKALUN}|YungHo{HOYUNG}|PorenHsiao{HSIAOPOREN}|－|PrasoonJha{JHAPRASOON}|TingLienLi{LITINGLIEN}____AtsushiOkada{OKADAATSUSHI}____BrianSiu{SIUBRIAN}|IvanKo{KOIVAN}|AlexLiu{LIUALEX}|JuliusWong{WONGJULIUS}|SteffiYuen{YUENSTEFFI}|MandyTam{TAMMANDY}|WilsonChan{CHANWILSON}|JeremyTeoh{TEOHJEREMY}|PeterChiu{CHIUPETER}|ChiHangYee{YEECHIHANG}|ChiKwokChan{CHANCHIKWOK}|ChiFaiNg{NGCHIFAI}|ChrisWong{WONGCHRIS}|ChouChieg-Lung{CHIEG-LUNGCHOU}|WuHis-Chin{HIS-CHINWU}|LiPo-I{PO-ILI}|ShaochuanWang{WANGSHAOCHUAN}|DevashishKaushal{KAUSHALDEVASHISH}|NikitaShrivastava{SHRIVASTAVANIKITA}|YiHuiChang{CHANGYIHUI}____一般口演003LUTS and stones____An office-based same day discharge study of Urolift for benign prostatic enlargement under pure local anesthesia|The initial experience of super pulse thulium fiber laser enucleation of the prostate for the management of benign prostatic hyperplasia|Investigation of the relationship between bladder function and sarcopenia, a case series study|Does the Placement of Pedicle Screws Increase the Risk of Ureteral Stones? A Single-center Retrospective Cohort Study|演題取り下げ|Distinguishing Nephrocalcinosis From Nephrolithiasis And Redefining Its Management In The Modern Era Of Endourology: A Urological Dilemma|Graft Kidney Stone Management with mini-PCNL: A Case Report

OP-003

一般口演003
LUTS and stones

YungChiShih{SHIHYUNGCHI}|－|JentingHsu{HSUJENTING}|NaiWenChang{CHANGNAIWEN}|Wei-ChengChen{CHENWEI-CHENG}|JiaJyunJhang{JHANGJIAJYUN}|KiwahAndanniBangsawan{BANGSAWANKIWAHANDANNI}____YusukeYagihashi{YAGIHASHIYUSUKE}____WeiTu{TUWEI}|ChaoYuanChang{CHANGCHAOYUAN}|ShiuDongChung{CHUNGSHIUDONG}|Shiu-DongChung{CHUNGSHIU-DONG}|ChinFongAu{AUCHINFONG}|MinHsinYang{YANGMINHSIN}|Kuo-ChenChung{CHUNGKUO-CHEN}|Yi-HueiChang{CHANGYI-HUEI}|Chi-PingHuang{HUANGCHI-PING}|IrfanWahyudi{WAHYUDIIRFAN}____一般口演004Others①____The safety and efficacy of robotic-assisted varicocelectomy for scrotal pain or infertility:initial results from a single surgeon|演題取り下げ|Lactate level as a simple prognostic indicator for Fournier's gangrene: 105 cases and 18 years of experience|Delayed iatrogenic bladder trauma following cesarean section: case report and literature review|Case Series with Literature Review: Male Genital Trauma in the Emergency Department|A Single Center Experience of Surgical Treatment for Retroperitoneal Fibrosis Causing Obstructive Uropathy|Superior Vesical Fissure: A Case Report of Rare Variant of Bladder Exstrophy in a Girl with Situs Inversus

OP-004

一般口演004
Others①

Ruei-JeChang{CHANGRUEI-JE}|－|AmrutPPhonde{PHONDEAMRUTP}|Chun-PingHuang{HUANGCHUN-PING}|ManojYadav{YADAVMANOJ}|Shun-LinLiu{LIUSHUN-LIN}____HisaeNishii{NISHIIHISAE}____KetanMehra{MEHRAKETAN}|DevashishKaushal{KAUSHALDEVASHISH}|KumarMadhavan{MADHAVANKUMAR}|NikitaShrivastava{SHRIVASTAVANIKITA}|Chih-WeiTsao{TSAOCHIH-WEI}|EnMeng{MENGEN}|Hui-KungTing{TINGHUI-KUNG}|Chi-PngHuang{HUANGCHI-PNG}|Chao-HsiangChang{CHANGCHAO-HSIANG}|Chin-ChungYeh{YEHCHIN-CHUNG}|Po-JenHsiao{HSIAOPO-JEN}|Yi-HueiChang{CHANGYI-HUEI}|Wen-ChiChen{CHENWEN-CHI}|Liang-WeiChiu{CHIULIANG-WEI}____一般口演005Others②____A Case Report and Literature Review: Giant Urethral Calculi in a Patient with Anorectal Malformation|演題取り下げ|OBSERVATIONAL STUDY OF DIAGNOSIS, MANAGEMENT AND OUTCOMES OF BLADDER PARAGANGLIOMA CASES|The Disappearing Vessel Loop Dilemma: Unnoticed Sudden Removal by Laparoscopic Suction Instrument, a Case Report|Unilateral Renal Agenesis with Ipsilateral Ectopic Ureterocele: A Rare Case Report|Single-Center Experience of Kidney Transplantation: A Comparison Between Living Donor and Cadaveric Donor Outcomes in Taiwan

OP-005

一般口演005
Others②

三宅牧人{みやけまきとMIYAKEMAKITO}|西川涼馬{にしかわりょうまNISHIKAWARYOMA}|冨田諒太郎{とみだりょうたろうTOMIDARYOTARO}|西山直隆{にしやまなおたかNISHIYAMANAOTAKA}____中川徹{なかがわとおるNAKAGAWATORU}|藤本清秀{ふじもときよひでFUJIMOTOKIYOHIDE}____森實修一{もりざねしゅういちMORIZANESHUICHI}|武中篤{たけなかあつしTAKENAKAATSUSHI}|北村寛{きたむらひろしKITAMURAHIROSHI}____シンポジウム2BCG unresponsive NMIBC治療の新展開____BCG unresponsive NMIBC の概念整理 & 日本人のためのリアルワールドエビデンス|BCG unresponsive NMIBC治療の新展開～JUOG多施設研究から得られたBCG unresponsive NMIBC に関するバイオマーカーの知見～|BCG unresponsive CISに対する治療の新展開|BCG unresponsive NMIBC に対する治療開発の現状

SY2

シンポジウム2
BCG unresponsive NMIBC治療の新展開

大澤崇宏{おおさわたかひろOOSAWATAKAHIRO}____神波大己{かんばともみKANBATOMOMI}________教育講演1小径腎がんに対する治療____小径腎がんに対する治療

EL1

教育講演1
小径腎がんに対する治療

軸屋良介{じくやりょうすけJIKUYARYOSUKE}|佐藤博美{さとうひろみSATOHIROMI}|志村寛史{しむらひろしSHIMURAHIROSHI}|佐藤克哉{さとうかつやSATOKATSUYA}____榎田英樹{えのきだひできENOKIDAHIDEKI}|白石晃司{しらいしこうじSHIRAISHIKOJI}____蓮見壽史{はすみひさしHASUMIHISASHI}|槙山和秀{まきやまかずひでMAKIYAMAKAZUHIDE}|成田伸太郎{なりたしんたろうNARITASHINTARO}|石田雅宣{いしだまさのりISHIDAMASANORI}|関根悠哉{せきねゆうやSEKINEYUYA}|小林瑞貴{こばやしみずきKOBAYASHIMIZUKI}|山本竜平{やまもとりょうへいYAMAMOTORYOHEI}|沼倉一幸{ぬまくらかずゆきNUMAURAKAZUYUKI}|齋藤満{さいとうみつるSAITOMITSURU}|松下慎{まつしたまことMATSUSHITAMAKOTO}|藤田和利{ふじたかずとしFUJITAKAZUTOSHI}|野々村祝夫{ののむらのりおNONOMURANORIO}|羽渕友則{はぶちとものりHABUCHITOMONORI}|眞仁田聡{まにたさとしMANITASATOSHI}|望月孝規{もちづきたかのりMOCHIZUKITAKANORI}|須田遼祐{すだりょうすけSUDARYOSUKE}|吉良聡{きらさとるKIRASATORU}|澤田智史{さわだのりふみSAWADANORIFUMI}|武田正之{たけだまさゆきTAKEDAMASAYUKI}|喜多村和郎{きたむらかずおKITAMURAKAZUO}|三井貴彦{みついたかひこMITSUITAKAHIKO}|千葉公嗣{ちばこうじCHIBAKOJI}|三宅秀明{みやけひであきMIYAKEHIDEAKI}|青井貴之{あおいたかしAOITAKASHI}____シンポジウム3若手基礎研究者Showcase企画____腎癌の多様性と精密医療実現に向けた層別化法の開発|ラード食による前立腺癌増悪における腸内細菌叢および腫瘍浸潤制御性T細胞の役割|大脳皮質における排尿関連細胞の神経活動を観察～個々の神経細胞の種類・経路・機能を検討～|ヒトiPS細胞由来Leydig様細胞の作製 (LOH症候群に対する再生医療を目指して)

SY3

シンポジウム3
若手基礎研究者Showcase企画

猪口淳一{いのくちじゅんいちINOKUCHIJUNICHI}____影山進{かげやますすむKAGEYAMASUSUMU}________教育講演2腎盂・尿管癌の診断と治療____腎盂・尿管癌の診断と治療

EL2

教育講演2
腎盂・尿管癌の診断と治療

加藤実{かとうみのるKATOMINORU}|早川望{はやかわのぞみHAYAKAWANOZOMI}|片山聡{かたやまさとしKATAYAMASATOSHI}|田岡利宜也{たおかりきやTAOKARIKIYA}____菊地栄次{きくちえいじKIKUCHIEIJI}|松井喜之{まついよしゆきMATSUIYOSHIYUKI}____内田潤次{うちだじゅんじUCHIDAJUNJI}|菊地栄次{きくちえいじKIKUCHIEIJI}|吉永香澄{よしながかすみYOSHINAGAKASUMI}|河田達志{かわだたつしKAWADATATSUSHI}|定平卓也{さだひらたくやSADAHIRATAKUYA}|富永悠介{とみながゆうすけTOMINAGAYUSUKE}|岩田健宏{いわたたけひろIWATATAKEHIRO}|西村慎吾{にしむらしんごNISHIMURASHINGO}|別宮謙介{べっくけんすけBEKKUKENSUKE}|小林知子{こばやしともこKOBAYASHITOMOKO}|枝村康平{えだむらこうへいEDAMURAKOHEI}|渡部昌美{わたなべまさみWATANABEMASAMI}|渡邉豊彦{わたなべとよひこWATANABETOYOHIKO}|荒木元朗{あらきもとおARAKIMOTOO}|杉元幹史{すぎもとみきおSUGIMOTOMIKIO}____シンポジウム4新時代を迎えた転移性尿路上皮がん治療____転移性尿路上皮癌治療におけるバイオマーカーの理想と現実|免疫チェックポイント阻害薬による併用療法, "光と影"|UC subtype, "挫折と挑戦"|Next generation, "可能性と課題"

SY4

シンポジウム4
新時代を迎えた転移性尿路上皮がん治療

安部崇重{あべたかしげABETAKASHIGE}|大庭康司郎{おおばこうじろうOHBAKOJIRO}|髙木敏男{たかぎとしおTAKAGITOSHIO}|内藤整{ないとうせいNAITOSEI}____小原航{おばらわたるOBARAWATARU}|伊藤敬一{いとうけいいちITOKEIICHI}____宮田遥{みやたはるかMIYATAHARUKA}|菊地央{きくちひろしKIKUCHIHIROSHI}|松本隆児{まつもとりゅうじMATSUMOTORYUJI}|大澤崇宏{おおさわたかひろOSAWATAKAHIRO}|光成健輔{みつなりけんすけMITSUNARIKENSUKE}|松尾朋博{まつおともひろMATSUOTOMOHIRO}|望月保志{もちづきやすしMOCHIZUKIYASUSHI}|今村亮一{いまむらりょういちIMAMURARYOICHI}____シンポジウム5IO時代の転移性腎がんに対する外科治療の役割____IO時代のCytoreductive Nephrectomy (CN)の意義と課題(特に即時CNについて)|IO時代のCNの意義と課題（特にdeferred CN）|IO時代の腎癌ロボット支援手術を安全に行うための注意点|IO時代の転移巣切除の意義と課題

SY5

シンポジウム5
IO時代の転移性腎がんに対する外科治療の役割

宮居弘輔{みやいこうすけMIYAIKOSUKE}____大野芳正{おおのよしおONOYOSHIO}________教育講演3精巣腫瘍の病理学 -WHO2022のupdateとその先に向けて-____精巣腫瘍の病理学 -WHO2022のupdateとその先に向けて-

EL3

教育講演3
精巣腫瘍の病理学 -WHO2022のupdateとその先に向けて-

川村正隆{かわむらまさたかKAWAMURAMASATAKA}|松川明弘{まつかわあきひろMATSUKAWAAKIHIRO}|嘉島相輝{かしまそうきKASHIMASOKI}|水野桂{みずのけいMIZUNOKEI}____藤田和利{ふじたかずとしFUJITAKAZUTOSHI}|釜井隆男{かまいたかおKAMAITAKAO}____森啓一郎{もりけいいちろうMORIKEIICHIRO}|柳澤孝文{やなぎさわたかふみYANAGISAWATAKAFUMI}|木村章嗣{きむらしょうじKIMURASHOJI}|三木淳{みきじゅんMIKIJUN}|木村高弘{きむらたかひろKIMURATAKAHIRO}____シンポジウム6私の留学体験記____カナダ・トロントでの研究留学:腎移植保存技術の新たな可能性を求めて|ウィーン留学の経験|米国・コネチカット州・イェール大学への留学 ―腎がん免疫研究に魅せられて―|私のボストン留学体験記

SY6

シンポジウム6
私の留学体験記

宮嶋哲{みやじまあきらMIYAJIMAAKIRA}____羽渕友則{はぶちとものりHABUCHITOMONORI}________教育講演4ロボット支援手術における医療安全、その傾向と対策____ロボット支援手術における医療安全、その傾向と対策

EL4

教育講演4
ロボット支援手術における医療安全、その傾向と対策

濵本周造{はまもとしゅうぞうHAMAMOTOSHUZO}|眞﨑拓朗{まさきたくろうMASAKITAKUROU}|柿木寛明{かきのきひろあきKAKINOKIHIROAKI}|多武保光宏{たんぼみつひろTAMBOMITSUHIRO}|八木澤隆史{やぎさわたかふみYAGISAWATAKAFUMI}|塩崎啓登{しおざきけいとSHIOZAKIKEITO}|増田朋子{ますだともこMASUDATOMOKO}|井上貴昭{いのうえたかあきINOUETAKAAKI}|出口龍良{でぐちりゅうすけDEGUCHIRYUSUKE}____市川智彦{いちかわともひこICHIKAWATOMOHIKO}|山口聡{やまぐちさとしYAMAGUCHISATOSHI}____田口和己{たぐちかずみTAGUCHIKAZUMI}|岡田淳志{おかだあつしOKADAATSUSHI}|安井孝周{やすいたかひろYASUITAKAHIRO}|宮﨑薫{みやざきかおるMIYAZAKIKAORU}|志賀健一郎{しがけんいちろうSHIGAKEN-ICHIRO}|阿部立郎{あべたつろうABETATSUROU}|木田和貴{きだかずたかKIDAKAZUTAKA}|井上裕之{いのうえひろゆきINOUEHIROYUKI}|内藤誠二{ないとうせいじNAITOSEIJI}|横溝晃{よこみぞあきらYOKOMIZOAKIRA}|岡野圭剛{おかのよしたけOKANOYOSHITAKE}|上野志穂{うえのしほUENOSHIHO}|須永風由子{すながふゆこSUNAGAFUYUKO}|坂本貴優{さかもとたかまさSAKAMOTOTAKAMASA}|紀伊寿彦{きいとしひこKIITOSHIHIKO}|鮫島未央{さめじまみおSAMEJIMAMIO}|北村盾二{きたむらじゅんじKITAMURAJUNJI}|宮川仁平{みやかわじんぺいMIYAKAWAJIMPEI}|中村雄{なかむらゆうNAKAMURAYU}|金城真実{きんじょうまなみKINJOMANAMI}|福原浩{ふくはらひろしFUKUHARAHIROSHI}|井崎博文{いざきひろふみIZAKIHIROFUMI}|古川順也{ふるかわじゅんやFURUKAWAJUNYA}|中村耀{なかむらようNAKAMURAYO}|古谷圭識{ふるやよしつねFURUYAYOSHITSUNE}|堀真衣{ほりまいHORIMAI}|依田憲治{よだけんじYODAKENZI}|松島常{まつしまひさしMATSUSHIMAHISASHI}|久米春喜{くめはるきKUMEHARUKI}|丸山容平{まるやまようへいMARUYAMAYOHEI}|山下真平{やましたしんぺいYAMASHITASHIMPEI}|柑本康夫{こうじもとやすおKOHJIMOTOYASUO}|原勲{はらいさおHARAISAO}|鈴木淳史{すずきあつしSUZUKIATSUSHI}____シンポジウム7尿路結石症の低侵襲治療____全国調査から考えるECIRSの現状|PCNLの実際と臨床評価|PNLを安全に行うためのプランニングと術前評価|吸引アクセスシースを利用したMini-PCNLの実際|TUL～硬性鏡でのアプローチ|TULの合併症とその対策|尿路結石症の低侵襲治療～シングルユース軟性尿管鏡|Hybrid fTUL with Flexible and Navigable Suction UAS|ESWLの現状とその適応

SY7

シンポジウム7
尿路結石症の低侵襲治療

MasahikoIsogai{ISOGAIMASAHIKO}|ReiUnno{UNNOREI}|RyosukeChaya{CHAYARYOSUKE}|ShintaroMori{MORISHINTARO}|KenWakai{WAKAIKEN}|TakahiroYanase{YANASETAKAHIRO}|KenjiZennami{ZENNAMIKENJI}|NaokiFujita{FUJITANAOKI}|TakehiroHanazawa{HANAZAWATAKEHIRO}|YoshitsuguNasu{NASUYOSHITSUGU}____KatsuhitoMiyazawa{MIYAZAWAKATSUHITO}____ShuzoHamamoto{HAMAMOTOSHUZO}|KoeiTorii{TORIIKOEI}|KengoKawase{KAWASEKENGO}|ReiUnno{UNNOREI}|RyosukeAndo{ANDORYOSUKE}|AtsushiOkada{OKADAATSUSHI}|TakahiroYasui{YASUITAKAHIRO}|HeikoYang{YANGHEIKO}|KazumiTaguchi{TAGUCHIKAZUMI}|ThomasChi{CHITHOMAS}|FranklinHuang{HUANGFRANKLIN}|YasuhitoSue{SUEYASUHITO}|TakahiroYanase{YANASETAKAHIRO}|TatsuyaHattori{HATTORITATSUYA}|NamiTomiyama{TOMIYAMANAMI}|MasatakaAzemoto{AZEMOTOMASATAKA}|AkihiroNakane{NAKANEAKIHIRO}|YukinoriOkada{OKADAYUKINORI}|TomohiroMatsuo{MATSUOTOMOHIRO}|ShotaKakita{KAKITASHOTA}|HiroyukiHonda{HONDAHIROYUKI}|KyoheiAraki{ARAKIKYOHEI}|KensukeMitsunari{MITSUNARIKENSUKE}|KojiroOhba{OHBAKOJIRO}|YasushiMochizuki{MOCHIZUKIYASUSHI}|RyoichiImamura{IMAMURARYOICHI}|YusukeOnoda{ONODAYUSUKE}|RieTajiri{TAJIRIRIE}|ShoutaOhki{OHKISHOUTA}|KazuhikoAzuma{AZUMAKAZUHIKO}|HirotoKato{KATOHIROTO}|SanaeIkehara{IKEHARASANAE}|YusukeGoto{GOTOYUSUKE}|KyokushinHou{HOUKYOKUSHIN}|ShinichiSakamoto{SAKAMOTOSHINICHI}|KazuhiroAraki{ARAKIKAZUHIRO}|YukioNaya{NAYAYUKIO}|TomohikoIchikawa{ICHIKAWATOMOHIKO}|YuzuruIkehara{IKEHARAYUZURU}|HuangMing{MINGHUANG}|RyosukeChaya{CHAYARYOSUKE}|YuyaSasaki{SASAKIYUYA}|MihokoMaruyama{MARUYAMAMIHOKO}|NoriyasuKawai{KAWAINORIYASU}|TakuhisaNukaya{NUKAYATAKUHISA}|KiyohitoIshikawa{ISHIKAWAKIYOHITO}|TomozawaShuhei{SHUHEITOMOZAWA}|AkihiroKawai{KAWAIAKIHIRO}|WataruNakamura{NAKAMURAWATARU}|YoshinariMuto{MUTOYOSHINARI}|MasanobuSaruta{SARUTAMASANOBU}|TomonariMotonaga{MOTONAGATOMONARI}|MasashiTakenaka{TAKENAKAMASASHI}|KiyoshiTakahara{TAKAHARAKIYOSHI}|MamoruKusaka{KUSAKAMAMORU}|RyoichiShiroki{SHIROKIRYOICHI}|TohruYoneyama{YONEYAMATOHRU}|YukiTobisawa{TOBISAWAYUKI}|MasakiMomota{MOMOTAMASAKI}|HiroyukiIto{ITOHIROYUKI}|KazuakiYoshikawa{YOSHIKAWAKAZUAKI}|ShingoHatakeyama{HATAKEYAMASHINGO}|AkioHoriguchi{HORIGUCHIAKIO}|MasayukiShinchi{SHINCHIMASAYUKI}|KenichiroOjima{OJIMAKENICHIRO}|YuheiSegawa{SEGAWAYUHEI}|KeIto{ITOKE}|NorikoKosaka{KOSAKANORIKO}____総会賞ポスター01感染症・尿路結石症____Elucidation of the Mechanism of Kidney Stone Formation by Intestinal Bacterial Changes and Application of Probiotics for Prevention|Single nucleus RNA sequencing revealed the origins and characteristics of macrophages associated with Randall's plaques|Genetic Correlation and Mendelian Randomization Analysis of Urolithiasis and Related Phenotypes: Identification of Genetic Pathways of Urolithiasis|The psoas major muscle volume may predict systemic inflammatory response syndrome induced by pyelonephritis in patients with upper urinary tract stones|Elucidating the mechanism of ureteral stent occlusion using a new method of SEM analysis|Investigation of recurrence risk and development of a practical prediction model for postoperative kidney stone patients|The microbiota of the distal ileum under antibiotic prophylaxis: does fecal exposure during ICUD increase gastrointestinal complications?|Significance of immunoglobulin N-glycans in sepsis-induced disseminated intravascular coagulation|Safety of early discontinuation of antibiotics in anastomotic urethroplasty for bulbar urethral stricture: A preliminary single-center experience|Chronological trends of resistant E. coli isolated from community-acquired urinary tract infections

AOP-01

総会賞ポスター01
感染症・尿路結石症

髙橋聡{たかはしさとしTAKAHASHISATOSHI}|伊藤晋{いとうしんITOUSHIN}|重村克巳{しげむらかつみSHIGEMURAKATSUMI}|和田耕一郎{わだこういちろうWADAKOICHIRO}____濵砂良一{はますなりょういちHAMASUNARYOICHI}|石川清仁{いしかわきよひとISHIKAWAKIYOHITO}________シンポジウム8尿路性器感染症のガイドラインを読み解く____尿路性器感染症のガイドラインを読み解く～感染制御～|非淋菌性尿道炎の診療ガイドラインについて―M. genitaliumを中心に―|周術期感染予防ガイドライン|JAID/JSC感染症治療ガイド 2023を読み解く

SY8

シンポジウム8
尿路性器感染症のガイドラインを読み解く

山本新吾{やまもとしんごYAMAMOTOSHINGO}____宮﨑淳{みやざきじゅんMIYAZAKIJUN}________教育講演5泌尿器科領域における抗菌薬耐性(AMR)対策アクションプラン____泌尿器科領域における抗菌薬耐性(AMR)対策アクションプラン

EL5

教育講演5
泌尿器科領域における抗菌薬耐性(AMR)対策アクションプラン

小林加直{こばやしかなおKOBAYASHIKANAO}|桧山佳樹{ひやまよしきHIAYMAYOSHIKI}|東郷容和{とうごうよしかずTOGOYOSHIKAZU}|松本正広{まつもとまさひろMATSUMOTOMASAHIRO}____安田満{やすだみつるYASUDAMITSURU}|亀井潤{かめいじゅんKAMEIJUN}____西山直隆{にしやまなおたかNISHIYAMANAOTAKA}|北村寛{きたむらひろしKITAMURAHIROSHI}|吉岡慎平{よしおかしんぺいYOSHIOKASHIMPEI}|貝塚洋平{かいずかようへいKAIZUKAYOHEI}|長澤誠司{ながさわせいじNAGASAWASEIJI}|山本新吾{やまもとしんごYAMAMOTOSHINGO}____シンポジウム9あなたならどうする？重症尿路感染症____複雑性尿路感染症における原因菌の分離動向と耐性菌の現状|耐性菌に対する抗菌薬選択|ウロセプシスへの対応|あなたならどうする?細菌性前立腺炎

SY9

シンポジウム9
あなたならどうする？重症尿路感染症

YuKijima{KIJIMAYU}|ShotaFukae{FUKAESHOTA}|MitsuruSaitou{SAITOUMITSURU}|TaikiOgasa{OGASATAIKI}|KeiSakurabayashi{SAKURABAYASHIKEI}|MizukiHisano{HISANOMIZUKI}|MasayoshiOkumi{OKUMIMASAYOSHI}|TakehiroOhyama{OHYAMATAKEHIRO}|KeijiTakahashi{TAKAHASHIKEIJI}____RyoichiImamura{IMAMURARYOICHI}____ToshihitoHirai{HIRAITOSHIHITO}|KazuhiroIwadoh{IWADOHKAZUHIRO}|YasunoriNishimura{NISHIMURAYASUNORI}|HiroyukiHashimoto{HASHIMOTOHIROYUKI}|KoheiUnagami{UNAGAMIKOHEI}|TomokazuShimizu{SHIMIZUTOMOKAZU}|HidekiIshida{ISHIDAHIDEKI}|ToshioTakagi{TAKAGITOSHIO}|YokoHiga{HIGAYOKO}|SoichiMatsumura{MATSUMURASOICHI}|RyoTanaka{TANAKARYO}|ShigeakiNakazawa{NAKAZAWASHIGEAKI}|YoichiKakuta{KAKUTAYOICHI}|NorioNonomura{NONOMURANORIO}|NaoyaToriu{TORIUNAOYA}|RyoKamimatsuse{KAMIMATSUSERYO}|YukiKita{KITAYUKI}|RyoheiYamamoto{YAMAMOTORYOHEI}|YuyaSekine{SEKINEYUYA}|HoromiSato{SATOHOROMI}|MizukiKobayashi{KOBAYASHIMIZUKI}|KazuyukiNumakura{NUMAKURAKAZUYUKI}|ShintaroNarita{NARITASHINTARO}|TakashiKobayashi{KOBAYASHITAKASHI}|MotokoYanagita{YANAGITAMOTOKO}|TomonoriHabuchi{HABUCHITOMONORI}|YukiNakagawa{NAKAGAWAYUKI}|KentaIchino{ICHINOKENTA}|KatsuhitoYuzawa{YUZAWAKATSUHITO}|KeijiTakahashi{TAKAHASHIKEIJI}|MasayoshiNagata{NAGATAMASAYOSHI}|HisamitsuIde{IDEHISAMITSU}|ShunjiNarumi{NARUMISHUNJI}|YoshihikoWatarai{WATARAIYOSHIHIKO}|ShigeoHorie{HORIESHIGEO}|MasakiMuramatsu{MURAMATSUMASAKI}|TakeshiKawamura{KAWAMURATAKESHI}|YoshihiroItabashi{ITABASHIYOSHIHIRO}|YujiroAoki{AOKIYUJIRO}|TakashiYonekura{YONEKURATAKASHI}|MahoMaeda{MAEDAMAHO}|JunyaHashimoto{HASHIMOTOJUNYA}|HideyoOguchi{OGUCHIHIDEYO}|YukoHamasaki{HAMASAKIYUKO}|KenSakai{SAKAIKEN}|TakayaAbe{ABETAKAYA}|FumiakiTakahashi{TAKAHASHIFUMIAKI}|RenpeiKato{KATORENPEI}|ShigekatsuMaekawa{MAEKAWASHIGEKATSU}|RyoTakata{TAKATARYO}|JunSugimura{SUGIMURAJUN}|KozoTanno{TANNOKOZO}|ToshikazuAbe{ABETOSHIKAZU}|WataruObara{OBARAWATARU}|MasatsuguMiyashita{MIYASHITAMASATSUGU}|HidetoTaga{TAGAHIDETO}|YuutaInoue{INOUEYUUTA}|TakashiUeda{UEDATAKASHI}|KazumiKomaki{KOMAKIKAZUMI}|KeiichiTamagaki{TAMAGAKIKEIICHI}|FumiyaHongo{HONGOFUMIYA}|OsamuUkimura{UKIMURAOSAMU}|ShoNishida{NISHIDASHO}|KyoukoMinamisono{MINAMISONOKYOUKO}|ToshimasaNakao{NAKAOTOSHIMASA}|KimihikoMoriya{MORIYAKIMIHIKO}|DaikiIwami{IWAMIDAIKI}|HarunaKawano{KAWANOHARUNA}|MaiYamazaki{YAMAZAKIMAI}|TomokiKimura{KIMURATOMOKI}|MihoMiyoshi{MIYOSHIMIHO}|HidetakaEguchi{EGUCHIHIDETAKA}|YasushiOkazaki{OKAZAKIYASUSHI}|SatoruMutou{MUTOUSATORU}____総会賞ポスター02腎不全・腎移植____Optimization of a model for predicting renal function after living kidney transplantation using CT volumetry|Analysis of genotypes and protein expression in BK polyomavirus nephropathy after kidney transplantation|Steroid Pulse Therapy for the Kidney Transplant Recipients with Advanced Tertiary Lymphoid Tissue in the Renal Graft|Application of CT imaging analysis technology in kidney transplantation|Verification of Herpes Zoster in renal transplant patients in single-center study|The evaluation of indoxyl sulfate in the general population in Kanegasaki Iwate|Excellent outcomes of 3-month allograft biopsy in flow crossmatch-positive living donor kidney transplant recipients treated with desensitization therapy|Three cases of ureteral stenosis requiring surgical repair after kidney transplantation|Genetic traits of intracranial aneurysm associated with autosomal dominant polycystic kidney disease

AOP-02

総会賞ポスター02
腎不全・腎移植

込山元清{こみやまもときよKOMIYAMAMOTOKIYO}|横山幸浩{よこやまゆきひろYOKOYAMAYUKIHIRO}|中村元信{なかむらもとのぶNAKAMURAMOTONOBU}|安藤正志{あんどうまさしANDOMASASHI}|曽根美雪{そねみゆきSONEMIYUKI}____西村和郎{にしむらかずおNISHIMURAKAZUO}|木下秀文{きのしたひでふみKINOSHITAHIDEFUMI}________シンポジウム10後腹膜肉腫のトータルマネージメント____後腹膜肉腫の治療・疾患に対する特徴的アプローチとそのためのトータルマネージメント。|後腹膜肉腫に対する診療科横断的外科治療 名古屋大学希少がんセンターでの取り組み|九州がんセンターにおける後腹膜肉腫診療体制|後腹膜肉腫に対する薬物療法|後腹膜腫瘍のIVR -IVRで何ができるのか-

SY10

シンポジウム10
後腹膜肉腫のトータルマネージメント

竹越一博{たけこしかずひろTAKEKOSHIKAZUHIRO}____井川掌{いがわつかさIGAWATSUKASA}____與那嶺正人{よなみねまさとYONAMINEMASATO}____教育講演6本邦における褐色細胞腫・パラガングリオーマ(pheochrmocytoma/ paraganglioma;PPGL)の遺伝子診断の現状と展望____本邦における褐色細胞腫・パラガングリオーマ(pheochrmocytoma/ paraganglioma; PPGL)の遺伝子診断の現状と展望

EL6

教育講演6
本邦における褐色細胞腫・パラガングリオーマ(pheochrmocytoma/ paraganglioma;PPGL)の遺伝子診断の現状と展望

滝澤奈恵{たきざわなえTAKIZAWANAE}|今村有佑{いまむらゆうすけIMAMURAYUSUKE}|武田利和{たけだとしかずTAKEDATOSHIKAZU}|川崎芳英{かわさきよしひでKAWASAKIYOSHIHIDE}____井川掌{いがわつかさIGAWATSUKASA}|伊藤明宏{いとうあきひろITOAKIHIRO}____木下秀文{きのしたひでふみKINOSHITAHIDEFUMI}|坂本信一{さかもとしんいちSAKAMOTOSHINICHI}|雨宮佑樹{あめみやゆうきAMEMIYAYUUKI}|木下陽介{きのしたようすけKINOSHITAYOUSUKE}|嶋田陽葵{しまだひろきSHIMADAHIROKI}|柴田裕貴{しばたひろきSHIBATAHIROKI}|佐藤航大{さとうこうだいSATOKOUDAI}|山田康隆{やまだやすたかYAMADAYASUTAKA}|佐塚智和{さずかともかずSAZUKATOMOKAZU}|市川智彦{いちかわともひこICHIKAWATOMOHIKO}|大家基嗣{おおやもとつぐOYAMOTOTSUGU}|手塚雄太{てづかゆうたTEZUKAYUTA}|小野美澄{おのよしきよONOYOSHIKIYO}|大石久{おおいしひさしOISHIHISASHI}|高橋紀善{たかはしのりよしTAKAHASHINORIYOSHI}|佐藤友紀{さとうとものりSATOTOMONORI}|方山博路{かたやまひろみちKATAYAMAHIROMICHI}|佐竹洋平{さたけようへいSATAKEYOHEI}|佐藤琢磨{さとうたくまSATOTAKUMA}|川守田直樹{かわもりたなおきKAWAMORITANAOKI}|神宮啓一{じんぐうけいいちJINGUKEIICHI}|片桐秀樹{かたぎりひできKATAGIRIHIDEKI}|伊藤明宏{いとうあきひろITOAKIHIRO}____ワークショップ1副腎外科：高難度症例に挑む____複雑な背景を伴う副腎腫瘍に対する腫瘍学的転帰と外科的転帰を考慮した術式選択|副腎腫瘍に対する後腹膜アプローチによる手術;適応はどこまで?|腹腔鏡下副腎部分切除術の高難易度症例|褐色細胞腫における高難度手術と周術期管理

WS1

ワークショップ1
副腎外科：高難度症例に挑む

KoichiOshima{OSHIMAKOICHI}|YoSatoji{SATOJIYO}|YuichiSato{SATOYUICHI}|－|TakuyaSakata{SAKATATAKUYA}|DaisukeMatsumoto{MATSUMOTODAISUKE}|ShunIwasa{IWASASHUN}|YukiNakamura{NAKAMURAYUKI}|AkioHoriguchi{HORIGUCHIAKIO}|SatoshiYazawa{YAZAWASATOSHI}____MitsuruNoguchi{NOGUCHIMITSURU}____ToekiYanagi{YANAGITOEKI}|YutoMori{MORIYUTO}|YurinaFujimori{FUJIMORIYURINA}|KazukiKokura{KOKURAKAZUKI}|KojiShigesaka{SHIGESAKAKOJI}|MotohiroTaguchi{TAGUCHIMOTOHIRO}|YasuhiroShinkai{SHINKAIYASUHIRO}|YusukeYamada{YAMADAYUSUKE}|ShukenGo{GOSHUKEN}|AkihiroKanematsu{KANEMATSUAKIHIRO}|ShingoYamamoto{YAMAMOTOSHINGO}|DaikiTanaka{TANAKADAIKI}|SeiichiroTominaga{TOMINAGASEIICHIRO}|TomohiroKuwahara{KUWAHARATOMOHIRO}|KenjiOmae{OMAEKENJI}|JyunyaHata{HATAJYUNYA}|SoichiroOgawa{OGAWASOICHIRO}|NoboruOyachi{OYACHINOBORU}|HideakiTanaka{TANAKAHIDEAKI}|TakayukiIdaka{IDAKATAKAYUKI}|TetsuoIshikawa{ISHIKAWATETSUO}|TakahikoMitsui{MITSUITAKAHIKO}|SusumuYokoya{YOKOYASUSUMU}|NoriakiKurita{KURITANORIAKI}|HitoshiOhto{OHTOHITOSHI}|YoshiyukiKojima{KOJIMAYOSHIYUKI}|KentaroMizuno{MIZUNOKENTARO}|RyoheiAzuma{AZUMARYOHEI}|HidenoriNishio{NISHIOHIDENORI}|HidekiHonma{HONMAHIDEKI}|TakahiroYasui{YASUITAKAHIRO}|YutaroHayashi{HAYASHIYUTARO}|YukihiroUmemoto{UMEMOTOYUKIHIRO}|TetsujiMaruyama{MARUYAMATETSUJI}|HiroshiAsanuma{ASANUMAHIROSHI}|MizukiIzawa{IZAWAMIZUKI}|YoshiakiIshizuka{ISHIZUKAYOSHIAKI}|AtsukoSato{SATOATSUKO}|HiroyukiSatoh{SATOHHIROYUKI}|MototsuguOya{OYAMOTOTSUGU}|MasanoriMurakami{MURAKAMIMASANORI}|ShunyaMatsumoto{MATSUMOTOSHUNYA}|MasakiKobayashi{KOBAYASHIMASAKI}|YudaiIshikawa{ISHIKAWAYUDAI}|HiroshiFukushima{FUKUSHIMAHIROSHI}|ShoheiFukuda{FUKUDASHOHEI}|YumaWaseda{WASEDAYUMA}|HajimeTanaka{TANAKAHAJIME}|SoichiroYoshida{YOSHIDASOICHIRO}|TetsuyaYamada{YAMADATETSUYA}|YasuhisaFujii{FUJIIYASUHISA}|HiromiEdo{EDOHIROMI}|MasayukiShinchi{SHINCHIMASAYUKI}|KenichiroOjima{OJIMAKENICHIRO}|YuheiSegawa{SEGAWAYUHEI}|KeiichiIto{ITOKEIICHI}|HiroshiShinmoto{SHINMOTOHIROSHI}|YosukeNakajima{NAKAJIMAYOSUKE}|SatoshiSato{SATOSATOSHI}____総会賞ポスター03小児泌尿器科・その他____What we learned from patients with neourethral stricture in adulhood after childhood hypospadias repair|Validation of the new questionnaire for measuring the transition readiness of children who require clean intermittent catheterization|Cryptorchidism after the Fukushima Daiichi Nuclear Power Plant accident -true or false?|演題取り下げ|Determine the cause of childhood hypogonadism in boys with Prader-Willi syndrome|Germ cell count in retractile testis is maintained with advancing age|Utility of ureteral jet angle by color Doppler ultrasound on predicting the development of urinary tract infection and improvement of vesicoureteral reflux|Prolonged asymptomatic hypoglycemia after resection of pheochromocytoma: a prospective study using intermittent-scanning continuous glucose monitoring|Internal validation of the pubo-urethral stump angle as a predictor for the complexity of anastomotic urethroplasty in pelvic fracture urethral injury|Advance Care Planning and Home Palliative Care for Patients with Advanced Prostate Cancer

AOP-03

総会賞ポスター03
小児泌尿器科・その他

HohyunLee{LEEHOHYUN}|RyutaSobu{SOBURYUTA}|YoheiOkuda{OKUDAYOHEI}|MaisySong{SONGMAISY}|－|ShuujiIsotani{ISOTANISHUUJI}|Chia-ChihHsieh{HSIEHCHIA-CHIH}|MasanaoShinohara{SHINOHARAMASANAO}|JuleneOng{ONGJULENE}____ToshioTakagi{TAKAGITOSHIO}|See-TongPang{PangSee-Tong}____HoyoungBae{BAEHOYOUNG}|SangjunYoo{YOOSANGJUN}|MinChulCho{CHOMINCHUL}|HwancheolSon{SONHWANCHEOL}|HyeonJeong{JEONGHYEON}|JunghoonLee{LEEJUNGHOON}|KashimaSoki{SOKIKASHIMA}|NobuhiroFujiyama{FUJIYAMANOBUHIRO}|HiroshiHamana{HAMANAHIROSHI}|MasashiTakeda{TAKEDAMASASHI}|MituruSaito{SAITOMITURU}|ShintaroNarita{NARITASHINTARO}|HiroshiNanjo{NANJOHIROSHI}|TakamituInoue{INOUETAKAMITU}|KishiHiroyuki{HIROYUKIKISHI}|ShusukeAkamatsu{AKAMATSUSHUSUKE}|TakashiKobayashi{KOBAYASHITAKASHI}|TomonoriHabuchi{HABUCHITOMONORI}|TaigoKato{KATOTAIGO}|ShunsukeInoguchi{INOGUCHISHUNSUKE}|AkihiroYoshimura{YOSHIMURAAKIHIRO}|ToshikiOka{OKATOSHIKI}|GakuYamamichi{YAMAMICHIGAKU}|YuIshizuya{ISHIZUYAYU}|TakujiHayashi{HAYASHITAKUJI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|KojiHatano{HATANOKOJI}|AtsunariKawashima{KAWASHIMAATSUNARI}|JunkoMurai{MURAIJUNKO}|NorioNonomura{NONOMURANORIO}|DongrulShin{SHINDONGRUL}|JungyoSuh{SUHJUNGYO}|CherynSong{SONGCHERYN}|YasunoriTanaka{TANAKAYASUNORI}|OsamuMito{MITOOSAMU}|TomokiKimura{KIMURATOMOKI}|TaikiOgasa{OGASATAIKI}|TakuroKobayashi{KOBAYASHITAKURO}|IppeiHiramatsu{HIRAMATSUIPPEI}|TakeshiIeda{IEDATAKESHI}|ToshiyukiChina{CHINATOSHIYUKI}|MasayoshiNagata{NAGATAMASAYOSHI}|YukiNakagawa{NAKAGAWAYUKI}|HisamitsuIde{IDEHISAMITSU}|ShigeoHorie{HORIESHIGEO}|Wen-HsinTseng{TSENGWEN-HSIN}|Chien-LiangLiu{LIUCHIEN-LIANG}|StevenK.Huang{HUANGSTEVENK.}|AllenW.Chiu{CHIUALLENW.}|NaokiFuzita{FUZITANAOKI}|YouheiKawashima{KAWASHIMAYOUHEI}|SatoshiSato{SATOSATOSHI}|KazuyukiNumakura{NUMAKURAKAZUYUKI}|YuyaSekine{SEKINEYUYA}|ShingoHatakeyama{HATAKEYAMASHINGO}|ValerieHlGan{GANVALERIEHL}|EdwinJAslim{ASLIMEDWINJ}|ReneGastinga{GASTINGARENE}|LayGuatNg{NGLAYGUAT}|EeJeanLim{LIMEEJEAN}____Selected Oral 5Renal tumors and kidney transplantation____Effect of EphA2 silencing on inhibiting the progression of renal cell carcinoma in an orthotopic mouse model|Comprehensive immune phenotyping for biomarkers of immunotherapy efficacy and novel IL-8-targeted combined therapy in a next-generation renal cancer PDX model|SLFN11 polarizes macrophages to M1 phenotype within the renal cell carcinoma microenvironment and contributes to the efficacy of immune checkpoint inhibitors|Prediction Modeling of Outcome according to Surgical Method for T1 Renal Tumors using Machine Learning Algorithms|演題取り下げ|Renal functional outcomes in robot-assisted partial nephrectomy using minimum layer resection method with virtual 3D partial nephrectomy image assistance|A Rare Subtype of Renal Cell Carcinoma: MiT Family Translocation Renal Cell Carcinoma - A Single-center Experience and Case Series|IO-IO vs. IO-TKI: which is better for patients with advanced or metastatic renal cell carcinoma: Outcomes of combination immunotherapy in real world practice|What do you know about renal transplantation in Singapore?: A pilot survey-based questionnaire assessing knowledge and perceptions amongst the public|Withdrawn

SO-5

Selected Oral 5
Renal tumors and kidney transplantation

MasashiKubota{KUBOTAMASASHI}|TakeshiNamekawa{NAMEKAWATAKESHI}|MitsuoOkada{OKADAMITSUO}|MasakazuAbe{ABEMASAKAZU}|TakutoOgasawara{OGASAWARATAKUTO}____KojiHatano{HATANOKOJI}____SatomiYoshida{YOSHIDASATOMI}|TakayukiSumiyoshi{SUMIYOSHITAKAYUKI}|RyomaKurahashi{KURAHASHIRYOMA}|KimihiroShimatani{SHIMATANIKIMIHIRO}|YuyaSekine{SEKINEYUYA}|AtsuroSawada{SAWADAATSURO}|HiromitsuNegoro{NEGOROHIROMITSU}|RyoichiSaito{SAITORYOICHI}|ShusukeAkamatsu{AKAMATSUSHUSUKE}|KojiKawakami{KAWAKAMIKOJI}|TakashiKobayashi{KOBAYASHITAKASHI}|TakayukiGoto{GOTOTAKAYUKI}|MartinGleave{GLEAVEMARTIN}|AdrianIon-Margineanu{ION-MARGINEANUADRIAN}|MingyuSheng{SHENGMINGYU}|ChristianFreudiger{FREUDIGERCHRISTIAN}|SamirS.Taneja{TANEJASAMIRS.}|MilesP.Mannas{MANNASMILESP.}|MasayukiTakehara{TAKEHARAMASAYUKI}|KoukichiMurakami{MURAKAMIKOUKICHI}|TakahiroAdachi{ADACHITAKAHIRO}|GouNagao{NAGAOGOU}|TakeshiKashima{KASHIMATAKESHI}|YousukeHirasawa{HIRASAWAYOUSUKE}|NaoyaSatake{SATAKENAOYA}|KenjirouHayashi{HAYASHIKENJIROU}|ToshihideShishido{SHISHIDOTOSHIHIDE}|YoshioOhno{OHNOYOSHIO}|YouichiAraki{ARAKIYOUICHI}|KazuhiroSaitou{SAITOUKAZUHIRO}|ShigekatsuMaekawa{MAEKAWASHIGEKATSU}|ShinjiTamada{TAMADASHINJI}|YutaGoto{GOTOYUTA}|DaichiTamura{TAMURADAICHI}|RenpeiKato{KATORENPEI}|RyoTakata{TAKATARYO}|UjiieTakashi{TAKASHIUJIIE}|WataruObara{OBARAWATARU}|KoheiHashimoto{HASHIMOTOKOHEI}|TetsuyaShindo{SHINDOTETSUYA}|YukiKyoda{KYODAYUKI}|KoKobayashi{KOBAYASHIKO}|ToshiakiTanaka{TANAKATOSHIAKI}|NaoyaMasumori{MASUMORINAOYA}____一般口演006前立腺腫瘍／診断・マーカー①____Changes of risk stratification by incorporating multiparametric MRI into T staging in high-risk localized prostate cancer: A population-based scenario analysis|Stimulated Raman histology and artificial intelligence provide near real-time prostate cancer diagnosis from MRI targeted prostate biopsies|Development of color map using MRI apparent diffusion coefficients and their usefulness in MRI-transrectal ultrasound fusion imaging biopsy|MRI findings and cancer detection rates in patients with multiple prostate biopsies|The oncological impact of treatment modalities based on PI-RADs category in highor very high risk prostate cancer

OP-006

一般口演006
前立腺腫瘍／診断・マーカー①

GoNagao{NAGAOGO}|MasayukiAkai{AKAIMASAYUKI}|TomoyaYamasaki{YAMASAKITOMOYA}|MikiNaito{NAITOMIKI}|HikaruMikami{MIKAMIHIKARU}____AtsukoFujihara{FUJIHARAATSUKO}____YosukeHirasawa{HIRASAWAYOSUKE}|ShunsukeAsada{ASADASHUNSUKE}|HirokiOgura{OGURAHIROKI}|AyuNohara{NOHARAAYU}|YutaNakamori{NAKAMORIYUTA}|TakeshiKashima{KASHIMATAKESHI}|TakeshiHahimoto{HAHIMOTOTAKESHI}|KenjiroHayashi{HAYASHIKENJIRO}|NaoyaSatake{SATAKENAOYA}|ToshihideShishido{SHISHIDOTOSHIHIDE}|KazuhiroSaito{SAITOKAZUHIRO}|YoshioOhno{OHNOYOSHIO}|KazuyaTozawa{TOZAWAKAZUYA}|TatumiSekiya{SEKIYATATUMI}|MituoOkada{OKADAMITUO}|GoNagao{NAGAOGO}|SumireSanto{SANTOSUMIRE}|JunyaHara{HARAJUNYA}|TakuyaHagiwara{HAGIWARATAKUYA}|HakaruMasumoto{MASUMOTOHAKARU}|YujiYata{YATAYUJI}|TomohiroHongo{HONGOTOMOHIRO}|KeiFujio{FUJIOKEI}|OtsukiHideo{HIDEOOTSUKI}|KyosukeIwane{IWANEKYOSUKE}|RyoTasaka{TASAKARYO}|YukiKohada{KOHADAYUKI}|KenshiroTakemoto{TAKEMOTOKENSHIRO}|ShunsukeMiyamoto{MIYAMOTOSHUNSUKE}|KoheiKobatake{KOBATAKEKOHEI}|YoheiSekino{SEKINOYOHEI}|HiroyukiKitano{KITANOHIROYUKI}|KeisukeGoto{GOTOKEISUKE}|AkihiroGoriki{GORIKIAKIHIRO}|KeisukeHieda{HIEDAKEISUKE}|HinataNibuyuki{NIBUYUKIHINATA}|SyunyaNoguchi{NOGUCHISYUNYA}|JunAkatsuka{AKATSUKAJUN}|HiroyaHasegawa{HASEGAWAHIROYA}|KotaroObayashi{OBAYASHIKOTARO}|HayatoTakeda{TAKEDAHAYATO}|YukiEndo{ENDOYUKI}|YukaToyama{TOYAMAYUKA}|GoKimura{KIMURAGO}|ToshihiroTakizawa{TAKIZAWATOSHIHIRO}|YukihiroKondo{KONDOYUKIHIRO}____一般口演007前立腺腫瘍／診断・マーカー②____Impact of local invasion of prostate cancer on oncologic outcomes: A comparison between preoperative MRI and prostatectomy pathology|A study of apparent diffusion coefficient in MRI before and after endocrine treatment for prostate cancer|Comparative study of transperineal and transrectal prostate biopsy for the results of needle biopsy and the localization of prostate cancer in RARP specimens|Factors Associated with Upgrading to pT3 in cT1 or cT2 Prostate Cancer|snRNAs from radical prostatectomy specimens have the potential to serve as prognostic factors for clinical recurrence after biochemical recurrence

OP-007

一般口演007
前立腺腫瘍／診断・マーカー②

KazuhikoOshinomi{OSHINOMIKAZUHIKO}|YoshitakaSekine{SEKINEYOSHITAKA}|HiroshiYaegashi{YAEGASHIHIROSHI}|YukaToyama{TOYAMAYUKA}|KazutoIto{ITOKAZUTO}____ShingoHatakeyama{HATAKEYAMASHINGO}____SatoshiAsakura{ASAKURASATOSHI}|YokoSeki{SEKIYOKO}|AtsushiMiyama{MIYAMAATSUSHI}|HirohikoWatanabe{WATANABEHIROHIKO}|ShotaKikuchi{KIKUCHISHOTA}|HirotakaKishi{KISHIHIROTAKA}|ShoOkada{OKADASHO}|MasahiroKurokawa{KUROKAWAMASAHIRO}|ToshikiMugita{MUGITATOSHIKI}|YoshihiroNakagami{NAKAGAMIYOSHIHIRO}|MasakazuNagata{NAGATAMASAKAZU}|TakashiFukagai{FUKAGAITAKASHI}|YujiFujizuka{FUJIZUKAYUJI}|SyunNakazawa{NAKAZAWASYUN}|YusukeTsuji{TSUJIYUSUKE}|AkiraOhtsu{OHTSUAKIRA}|YoshiyukiMiyazawa{MIYAZAWAYOSHIYUKI}|SeijiArai{ARAISEIJI}|MasashiNomura{NOMURAMASASHI}|HidekazuKoike{KOIKEHIDEKAZU}|HiroshiMatsui{MATSUIHIROSHI}|KeiShibuya{SHIBUYAKEI}|KazutoIto{ITOKAZUTO}|KazuhiroSuzuki{SUZUKIKAZUHIRO}|AtsushiMizokami{MIZOKAMIATSUSHI}|KazufumiNakashima{NAKASHIMAKAZUFUMI}|SotaroMiw{MIWSOTARO}|TohruMiyagi{MIYAGITOHRU}|MitsuhiroTakashima{TAKASHIMAMITSUHIRO}|TakayoshiKoura{KOURATAKAYOSHI}|KyosukeKaji{KAJIKYOSUKE}|GoKimura{KIMURAGO}|JunAkatsuka{AKATSUKAJUN}|EndoYuki{YUKIENDO}|TakedaHayato{HAYATOTAKEDA}|ObayashiKotaro{KOTAROOBAYASHI}|MikamiHikaru{HIKARUMIKAMI}|FunatoRyota{RYOTAFUNATO}|TakadateMami{MAMITAKADATE}|InoueHonami{HONAMIINOUE}|KondoYukihiro{YUKIHIROKONDO}|RyoOki{OKIRYO}|TomohiroMagari{MAGARITOMOHIRO}|YosukeFuruya{FURUYAYOSUKE}|KazumasaFukuda{FUKUDAKAZUMASA}|HaruyukiOgura{OGURAHARUYUKI}|IsaoKurosawa{KUROSAWAISAO}|YasushiKaji{KAJIYASUSHI}____一般口演008前立腺腫瘍／診断・マーカー③____Does Prostate health index (phi) contribute to the detection of significant prostate cancer in patients with negative MRI findings?|Utility of "phi (prostate health index) first approach" as flowchart of diagnosing prostate cancer in patients with PSA below 10 ng/mL|Usefulness of the Prostate Health Index in detecting clinically significant prostate cancer in a prostate cancer screening system|The role of the [-2] proPSA-related index in zone-specific detection of prostate cancer|A diagnostic significance of prostate health index (phi)-MRI sequence flow in patients with PSA below 10 ng/ml

OP-008

一般口演008
前立腺腫瘍／診断・マーカー③

HiroyukiInoue{INOUEHIROYUKI}|MasayaIto{ITOMASAYA}|ToshifumiTakahashi{TAKAHASHITOSHIFUMI}|HiroshiShimura{SHIMURAHIROSHI}|－____KazutoIto{ITOKAZUTO}____KazutakaKida{KIDAKAZUTAKA}|YasuhiroNakano{NAKANOYASUHIRO}|MakotoMiyoshi{MIYOSHIMAKOTO}|TashuroAbe{ABETASHURO}|SachikoIchikura{ICHIKURASACHIKO}|KenichiroShiga{SHIGAKENICHIRO}|TakuroMasaki{MASAKITAKURO}|ManamiAishima{AISHIMAMANAMI}|KaoruMiyazaki{MIYAZAKIKAORU}|MineoTakei{TAKEIMINEO}|SeijiNaito{NAITOSEIJI}|AkiraYokomizo{YOKOMIZOAKIRA}|IchiroYonese{YONESEICHIRO}|TakahikoSoma{SOMATAKAHIKO}|MasahiroToide{TOIDEMASAHIRO}|TsukasaShinoda{SHINODATSUKASA}|RieTanaka{TANAKARIE}|HajimeKido{KIDOHAJIME}|TomonoriKanagawa{KANAGAWATOMONORI}|ShuzoIkuta{IKUTASHUZO}|FumitakaKoga{KOGAFUMITAKA}|MasakazuNakashima{NAKASHIMAMASAKAZU}|KouheiMaruno{MARUNOKOUHEI}|TatsuyaHazama{HAZAMATATSUYA}|YuyaYamada{YAMADAYUYA}|KazuroKikkawa{KIKKAWAKAZURO}|ShigeakiUmeoka{UMEOKASHIGEAKI}|MasahiroTamaki{TAMAKIMASAHIRO}|NoriyukiIto{ITONORIYUKI}|TakanoriMochizuki{MOCHIZUKITAKANORI}|SatoruKira{KIRASATORU}|NorifumiSawada{SAWADANORIFUMI}|MasayukiTakeda{TAKEDAMASAYUKI}|TakahikoMitsui{MITSUITAKAHIKO}____一般口演009前立腺腫瘍／診断・マーカー④____Evaluation of the accuracy of prostate cancer diagnosis by combining MRI/US fusion guided prostate needle biopsy and phi measurement|How many systematic biopsy cores can be safely reduced in transperineal MRI/TRUS fusion image-guided targeted biopsy?|Comparative evaluation of detection rates for csPCa using MRI-targeted biopsy alone versus in combination with systematic biopsies|Prostate cancer biopsy in Yamanashi Prefecture: Changes over 20 Years|演題取り下げ

OP-009

一般口演009
前立腺腫瘍／診断・マーカー④

－|YutoOno{ONOYUTO}|ShuntaroSuzuki{SUZUKISHUNTARO}|RyogaHashimoto{HASHIMOTORYOGA}____YoshitakaSekine{SEKINEYOSHITAKA}____YukiKohada{KOHADAYUKI}|RyoTasaka{TASAKARYO}|KenshiroTakemoto{TAKEMOTOKENSHIRO}|MikiNaito{NAITOMIKI}|SyunsukeMiyamoto{MIYAMOTOSYUNSUKE}|KoheiKobatake{KOBATAKEKOHEI}|YoheiSekino{SEKINOYOHEI}|HiroyukiKitano{KITANOHIROYUKI}|KeisukeGoto{GOTOKEISUKE}|AkihiroGoriki{GORIKIAKIHIRO}|KeisukeHieda{HIEDAKEISUKE}|NobuyukiHinata{HINATANOBUYUKI}|SatoshiOno{ONOSATOSHI}|YuichiroFurukawa{FURUKAWAYUICHIRO}|MasahiroFuse{FUSEMASAHIRO}|SatokiAbe{ABESATOKI}|MasahiroTodaka{TODAKAMASAHIRO}|HiroyukiFujinami{FUJINAMIHIROYUKI}|ShinyaSejiyama{SEJIYAMASHINYA}|ShinroHata{HATASHINRO}|ToruInoue{INOUETORU}|TadasukeAndo{ANDOTADASUKE}|ToshitakaShin{SHINTOSHITAKA}|HiromitsuMimata{MIMATAHIROMITSU}|TakanoriSano{SANOTAKANORI}|HidetakaMuratsu{MURATSUHIDETAKA}|YuzoNakano{NAKANOYUZO}____一般口演010前立腺腫瘍／診断・マーカー⑤____演題取り下げ|Withdrawn|Clinical Predictive Factors for Clinically Significant Cancer in Prostate Re-biopsy Using MRI/TRUS Fusion-Guided Biopsy|A study of prostate cancer patients who underwent regenerative surgery at Koeris Trinity|A study of MRI-targeted biopsy in our hospital

OP-010

一般口演010
前立腺腫瘍／診断・マーカー⑤

JunichiTaira{TAIRAJUNICHI}|AkinoriWada{WADAAKINORI}|KatsukiMuramoto{MURAMOTOKATSUKI}|KentaOnishi{ONISHIKENTA}|YousukeIkegami{IKEGAMIYOUSUKE}____ToruSugihara{SUGIHARATORU}____KenjiKawatoko{KAWATOKOKENJI}|DaiTakamatsu{TAKAMATSUDAI}|MasakiShiota{SHIOTAMASAKI}|HiroakiOgata{OGATAHIROAKI}|JunHata{HATAJUN}|EmiOishi{OISHIEMI}|SatokoSakata{SAKATASATOKO}|YoshihikoFuruta{FURUTAYOSHIHIKO}|MaoShibata{SHIBATAMAO}|YoshinaoOda{ODAYOSHINAO}|MasatoshiEto{ETOMASATOSHI}|ToshiharuNinomiya{NINOMIYATOSHIHARU}|SusumuKageyama{KAGEYAMASUSUMU}|YukiOkinaka{OKINAKAYUKI}|ToruYoshida{YOSHIDATORU}|SatoshiIshitoya{ISHITOYASATOSHI}|TakashiOsafune{OSAFUNETAKASHI}|ChulJangKim{KIMCHULJANG}|SoUshijima{USHIJIMASO}|RyosukeMurai{MURAIRYOSUKE}|MitsuhiroNarita{NARITAMITSUHIRO}|ZenkaiNishikawa{NISHIKAWAZENKAI}|YoshimasaHarada{HARADAYOSHIMASA}|TaichiSano{SANOTAICHI}|FumihikoUrabe{URABEFUMIHIKO}|KotaKatsumi{KATSUMIKOTA}|HidetsuguTakahashi{TAKAHASHIHIDETSUGU}|WataruFukuokaya{FUKUOKAYAWATARU}|KeiichiroMori{MORIKEIICHIRO}|TakafumiYanagisawa{YANAGISAWATAKAFUMI}|KosukeIwatani{IWATANIKOSUKE}|KojiroTashiro{TASHIROKOJIRO}|MasayaMurakami{MURAKAMIMASAYA}|KenichiHata{HATAKENICHI}|JunMiki{MIKIJUN}|TakahiroKimura{KIMURATAKAHIRO}|NobumichiTanaka{TANAKANOBUMICHI}|YasushiNakai{NAKAIYASUSHI}|AkiraTachibana{TACHIBANAAKIRA}|NobutakaNishimura{NISHIMURANOBUTAKA}|TakanoriYoshida{YOSHIDATAKANORI}|FumisatoMaesaka{MAESAKAFUMISATO}|MitsuruTomizawa{TOMIZAWAMITSURU}|YosukeMorizawa{MORIZAWAYOSUKE}|ShuntaHori{HORISHUNTA}|DaisukeGotoh{GOTOHDAISUKE}|MakitoMiyake{MIYAKEMAKITO}|KiyohideFujimoto{FUJIMOTOKIYOHIDE}|NayukaMatsuyama{MATSUYAMANAYUKA}|SatoshiYoshida{YOSHIDASATOSHI}|MasatoWatanabe{WATANABEMASATO}|AtsukoOkumura{OKUMURAATSUKO}|AkihisaTakeda{TAKEDAAKIHISA}____一般口演011前立腺腫瘍／診断・マーカー⑥____Secular trends in the prevalence of prostate cancer over a half-century based on consecutive autopsy cases in a Japanese community: the Hisayama Study|Contemporary trends of prostate cancer detected by elevated PSA in Shiga Prefecture|Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study|Risk factor for skeletal-related event in patients with metastatic castration-sensitive prostate cancer: A retrospective multicenter study|Tartrate-resistant acid phosphatase type 5b as a useful marker for the detection and monitoring of bone metastases in patients with prostate cancer

OP-011

一般口演011
前立腺腫瘍／診断・マーカー⑥

TaigoKato{KATOTAIGO}|GoNoguchi{NOGUCHIGO}|AkihitoTakeuchi{TAKEUCHIAKIHITO}|RyutaWatanabe{WATANABERYUTA}|KyosukeIwane{IWANEKYOSUKE}|TakanobuMotoshima{MOTOSHIMATAKANOBU}|MasashiArai{ARAIMASASHI}|TokiyoshiTanegashima{TANEGASHIMATOKIYOSHI}|SaekiSaito{SAITOSAEKI}|HiroshiFukushima{FUKUSHIMAHIROSHI}____JunyaFurukawa{FURUKAWAJUNYA}____YoheiOkuda{OKUDAYOHEI}|ToshikiOka{OKATOSHIKI}|AkihiroYoshimura{YOSHIMURAAKIHIRO}|YusukeOno{ONOYUSUKE}|HirokiHigashihara{HIGASHIHARAHIROKI}|YuIsizuya{ISIZUYAYU}|TakujiHayashi{HAYASHITAKUJI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|KojiHatano{HATANOKOJI}|AtsunariKawashima{KAWASHIMAATSUNARI}|KazumaKiyotani{KIYOTANIKAZUMA}|NorioNonomura{NONOMURANORIO}|RyosukeJikuya{JIKUYARYOSUKE}|ErikaMuraoka{MURAOKAERIKA}|TatsuyaInoue{INOUETATSUYA}|ChisaWada{WADACHISA}|SachiKawaura{KAWAURASACHI}|KotaAomori{AOMORIKOTA}|YasutakaIribe{IRIBEYASUTAKA}|HirotakaNagasaka{NAGASAKAHIROTAKA}|HirojiUemura{UEMURAHIROJI}|SatoshiFujii{FUJIISATOSHI}|HisashiHasumi{HASUMIHISASHI}|KazuhideMakiyama{MAKIYAMAKAZUHIDE}|MakotoSumitomo{SUMITOMOMAKOTO}|AyaYoshimura{YOSHIMURAAYA}|TakashiWatanabe{WATANABETAKASHI}|HisanoYanagi{YANAGIHISANO}|EijiSugihara{SUGIHARAEIJI}|KenjiZennami{ZENNAMIKENJI}|KiyoshiTakahara{TAKAHARAKIYOSHI}|HideyukiSaya{SAYAHIDEYUKI}|RyoichiShiroki{SHIROKIRYOICHI}|KeitoKagimoto{KAGIMOTOKEITO}|MamiChosei{CHOSEIMAMI}|NaoyaSugihara{SUGIHARANAOYA}|KeigoNishida{NISHIDAKEIGO}|HarunaArai{ARAIHARUNA}|TomohisaSakaue{SAKAUETOMOHISA}|MieKurata{KURATAMIE}|NoriyoshiMiura{MIURANORIYOSHI}|RikoKitazawa{KITAZAWARIKO}|TadahikoKikugawa{KIKUGAWATADAHIKO}|ShigekiHigashiyama{HIGASHIYAMASHIGEKI}|TakashiSaika{SAIKATAKASHI}|YukiKohada{KOHADAYUKI}|TakafumiFukushima{FUKUSHIMATAKAFUMI}|KensiroTakemoto{TAKEMOTOKENSIRO}|MikiNaito{NAITOMIKI}|SyunsukeMiyamoto{MIYAMOTOSYUNSUKE}|KoheiKobatake{KOBATAKEKOHEI}|YoheiSekino{SEKINOYOHEI}|HiroyukiKitano{KITANOHIROYUKI}|KeisukeGoto{GOTOKEISUKE}|AkihiroGoriki{GORIKIAKIHIRO}|KeisuHieda{HIEDAKEISU}|NoHinata{HINATANO}|YujiMiura{MIURAYUJI}|ToshikiAnami{ANAMITOSHIKI}|YoshihiroKomohara{KOMOHARAYOSHIHIRO}|ShigeyasuKitano{KITANOSHIGEYASU}|MasayaBaba{BABAMASAYA}|TomomiKamba{KAMBATOMOMI}|NobuyukiTanaka{TANAKANOBUYUKI}|KimiharuTakamatsu{TAKAMATSUKIMIHARU}|AtsukoSato{SATOATSUKO}|KeishiroFukumoto{FUKUMOTOKEISHIRO}|YotaYasumizu{YASUMIZUYOTA}|ToshikazuTakeda{TAKEDATOSHIKAZU}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|ShinyaMorita{MORITASHINYA}|TakeoKosaka{KOSAKATAKEO}|HiroshiAsanuma{ASANUMAHIROSHI}|MototsuguOya{OYAMOTOTSUGU}|DaisukeIto{ITODAISUKE}|KotaItahashi{ITAHASHIKOTA}|ShoheiKoyama{KOYAMASHOHEI}|MasatoshiEto{ETOMASATOSHI}|HiroyoshiNishikawa{NISHIKAWAHIROYOSHI}|SeiichiroTakao{TAKAOSEIICHIRO}|AkiFurusawa{FURUSAWAAKI}|MotofumiSuzuki{SUZUKIMOTOFUMI}|MakotoKano{KANOMAKOTO}|ShuheiOkuyama{OKUYAMASHUHEI}|HiroshiYamamoto{YAMAMOTOHIROSHI}|MiyuKano{KANOMIYU}|MarkBall{BALLMARK}|PeterChoyke{CHOYKEPETER}|MarstonLinehan{LINEHANMARSTON}|YasuhisaFujii{FUJIIYASUHISA}|HisatakaKobayashi{KOBAYASHIHISATAKA}____総会賞ポスター04腎腫瘍：基礎____Identification of neoantigen specific T cells related to anti-cancer immune response in renal cell carcinoma patients with cryoablation|Development of personalized immunotherapy for metastatic renal cell carcinoma using integrative genomic and transcriptomic analyses|Targeting glutamine addiction with potent drug combination therapy for renal cell carcinoma|PSMA-positive tumor vessels around renal cancer have high tumor angiogenic potential and predict tumor recurrence|Evaluation of Radiomics Analysis of Preoperative CT Images for Predicting Postoperative Upstaging in Renal Cancer Case|Search for biomarkers to predict the efficacy of immune checkpoint inhibitors in the treatment of metastatic renal cell carcinoma|Unraveling CXCR5 expression and immunogenomics in clear-cell renal cell carcinoma: Clinical significance of CXCR5-positive tumor-infiltrating lymphocytes (TILs)|The elucidation of the immunosuppressive mechanism mediated by regulatory T cells through MHC class II on renal cell carcinoma|Therapeutic strategies for renal cell carcinoma targeting HSF4|Carbonic anhydrase-9-targeted near-infrared photoimmunotherapy as a novel theranostic modality for clear cell renal cell carcinoma

AOP-04

総会賞ポスター04
腎腫瘍：基礎

RyosukeJikuya{JIKUYARYOSUKE}|KoujiIzumi{IZUMIKOUJI}|GoKimura{KIMURAGO}|TsukasaMasuda{MASUDATSUKASA}|ShinyaMiyazaki{MIYAZAKISHINYA}|SatoshiWashino{WASHINOSATOSHI}|TakuyaHigashio{HIGASHIOTAKUYA}|AkifumiOnagi{ONAGIAKIFUMI}|HiromiNakanishi{NAKANISHIHIROMI}|EijiKashiwagi{KASHIWAGIEIJI}____YoshikoMaeda{MAEDAYOSHIKO}____GoNoguchi{NOGUCHIGO}|ErikaMuraoka{MURAOKAERIKA}|ShigekatsuMaekawa{MAEKAWASHIGEKATSU}|WataruObara{OBARAWATARU}|KazuyukiNumakura{NUMAKURAKAZUYUKI}|TomonoriHabuchi{HABUCHITOMONORI}|YujiMiura{MIURAYUJI}|GoKimura{KIMURAGO}|ChisatoOhe{OHECHISATO}|ToyonoriTsuzuki{TSUZUKITOYONORI}|SatoshiFujii{FUJIISATOSHI}|HirojiUemura{UEMURAHIROJI}|HidewakiNakagawa{NAKAGAWAHIDEWAKI}|HisashiHasumi{HASUMIHISASHI}|KazuhideMakiyama{MAKIYAMAKAZUHIDE}|AtsushiMizokami{MIZOKAMIATSUSHI}|MasahiroNozawa{NOZAWAMASAHIRO}|SuguruShirotake{SHIROTAKESUGURU}|TomokazuSazuka{SAZUKATOMOKAZU}|ShuzoHamamoto{HAMAMOTOSHUZO}|TsunenoriKondo{KONDOTSUNENORI}|SeiNaito{NAITOSEI}|TakashigeAbe{ABETAKASHIGE}|ShuntaOnodera{ONODERASHUNTA}|KatsumiYamaguchi{YAMAGUCHIKATSUMI}|HirotsuguUemura{UEMURAHIROTSUGU}|NobuyukiTanaka{TANAKANOBUYUKI}|TakemiShishido{SHISHIDOTAKEMI}|KazunoriShojo{SHOJOKAZUNORI}|YutoBaba{BABAYUTO}|KimiharuTakamatsu{TAKAMATSUKIMIHARU}|YotaYasumizu{YASUMIZUYOTA}|ToshikazuTakeda{TAKEDATOSHIKAZU}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|ShinyaMorita{MORITASHINYA}|TakeoKosaka{KOSAKATAKEO}|HiroshiAsanuma{ASANUMAHIROSHI}|MototsuguOya{OYAMOTOTSUGU}|FumiyaHongo{HONGOFUMIYA}|HidetoTaga{TAGAHIDETO}|MasatsuguMiyasita{MIYASITAMASATSUGU}|TakashiUeda{UEDATAKASHI}|AtsukoFujihara{FUJIHARAATSUKO}|TatsuyaHirota{HIROTATATSUYA}|KeiYamada{YAMADAKEI}|OsamuUkimura{UKIMURAOSAMU}|HidekiTakeshita{TAKESHITAHIDEKI}|MasaharuInoue{INOUEMASAHARU}|AkinonriNakayama{NAKAYAMAAKINONRI}|ShoichiNagamoto{NAGAMOTOSHOICHI}|TakayukiNakayama{NAKAYAMATAKAYUKI}|KeitaIzumi{IZUMIKEITA}|MasafumiOyama{OYAMAMASAFUMI}|SatoruKawakami{KAWAKAMISATORU}|KazutakaSaito{SAITOKAZUTAKA}|TomoakiMiyagawa{MIYAGAWATOMOAKI}|TakuyaTsujino{TSUJINOTAKUYA}|TakafumiYanagisawa{YANAGISAWATAKAFUMI}|TakeshiHashimoto{HASHIMOTOTAKESHI}|KensukeBetsumiya{BETSUMIYAKENSUKE}|ShingoToyoda{TOYODASHINGO}|KiyoshiTakahara{TAKAHARAKIYOSHI}|KazutoshiFujita{FUJITAKAZUTOSHI}|MotooAraki{ARAKIMOTOO}|YoshioOhno{OHNOYOSHIO}|TakahiroKimura{KIMURATAKAHIRO}|RyoichiShiroki{SHIROKIRYOICHI}|HaruhitoAzuma{AZUMAHARUHITO}|KeiichiSako{SAKOKEIICHI}|SyuntaMakabe{MAKABESYUNTA}|YuEndo{ENDOYU}|KeiYaginuma{YAGINUMAKEI}|HitomiImai{IMAIHITOMI}|RyoTanji{TANJIRYO}|RurikoTakinami{TAKINAMIRURIKO}|SeijiHoshi{HOSHISEIJI}|YuichiSato{SATOYUICHI}|SoichiroOgawa{OGAWASOICHIRO}|MotohideUemura{UEMURAMOTOHIDE}|YoshiyukiKojima{KOJIMAYOSHIYUKI}|KohjiroOhba{OHBAKOHJIRO}|YutaMukae{MUKAEYUTA}|JunkiHarada{HARADAJUNKI}|KyoheiAraki{ARAKIKYOHEI}|YuichiroNakamura{NAKAMURAYUICHIRO}|KensukeMitsunari{MITSUNARIKENSUKE}|TomohiroMatsuo{MATSUOTOMOHIRO}|YasushiMochizuki{MOCHIZUKIYASUSHI}|RyoichiImamura{IMAMURARYOICHI}|HatanoTakashi{TAKASHIHATANO}|AtsushiTakamoto{TAKAMOTOATSUSHI}|TakahiroOsawa{OSAWATAKAHIRO}|JunMiki{MIKIJUN}|AkihiroMatsukawa{MATSUKAWAAKIHIRO}|KojiroTashiro{TASHIROKOJIRO}|ShinEgawa{EGAWASHIN}|YasutomoNasu{NASUYASUTOMO}|NobuoShinohara{SHINOHARANOBUO}|MasatoshiEto{ETOMASATOSHI}____総会賞ポスター05腎腫瘍：臨床____Multi-dimensional profiling of rare kidney cancers facilitates precision medicine for kidney cancer patients|TCR repertoire after immune checkpoint inhibitors induction predicts prognosis in patients with renal cell carcinoma and urothelial carcinoma (BINIR study)|Japanese prospective registry of nivolumab plus ipilimumab for patients in 1L metastatic renal cell carcinoma (J-ENCORE study): The result of final analysis|Maturity of tertiary lymphoid structures in renal cell carcinoma: a prospective study|Percutaneous renal cryoablation for hereditary renal tumor|Neutrophil to lymphocyte ratio and tumor burden for treatment efficacy stratification in renal cell carcinoma patients receiving nivolumab plus ipilimumab|Deciphering RCC Immunotherapy Outcomes: Insights from a Japanese Multi-Institutional Study on the CANLPH Score's Impact|CLDN10-LAT1 signaling accelerates clear cell renal cell carcinoma progression|Risk prediction of pT3a upstaging in cT1 renal cell carcinoma utilizing a three-dimensional image analysis system|Safety and Efficacy of Cryotherapy for the Treatment of Renal Angiomyolipoma Related to Tuberous Sclerosis Complex

AOP-05

総会賞ポスター05
腎腫瘍：臨床

Yeong-ChinJou{JOUYEONG-CHIN}|HiroshiYamane{YAMANEHIROSHI}|－|ShoheiUeda{UEDASHOHEI}|BinHuang{HUANGBIN}|HiromuHoritani{HORITANIHIROMU}|LeeMing-Yang{MING-YANGLEE}____TakashiKobayashi{KOBAYASHITAKASHI}|Tai-LungCha{CHATAI-LUNG}____Hsin-TzuTsai{TSAIHSIN-TZU}|Tzong-ShinTzai{TZAITZONG-SHIN}|Yuh-ShyanTsai{TSAIYUH-SHYAN}|MotomuNakatake{NAKATAKEMOTOMU}|HajimeKurosaki{KUROSAKIHAJIME}|MoeNakagawa{NAKAGAWAMOE}|ShuichiMorizane{MORIZANESHUICHI}|AtsushiTakenaka{TAKENAKAATSUSHI}|TakafumiNakamura{NAKAMURATAKAFUMI}|AtsushiIrie{IRIEATSUSHI}|SatoruSenju{SENJUSATORU}|KoyuIto{ITOKOYU}|HiroshiHamana{HAMANAHIROSHI}|HiroyukiKishi{KISHIHIROYUKI}|KoetsuOgasawara{OGASAWARAKOETSU}|KeikoUdaka{UDAKAKEIKO}|YasuharuNishimura{NISHIMURAYASUHARU}|MasatoshiEto{ETOMASATOSHI}|ChengLuo{LUOCHENG}|ZongrenWang{WANGZONGREN}|LingwuChen{CHENLINGWU}|JunxingChen{CHENJUNXING}|YuxiWu{WUYUXI}|JiahaoLei{LEIJIAHAO}|AtsunariKawashima{KAWASHIMAATSUNARI}|ShinpeiYamashita{YAMASHITASHINPEI}|KosukeNakano{NAKANOKOSUKE}|MototakaSato{SATOMOTOTAKA}|YuuIshizuya{ISHIZUYAYUU}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|HitoshiTakayama{TAKAYAMAHITOSHI}|MasashiNakayama{NAKAYAMAMASASHI}|DaigoKato{KATODAIGO}|KojiHatano{HATANOKOJI}|IsaoHara{HARAISAO}|NorioNonomura{NONOMURANORIO}|ShenChengHuang{CHENGHUANGSHEN}|TungChun-Liang{CHUN-LIANGTUNG}|LiChin{CHINLI}|ChenPieChe{PIECHECHEN}____Selected Oral 6Urothelial tumors____Ataxin-3 cooperates AHNAK2 with in human bladder cancer that contributes worse prognosis through EMT signaling|Evaluating the antitumor effect of fusogenic vaccinia virus armed with immunostimulatory genes in subcutaneous bladder cancer models|Withdrawn|演題取り下げ|Cancer vaccine improves the efficacy of immune checkpoint inhibitor against refractory cancers|Interim results from a phase II clinical study of tislelizumab combined with gemcitabine and cisplatin as a bladder-sparing therapy for utDNA defined cCR MIBC|PUNCH02: Primary results from a phase II study of tislelizumab combined with RC48 as a bladder preservation therapy for utDNA-defined clinical CR MIBC patients|FAN score emerges as a powerful predictor of poor prognosis in patients with locally advanced bladder cancer|Upper Tract Urothelial Cancer Exhibits Distinct Molecular Signature from Urinary Bladder Urothelial Cancer

SO-6

Selected Oral 6
Urothelial tumors

濵本周造{はまもとしゅうぞうHAMAMOTOSHUZO}|守屋仁彦{もりやきみひこMORIYAKIMIHIKO}|増田均{ますだひとしMASUDAHITOSHI}|小林裕章{こばやしひろあきKOBAYASHIHIROAKI}____兼松明弘{かねまつあきひろKANEMATSUAKIHIRO}|加藤晴朗{かとうはるあきKATOHARUAKI}____海野怜{うんのれいUNNOREI}|田口和己{たぐちかずみTAGUCHIKAZUMI}|岡田淳志{おかだあつしOKADAATSUSHI}|安井孝周{やすいたかひろYASUITAKAHIRO}|椙村光貴{すぎむらこうきSUGIMURAKOKI}|日向泰樹{ひゅうがたいじゅHYUGATAIJU}|堀口明男{ほりぐちあきおHORIGUCHIAKIO}|新地祐介{しんちまさゆきSHINCHIMASAYUKI}|伊藤敬一{いとうけいいちITOKEIICHI}____シンポジウム11Reconstructive Urologyの最前線____ロボット支援システムを用いた上部尿路再建術|尿路再建術習得のために: 小児泌尿器科研修のすすめ|人工尿道括約筋埋込術のNext Stage: トラブルシューティングの戦略と方法|ロボット支援下手術を含めた下部尿路閉塞に対する再建手術の現状

SY11

シンポジウム11
Reconstructive Urologyの最前線

堀口明男{ほりぐちあきおHORIGUCHIAKIO}____石浦嘉之{いしうらよしゆきISHIURAYOSHIYUKI}________教育講演7日本泌尿器科学会 尿道狭窄症診療ガイドラインの概要と解説____日本泌尿器科学会 尿道狭窄症診療ガイドラインの概要と解説

EL7

教育講演7
日本泌尿器科学会 尿道狭窄症診療ガイドラインの概要と解説

髙尾徹也{たかおてつやTAKAOTETSUYA}|井上幸治{いのうえこうじINOUEKOUJI}|新地祐介{しんちまさゆきSHINCHIMASAYUKI}|田部井正{たべいただしTABEITADASHI}____田村芳美{たむらよしみTAMURAYOSHIMI}|柳雅人{やなぎまさとYANAGIMASATO}________シンポジウム12泌尿器科関連の外傷・救急疾患の対応について____精巣外傷の診断と治療:日常診療のポイント|陰茎折症と陰茎絞扼症に対する緊急対応について|尿道異物と続発する合併症への対応|持続勃起症の診断・治療

SY12

シンポジウム12
泌尿器科関連の外傷・救急疾患の対応について

AkinaruYamamoto{YAMAMOTOAKINARU}|KenjiNakamura{NAKAMURAKENJI}|TomohiroIwasawa{IWASAWATOMOHIRO}|YukiHarada{HARADAYUKI}|MasakazuGonda{GONDAMASAKAZU}|RyoichiMaenosono{MAENOSONORYOICHI}|KantaHori{HORIKANTA}|TakashiMatsumoto{MATSUMOTOTAKASHI}|TakanobuUtsumi{UTSUMITAKANOBU}|RyunosukeNakagawa{NAKAGAWARYUNOSUKE}____HidekiEnokida{ENOKIDAHIDEKI}____AtsunariKawashima{KAWASHIMAATSUNARI}|ShunsukeInoguchi{INOGUCHISHUNSUKE}|TomohiroKanaki{KANAKITOMOHIRO}|YukiHoribe{HORIBEYUKI}|NesrineSassi{SASSINESRINE}|ToshihiroUemura{UEMURATOSHIHIRO}|TakujiHayashi{HAYASHITAKUJI}|YuIshizuya{ISHIZUYAYU}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|TaigoKato{KATOTAIGO}|KojiHatano{HATANOKOJI}|NorioNonomura{NONOMURANORIO}|YukiKita{KITAYUKI}|HajimeTakamori{TAKAMORIHAJIME}|ShuheiKoike{KOIKESHUHEI}|RyousukeIkeuchi{IKEUCHIRYOUSUKE}|HideakiTakada{TAKADAHIDEAKI}|YukiTeramoto{TERAMOTOYUKI}|ToruSakatani{SAKATANITORU}|AkihiroHamada{HAMADAAKIHIRO}|KaoruMurakami{MURAKAMIKAORU}|TakayukiGoto{GOTOTAKAYUKI}|RyoichiSaito{SAITORYOICHI}|TakashiKobayashi{KOBAYASHITAKASHI}|NobuyukiTanaka{TANAKANOBUYUKI}|KotaItahashi{ITAHASHIKOTA}|AtsukoSato{SATOATSUKO}|KeishiroFukumoto{FUKUMOTOKEISHIRO}|YotaYasumizu{YASUMIZUYOTA}|ToshikazuTakeda{TAKEDATOSHIKAZU}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|ShinyaMorita{MORITASHINYA}|TakeoKosaka{KOSAKATAKEO}|HiroshiAsanuma{ASANUMAHIROSHI}|HiroyoshiNishikawa{NISHIKAWAHIROYOSHI}|MototsuguOya{OYAMOTOTSUGU}|KeitaHayakawa{HAYAKAWAKEITA}|KeisukeTsuji{TSUJIKEISUKE}|MasatomoKaneko{KANEKOMASATOMO}|YutaInoue{INOUEYUTA}|AtsukoFujihara{FUJIHARAATSUKO}|TakumiShiraishi{SHIRAISHITAKUMI}|KengoUeno{UENOKENGO}|MasayaNakanishi{NAKANISHIMASAYA}|ToshikoIhara{IHARATOSHIKO}|EiichiKonishi{KONISHIEIICHI}|OsamuUkimura{UKIMURAOSAMU}|NoriyasuKawai{KAWAINORIYASU}|ToshikiEtani{ETANITOSHIKI}|TakuNaiki{NAIKITAKU}|AkiraIto{ITOAKIRA}|TakahiroYasui{YASUITAKAHIRO}|KazukiNishimura{NISHIMURAKAZUKI}|KensukeHirosuna{HIROSUNAKENSUKE}|KazumasaKomura{KOMURAKAZUMASA}|YukiYoshikawa{YOSHIKAWAYUKI}|TakuyaTsujino{TSUJINOTAKUYA}|TakuyaOwari{OWARITAKUYA}|MitsuakiIshida{ISHIDAMITSUAKI}|MasahikoAjiro{AJIROMASAHIKO}|ShoheiKoyama{KOYAMASHOHEI}|HaruhitoAzuma{AZUMAHARUHITO}|AkihideYoshimi{YOSHIMIAKIHIDE}|ShuheiYamada{YAMADASHUHEI}|HarukaMiyata{MIYATAHARUKA}|RyujiMatsumoto{MATSUMOTORYUJI}|TakahiroOsawa{OSAWATAKAHIRO}|TakashigeAbe{ABETAKASHIGE}|YoshihikoHirohashi{HIROHASHIYOSHIHIKO}|ToshihikoTorigoe{TORIGOETOSHIHIKO}|NobuoShinohara{SHINOHARANOBUO}|RuiliangWang{WANGRUILIANG}|AlbertoContreras-Sanz{CONTRERAS-SANZALBERTO}|PeterCBlack{BLACKPETERC}|AtsushiOkato{OKATOATSUSHI}|MichelaRanieri{RANIERIMICHELA}|XingnanZheng{ZHENGXINGNAN}|MiZhou{ZHOUMI}|MatthewMilowsky{MILOWSKYMATTHEW}|SaraWobker{WOBKERSARA}|JonathanSerody{SERODYJONATHAN}|JeffreyDamrauer{DAMRAUERJEFFREY}|Kwok-KinWong{WONGKWOK-KIN}|HiroyoshiSuzuki{SUZUKIHIROYOSHI}|WilliamKim{KIMWILLIAM}|KoujiIzumi{IZUMIKOUJI}|ShuheiAoyama{AOYAMASHUHEI}|TaikiKamijima{KAMIJIMATAIKI}|HiroshiKano{KANOHIROSHI}|TomoyukiMakino{MAKINOTOMOYUKI}|RenatoNaito{NAITORENATO}|HiroakiIwamoto{IWAMOTOHIROAKI}|HiroshiYaegashi{YAEGASHIHIROSHI}|ShoheiKawaguchi{KAWAGUCHISHOHEI}|TakahiroNohara{NOHARATAKAHIRO}|KazuyoshiShigehara{SHIGEHARAKAZUYOSHI}|AtsushiMizokami{MIZOKAMIATSUSHI}____総会賞ポスター06尿路上皮腫瘍：基礎____Upper tract urothelial carcinoma developed due to inflammation induced by local infiltrated macrophage: findings from a novel mouse model|Establishment of a Preclinical Model for Sarcomatoid Bladder Cancer through Dual Knockout of Trp53 and Cdh1 in Mouse Bladder Organoids|Integrated single-cell and spatial transcriptomics reveals a novel immune escape mechanism by altering the extracellular matrix in advanced urothelial carcinoma|A fully automated novel artificial intelligence system to predict high-grade urothelial carcinoma from urine cytology slides: External validation study|Development of a Novel Magnetic Hyperthermia for Bladder Cancer Utilizing Anti-PD-L1 Antibody|NECTIN4 shapes the tumor microenvironment and immunotherapy outcomes in bladder cancer|Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN|Clinical significance of loss of FBXW7 function and effect of MYC inhibitor in muscle invasive bladder cancer|Enhanced efficacy of combined FGFR and PD-1 Inhibition in FGFR3-mutant bladder cancer: overcoming immune evasion by targeting Treg expansion|Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis

AOP-06

総会賞ポスター06
尿路上皮腫瘍：基礎

KazunoriShojo{SHOJOKAZUNORI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|TadahikoKikugawa{KIKUGAWATADAHIKO}|ToruSakatani{SAKATANITORU}|KyotaroFukuta{FUKUTAKYOTARO}|YujiroNagata{NAGATAYUJIRO}|TakuyaTsujino{TSUJINOTAKUYA}|YukiEndo{ENDOYUKI}|JunyaArima{ARIMAJUNYA}|ShoheiNagakawa{NAGAKAWASHOHEI}____JunichiInokuchi{INOKUCHIJUNICHI}____NobuyukiTanaka{TANAKANOBUYUKI}|TetsushiMurakami{MURAKAMITETSUSHI}|ShujiMikami{MIKAMISHUJI}|KeishiroFukumoto{FUKUMOTOKEISHIRO}|YotaYasumizu{YASUMIZUYOTA}|ToshikazuTakeda{TAKEDATOSHIKAZU}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|ShinyaMorita{MORITASHINYA}|TakeoKosaka{KOSAKATAKEO}|MototsuguOya{OYAMOTOTSUGU}|AkinaruYamamoto{YAMAMOTOAKINARU}|AtsunariKawashima{KAWASHIMAATSUNARI}|HiroakiHase{HASEHIROAKI}|YukiHoribe{HORIBEYUKI}|NesrineSassi{SASSINESRINE}|ToshihiroUemura{UEMURATOSHIHIRO}|YuIshizuya{ISHIZUYAYU}|TakujiHayashi{HAYASHITAKUJI}|TaigoKato{KATOTAIGO}|KojiHatano{HATANOKOJI}|KazutakeTsujikawa{TSUJIKAWAKAZUTAKE}|NorioNonomura{NONOMURANORIO}|ShingoKinnami{KINNAMISHINGO}|MikiSakamoto{SAKAMOTOMIKI}|TakatoraSawada{SAWADATAKATORA}|KeigoNishida{NISHIDAKEIGO}|TomoyaOhnishi{OHNISHITOMOYA}|RyutaWatanabe{WATANABERYUTA}|KenichiNishimura{NISHIMURAKENICHI}|TetsuyaFukumoto{FUKUMOTOTETSUYA}|NoriyoshiMiura{MIURANORIYOSHI}|YukiMiyauchi{MIYAUCHIYUKI}|YasunoriTakasuka{TAKASUKAYASUNORI}|TakashiSaika{SAIKATAKASHI}|TakayukiSumiyoshi{SUMIYOSHITAKAYUKI}|YukiKita{KITAYUKI}|HideakiTakada{TAKADAHIDEAKI}|KenjiNakamura{NAKAMURAKENJI}|AkihiroHamada{HAMADAAKIHIRO}|KaoruMurakami{MURAKAMIKAORU}|KimihikoMasui{MASUIKIMIHIKO}|TakayukiGoto{GOTOTAKAYUKI}|RyoichiSaito{SAITORYOICHI}|TakashiKobayashi{KOBAYASHITAKASHI}|KeiDaizumoto{DAIZUMOTOKEI}|NaokaOsafune{OSAFUNENAOKA}|KoheiTorii{TORIIKOHEI}|RyotaNishimura{NISHIMURARYOTA}|HisanoriUehara{UEHARAHISANORI}|RyoeiMinato{MINATORYOEI}|YutaroSasaki{SASAKIYUTARO}|RyotaroTomida{TOMIDARYOTARO}|YoshitoKusuhara{KUSUHARAYOSHITO}|TomoyaFukawa{FUKAWATOMOYA}|MasayukiTakahashi{TAKAHASHIMASAYUKI}|JunyaFurukawa{FURUKAWAJUNYA}|AkinoriMinato{MINATOAKINORI}|HisamiAono{AONOHISAMI}|RiekoKimuro{KIMURORIEKO}|KatsuyoshiHigashijima{HIGASHIJIMAKATSUYOSHI}|IkkoTomisaki{TOMISAKIIKKO}|KenichiHarada{HARADAKENICHI}|HiroshiMiyamoto{MIYAMOTOHIROSHI}|NaohiroFujimoto{FUJIMOTONAOHIRO}|ShogoYamazaki{YAMAZAKISHOGO}|KazumasaKomura{KOMURAKAZUMASA}|TakuyaHigashio{HIGASHIOTAKUYA}|TakuyaMatsuda{MATSUDATAKUYA}|ShuyaTsuchida{TSUCHIDASHUYA}|KazukiNishimura{NISHIMURAKAZUKI}|YukiYoshikawa{YOSHIKAWAYUKI}|TomohisaMatsunaga{MATSUNAGATOMOHISA}|RyoichiMaenosono{MAENOSONORYOICHI}|TomoakiTakai{TAKAITOMOAKI}|HayahitoNomi{NOMIHAYAHITO}|HaruhitoAzuma{AZUMAHARUHITO}|HiroshiKitamura{KITAMURAHIROSHI}|ShingoHatakeyama{HATAKEYAMASHINGO}|KiyoakiNishihara{NISHIHARAKIYOAKI}|NaoyaMasumori{MASUMORINAOYA}|KazutoshiFujita{FUJITAKAZUTOSHI}|HideakiMiyake{MIYAKEHIDEAKI}|TakahitoNegishi{NEGISHITAKAHITO}|MizukiKobayashi{KOBAYASHIMIZUKI}|MichihiroShono{SHONOMICHIHIRO}|EijiKikuchi{KIKUCHIEIJI}|HirofumiYoshino{YOSHINOHIROFUMI}|GangLi{LIGANG}|MitsuhikoTominaga{TOMINAGAMITSUHIKO}|SaekiSaito{SAITOSAEKI}|TakashiSakaguchi{SAKAGUCHITAKASHI}|ShuichiTatarano{TATARANOSHUICHI}|HidekiEnokida{ENOKIDAHIDEKI}|MasakiShiota{SHIOTAMASAKI}|ShigehiroTsukahara{TSUKAHARASHIGEHIRO}|JunMutaguchi{MUTAGUCHIJUN}|TokiyoshiTanegashima{TANEGASHIMATOKIYOSHI}|ShunsukeGoto{GOTOSHUNSUKE}|SatoshiKobayashi{KOBAYASHISATOSHI}|TakashiMatsumoto{MATSUMOTOTAKASHI}|MasatoshiEto{ETOMASATOSHI}____総会賞ポスター07尿路上皮腫瘍：臨床____Multiplex phenotyping of the B7 family immune checkpoint molecules reveal cellular heterogeneity and outcome of prognosis in urothelial carcinoma|Metabolic profiling of tissues in upper tract urothelial carcinoma reveals novel clinical significance through multi-omics analysis|Usefulness of UF-5000 automatic screening system in urothelial carcinoma diagnosis|The clinical utility of plasma circulating tumor DNA analysis for patients with metastatic urothelial cancer treated with pembrolizumab|A novel AI system for preoperative depth prediction in UTUC|Immunohistochemical expression of p53 and FGFR3 is a potential biomarker for predicting response to enfortumab vedotin in metastatic urothelial carcinoma|Comprehensive Genetic Analysis Reveals Novel Strategy for Bladder Preservation Treatment|JAVEMACS chart review study of avelumab maintenance for advanced urothelial carcinoma (aUC): analyses by prior platinum-based chemotherapy (PBC) characteristics|Prognostic effect of combination therapy of immune checkpoint inhibitors and probiotic drug in advanced urothelial carcinoma|Recurrence monitoring for non-muscle invasive bladder cancer using urinary cell-free DNA

AOP-07

総会賞ポスター07
尿路上皮腫瘍：臨床

KoeiTorii{TORIIKOEI}|－|KenjiOmae{OMAEKENJI}|MingRuLee{LEEMINGRU}|Mei-KarLeong{LEONGMEI-KAR}|YumaWaseda{WASEDAYUMA}|RettaCatherinaSihotang{SIHOTANGRETTACATHERINA}|YungChiShih{SHIHYUNGCHI}|Yu-KaiHuang{HUANGYU-KAI}____ShinichiSakamoto{SAKAMOTOSHINICHI}|RejeevKumar{KUMARREJEEV}____ShuzoHamomoto{HAMOMOTOSHUZO}|YutaroTanaka{TANAKAYUTARO}|MihokoMaruyama{MARUYAMAMIHOKO}|YoshihiroHurukawa{HURUKAWAYOSHIHIRO}|RieTajiri{TAJIRIRIE}|MasahikoIsogai{ISOGAIMASAHIKO}|TeruakiSugino{SUGINOTERUAKI}|KazumiTaguchi{TAGUCHIKAZUMI}|KazuhiroNiimi{NIIMIKAZUHIRO}|AtsushiOkada{OKADAATSUSHI}|YusukeMori{MORIYUSUKE}|TakahiroYasui{YASUITAKAHIRO}|ToshioTakagi{TAKAGITOSHIO}|NoriakiKurita{KURITANORIAKI}|TszYiTang{TANGTSZYI}|JiunHungGeng{GENGJIUNHUNG}|RieMuta{MUTARIE}|MadokaUrushido{URUSHIDOMADOKA}|ShunyaMatsumoto{MATSUMOTOSHUNYA}|MasakiKobayashi{KOBAYASHIMASAKI}|YukiNakamura{NAKAMURAYUKI}|YudaiIshikawa{ISHIKAWAYUDAI}|HiroshiFukushima{FUKUSHIMAHIROSHI}|ShoheiFukuda{FUKUDASHOHEI}|HajimeTanaka{TANAKAHAJIME}|SoichiroYoshida{YOSHIDASOICHIRO}|YasuhisaFujii{FUJIIYASUHISA}|NurRasyid{RASYIDNUR}|PoncoBirowo{BIROWOPONCO}|Atmoko@idi{ATMOKO@IDI}|WeiTu{TUWEI}|ShangJuHsieh{HSIEHSHANGJU}|ChaoYuanChang{CHANGCHAOYUAN}|ShiuDongChung{CHUNGSHIUDONG}|Wei-JenChen{CHENWEI-JEN}|AlexTlLin{LINALEXTL}|WilliamJsHuang{HUANGWILLIAMJS}|EricYi-HsiuHuang{HUANGERICYI-HSIU}|Hsiao-JenChung{CHUNGHSIAO-JEN}|Tzu-PingLin{LINTZU-PING}|I-ShenHuang{HUANGI-SHEN}|Tzu-ChunWei{WEITZU-CHUN}|Tzu-HaoHuang{HUANGTZU-HAO}|Ming-HsuanKu{KUMING-HSUAN}|Tzu-HsiangHsu{HSUTZU-HSIANG}____Selected Oral 7Stones____Observation of Randall's plaques and stone boundary regions in human renal papillary tissue using thin sections|演題取り下げ|Effect of daily weather conditions on emergency visits for renal colic in the Kanto region and Aichi Prefecture: a time series analysis|Association between hyperuricemia and kidney stone disease in a large-sale Taiwanese analysis|Menopause and Postmenopausal Hormone Therapy: Impact on Kidney Stone Disease in Taiwanese Women|The value of preoperative renal artery Doppler in predicting renal function recovery after ureteroscopic lithotripsy in upper urinary tract stone disease|The comparison of totally ultrasound-guided versus fluoroscopy-guided shockwave lithotripsy in renal stone treatment: a systematic review and meta-analysis|The safety and efficacy of mini-endoscopic combined intrarenal surgery using ‘Through and Through’ approach|Mini-percutaneous nephrolithotomy had faster patient recovery in managing large proximal ureteral stone than laparoscopic ureterolithotomy

SO-7

Selected Oral 7
Stones

舛森直哉{ますもりなおやMASUMORINAOYA}____髙橋悟{たかはしさとるTAKAHASHISATORU}________教育講演8男性下部尿路症状・前立腺肥大症診療ガイドラインと最新治療____男性下部尿路症状・前立腺肥大症診療ガイドラインと最新治療

EL8

教育講演8
男性下部尿路症状・前立腺肥大症診療ガイドラインと最新治療

成田伸太郎{なりたしんたろうNARITASHINTARO}|大日方大亮{おびなただいすけOBINATADAISUKE}|田口慧{たぐちさとるTAGUCHISATORU}|波多野浩士{はたのこうじHATANOKOJI}____久米春喜{くめはるきKUMEHARUKI}|齋藤一隆{さいとうかずたかSAITOKAZUTAKA}____高橋悟{たかはしさとるTAKAHASHISATORU}|亀井潤{かめいじゅんKAMEIJUN}|角谷成紀{かくたにしげのりKAKUTANISHIGENORI}|山田雄太{やまだゆうたYAMADAYUTA}|新美文彩{にいみあやNIIMIAYA}|山田大介{やまだだいすけYAMADADAISUKE}|久米春喜{くめはるきKUMEHARUKI}____シンポジウム13高齢泌尿器がん治療の最前線____高齢泌尿器がん診療・研究の現状と課題|高齢泌尿器がん手術周術期管理|高齢泌尿器がん手術における適応と注意点について|高齢泌尿器がん薬物療法

SY13

シンポジウム13
高齢泌尿器がん治療の最前線

【専門医制度対応講習単位認定プログラム】

*専門医制度対応講習単位認定プログラム[泌尿器科領域講習]

横井悠加{よこいゆかYOKOIYUKA}|井出志正{いでゆきまさIDEYUKIMASA}|京田有樹{きょうだゆうきKYODAYUKI}|南里正晴{なんりまさはるNANRIMASAHARU}____鳥本一匡{とりもとかずまさTORIMOTOKAZUMASA}|松下千枝{まつしたちえMATSUSHITACHIE}____松尾学{まつおまなぶMATSUOMANABU}____シンポジウム14下部尿路症状に対する行動療法____女性下部尿路症状に対する理学療法|男性に対する理学療法 (骨盤底筋トレーニング)の最前線|夜間頻尿に対する行動療法|間質性膀胱炎の保存的治療

SY14

シンポジウム14
下部尿路症状に対する行動療法

高橋良輔{たかはしりょうすけTAKAHASHIRYOUSUKE}____関戸哲利{せきどのりとしSEKIDONORITOSHI}________教育講演9カテーテルを用いた尿路管理のState of the Art____カテーテルを用いた尿路管理のState of the Art

EL9

教育講演9
カテーテルを用いた尿路管理のState of the Art

MasahiroSugiura{SUGIURAMASAHIRO}|FengCao{CAOFENG}|SaoriNishijima{NISHIJIMASAORI}|MarcoDevelasco{DEVELASCOMARCO}____TakeoKosaka{KOSAKATAKEO}____SanjiKanaoka{KANAOKASANJI}|ManatoKanesaka{KANESAKAMANATO}|HiroakiSatou{SATOUHIROAKI}|YasutakaYamada{YAMADAYASUTAKA}|TomokazuSazuka{SAZUKATOMOKAZU}|YusukeImamura{IMAMURAYUSUKE}|ShinichiSakamoto{SAKAMOTOSHINICHI}|AtsushiKaneda{KANEDAATSUSHI}|TomohikoIchikawa{ICHIKAWATOMOHIKO}|TatsuyaMasuda{MASUDATATSUYA}|YasuhikoKamikubo{KAMIKUBOYASUHIKO}|ShuichiShimabukuro{SHIMABUKUROSHUICHI}|HidekiMukouyama{MUKOUYAMAHIDEKI}|YoshinoriOshiro{OSHIROYOSHINORI}|KimioSugaya{SUGAYAKIMIO}|TadashiYamamoto{YAMAMOTOTADASHI}|YurieKura{KURAYURIE}|KenFukiage{FUKIAGEKEN}|KazukoSakai{SAKAIKAZUKO}|SaizoFujimoto{FUJIMOTOSAIZO}|ShingoToyoda{TOYODASHINGO}|KoichiSugimoto{SUGIMOTOKOICHI}|MamoruHashimoto{HASHIMOTOMAMORU}|TakafumiMinami{MINAMITAKAFUMI}|KazuhiroYoshimura{YOSHIMURAKAZUHIRO}|HirotsuguUemura{UEMURAHIROTSUGU}|KazutoNishio{NISHIOKAZUTO}|KazutoshiFujita{FUJITAKAZUTOSHI}____一般口演012前立腺腫瘍／基礎①____Molecular mechanism of cancer malignant transformation by PRC1.1 in castration resistant prostate Cancer|Investigation of new biomarkers of double-negative prostate cancer and proposing a control method using the CROX (Cluster Regulation of RUNX family) strategy|Suppression of TOB protein induces apoptosis via MAPK signaling pathway mediated activation in prostate cancer cell lines|Characterization of tumor-infiltrating polymorphonuclear cells in mouse prostate cancer

OP-012

一般口演012
前立腺腫瘍／基礎①

MarcoDevelasco{DEVELASCOMARCO}|ShigeruSugiki{SUGIKISHIGERU}|KumpeiTakahashi{TAKAHASHIKUMPEI}|KazukiOhashi{OHASHIKAZUKI}____SayuriTakahashi{TAKAHASHISAYURI}____YurieKura{KURAYURIE}|HiroyukiKita{KITAHIROYUKI}|KazukoSakai{SAKAIKAZUKO}|KoichiSugimoto{SUGIMOTOKOICHI}|MamoruHashimoto{HASHIMOTOMAMORU}|ShingoToyoda{TOYODASHINGO}|SaizoFujimoto{FUJIMOTOSAIZO}|TakafumiMinami{MINAMITAKAFUMI}|KazuhiroYoshimura{YOSHIMURAKAZUHIRO}|HirotsuguUemura{UEMURAHIROTSUGU}|KazutoNishio{NISHIOKAZUTO}|KazutoshiFujita{FUJITAKAZUTOSHI}|TetsuhiroHorie{HORIETETSUHIRO}|KenshirouKunii{KUNIIKENSHIROU}|KoudaiSuga{SUGAKOUDAI}|NobuyoMorita{MORITANOBUYO}|IppeiChikazawa{CHIKAZAWAIPPEI}|TarouIguchi{IGUCHITAROU}|YasuhitoIshigaki{ISHIGAKIYASUHITO}|KatsuhitoMiyazawa{MIYAZAWAKATSUHITO}|ShinoOshima{OSHIMASHINO}|MeikoAoki{AOKIMEIKO}|SenaOno{ONOSENA}|JunNaruse{NARUSEJUN}|SoichiroYuzuriha{YUZURIHASOICHIRO}|TatsuyaOtaki{OTAKITATSUYA}|TatsuyaUmemoto{UMEMOTOTATSUYA}|NobuyukiNakajima{NAKAJIMANOBUYUKI}|YoshiharuKawamura{KAWAMURAYOSHIHARU}|MasanoriHasegawa{HASEGAWAMASANORI}|YoshieKametani{KAMETANIYOSHIE}|SunaoShoji{SHOJISUNAO}|DaisukeObinata{OBINATADAISUKE}|TakumiArai{ARAITAKUMI}|YukiInagaki{INAGAKIYUKI}|ShoHashimoto{HASHIMOTOSHO}|KenNakahara{NAKAHARAKEN}|TsuyoshiYoshizawa{YOSHIZAWATSUYOSHI}|JunichiMochida{MOCHIDAJUNICHI}|SatoruTakahashi{TAKAHASHISATORU}____一般口演013前立腺腫瘍／基礎②____Analyzing the peripheral blood of mice to evaluate their response to androgen receptor-targeted therapy|Investigation of novel markers for prostate cancer stem cells using integrated bioinformatic analyses|Evaluation of immune response after high-intensity focused ultrasound therapy in localized prostate cancer|Analysis of Characteristics in Robot-Assisted Laparoscopic Prostatectomy Based on Comprehensive Risk Assessment

OP-013

一般口演013
前立腺腫瘍／基礎②

野口満{のぐちみつるNOGUCHIMITSURU}____橘田岳也{きったたけやKITTATAKEYA}________教育講演10神経因性下部尿路機能障害に対する外科的治療: 適応と成績____神経因性下部尿路機能障害に対する外科的治療:適応と成績

EL10

教育講演10
神経因性下部尿路機能障害に対する外科的治療: 適応と成績

曲友弘{まがりともひろMAGARITOMOHIRO}|山本達也{やまもとたつやYAMAMOTOTATSUYA}|樋口まどか{ひぐちHIGUCHIMADOKA}|本郷祥子{ほんごうさちこHONGOUSACHIKO}|濱川隆{はまかわたかしHAMAKAWATAKASHI}____窪田泰江{くぼたやすえKUBOTAYASUE}|本田正史{ほんだまさしHONDAMASASHI}____伊藤一人{いとうかずとITOKAZUTO}|黒澤功{くろさわいさおKUROSAWAISAO}|築山真由子{つきやままゆこTSUKIYAMAMAYUKO}|今雅史{こんまさふみKONMASAFUMI}|千葉博基{ちばひろきCHIBAHIROKI}|安部崇重{あべたかしげABETAKASHIGE}|安井孝周{やすいたかひろYASUITAKAHIRO}____シンポジウム15排尿機能専門医に聞こう！診断・治療に難渋した症例から診療のコツを学ぶ____「頭」に入れておきたい下部尿路機能に影響のある「頭」の疾患|原因不明の尿閉です!泌尿器科医が知っておくべき神経疾患に伴う尿閉|思春期・学童期の下部尿路症状へのアプローチ|女性の難治性排尿障害、本当に難治性ですか?|忘れてはいけない！下部尿路機能に影響する注意すべき薬剤

SY15

シンポジウム15
排尿機能専門医に聞こう！診断・治療に難渋した症例から診療のコツを学ぶ

WeiChen{CHENWEI}|KazukiHonda{HONDAKAZUKI}|YuOzawa{OZAWAYU}|JunMutaguchi{MUTAGUCHIJUN}|AtsunariKawashima{KAWASHIMAATSUNARI}|HiromitsuWatanabe{WATANABEHIROMITSU}|MinoruNakazono{NAKAZONOMINORU}|YuichiroKonnai{KONNAIYUICHIRO}|KoichiroMinami{MINAMIKOICHIRO}|HomareOkazoe{OKAZOEHOMARE}____NobuyukiHinata{HINATANOBUYUKI}____ShoheiFukuda{FUKUDASHOHEI}|SoichiroYoshida{YOSHIDASOICHIRO}|NaoKobayashi{KOBAYASHINAO}|KyoheiFukada{FUKADAKYOHEI}|BoFan{FANBO}|ShunyaMatsumoto{MATSUMOTOSHUNYA}|MasakiKobayashi{KOBAYASHIMASAKI}|YukiNakamura{NAKAMURAYUKI}|HiroshiFukushima{FUKUSHIMAHIROSHI}|YumaWaseda{WASEDAYUMA}|HajimeTanaka{TANAKAHAJIME}|YasuhisaFujii{FUJIIYASUHISA}|SuguruOka{OKASUGURU}|MunenoriFukunishi{FUKUNISHIMUNENORI}|YuhiOtani{OTANIYUHI}|KeijuHonma{HONMAKEIJU}|SachieKatayama{KATAYAMASACHIE}|AsamiUsui{USUIASAMI}|MakotoTanaka{TANAKAMAKOTO}|MichikataHayashida{HAYASHIDAMICHIKATA}|KazushigeSakaguchi{SAKAGUCHIKAZUSHIGE}|ShinjiUrakami{URAKAMISHINJI}|AhmedGamal{GAMALAHMED}|MarcioCovasMoschovas{COVASMOSCHOVASMARCIO}|RohanSharma{SHARMAROHAN}|ShadySaikali{SAIKALISHADY}|TravisRogers{ROGERSTRAVIS}|VipulPatel{PATELVIPUL}|MasahiroOda{ODAMASAHIRO}|ShoheiNagakawa{NAGAKAWASHOHEI}|ShigehiroTsukahara{TSUKAHARASHIGEHIRO}|TokiyoshiTanegashima{TANEGASHIMATOKIYOSHI}|ShunsukeGoto{GOTOSHUNSUKE}|SatoshiKobayashi{KOBAYASHISATOSHI}|TakashiMatsumoto{MATSUMOTOTAKASHI}|MasakiShiota{SHIOTAMASAKI}|KensakuMori{MORIKENSAKU}|MasatoshiEto{ETOMASATOSHI}|SyunsukeInoguchi{INOGUCHISYUNSUKE}|TakujiHayashi{HAYASHITAKUJI}|YuIshizuya{ISHIZUYAYU}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|TaigoKato{KATOTAIGO}|KojiHatano{HATANOKOJI}|NorioNonomura{NONOMURANORIO}|GakuIshikawa{ISHIKAWAGAKU}|AsukaSano{SANOASUKA}|AyanaTakemura{TAKEMURAAYANA}|SyunsukeWatanabe{WATANABESYUNSUKE}|KyoheiWatanabe{WATANABEKYOHEI}|YutoMatsushita{MATSUSHITAYUTO}|KeitaTamura{TAMURAKEITA}|DaisukeMotoyama{MOTOYAMADAISUKE}|AtsushiOtsuka{OTSUKAATSUSHI}|TeruoInamoto{INAMOTOTERUO}|HirokazuAbe{ABEHIROKAZU}|HidetsuguTakahashi{TAKAHASHIHIDETSUGU}|YusukeAndo{ANDOYUSUKE}|YutouNaroda{NARODAYUTOU}|RyutaroFukagai{FUKAGAIRYUTARO}|TetsushiTsuchida{TSUCHIDATETSUSHI}|DaisukeSakurai{SAKURAIDAISUKE}|MasashiTeramoto{TERAMOTOMASASHI}|MasahiroFujikawa{FUJIKAWAMASAHIRO}|AtsuhikoOchi{OCHIATSUHIKO}|KoichiroSuzuki{SUZUKIKOICHIRO}|TakahiroKimura{KIMURATAKAHIRO}|KeishiroFukumoto{FUKUMOTOKEISHIRO}|MasashiTakeuchi{TAKEUCHIMASASHI}|AtsukoSato{SATOATSUKO}|YotaYasumizu{YASUMIZUYOTA}|NobuyukiTanaka{TANAKANOBUYUKI}|ToshikazuTakeda{TAKEDATOSHIKAZU}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|TakeoKosaka{KOSAKATAKEO}|TasukuFurube{FURUBETASUKU}|HirofumiKawakubo{KAWAKUBOHIROFUMI}|YukoKitagawa{KITAGAWAYUKO}|MototsuguOya{OYAMOTOTSUGU}|ZyunkoKawase{KAWASEZYUNKO}|TakashiKawabata{KAWABATATAKASHI}|SyuyaTsuchida{TSUCHIDASYUYA}|TakuyaTsujino{TSUJINOTAKUYA}|YukiYoshikawa{YOSHIKAWAYUKI}|KazumasaKomura{KOMURAKAZUMASA}|HaruhitoAzuma{AZUMAHARUHITO}|AsukaKaji{KAJIASUKA}|SatoshiHarada{HARADASATOSHI}|KengoFujiwara{FUJIWARAKENGO}|KanaKohashiguchi{KOHASHIGUCHIKANA}|YoheiAbe{ABEYOHEI}|HirohitoNaito{NAITOHIROHITO}|YoichiroTohi{TOHIYOICHIRO}|TakumaKato{KATOTAKUMA}|RikiyaTaoka{TAOKARIKIYA}|HiroyukiTsunemori{TSUNEMORIHIROYUKI}|NobufumiUeda{UEDANOBUFUMI}|MikioSugimoto{SUGIMOTOMIKIO}____総会賞ビデオ1前立腺・膀胱____Pioneering AI-guided navigation in urological surgery: real-time ureter segmentation during robot-assisted radical cystectomy using convolutional neural network|Surgical navigation using AI image recognition: Identification of nerve-sparing layers during robot-assisted radical prostatectomy|State-of-the-art robotic prostatectomy after 19,000 cases of experience: retrograde nerve-sparing and peritoneal flap|AI object detection system for bladder tumors in white light and narrow-band imaging cystoscopic images|Establishment of Lymph Node Dissection Techniques in Robot-Assisted Laparoscopic Radical Cystectomy|The first ever report of robot-assisted radical cystectomy with intracorporeal neobladder conducted by the hinotori surgical robot system|A novel nerve-sparing technique using barbed sutures in robot-assisted radical prostatectomy|Learning Curve Analysis of Robot-Assisted Radical Prostatectomy Using Surgical Phase Recognition AI|Efficacy of a new Method for Urinary Incontinence in Robot-Assisted Radical Prostatectomy:Preserving Endopelvic Fascia with Anterior and Posterior Reinforcement|Surgical method to prevent anterior enterocele after robot-assisted radical cystectomy

AVP-01

総会賞ビデオ1
前立腺・膀胱

SarelHalachmi{HALACHMISAREL}|SihHanChen{CHENSIHHAN}|KazuhikoFujita{FUJITAKAZUHIKO}|－|ReiShinzawa{SHINZAWAREI}|AtsukoSato{SATOATSUKO}|HidekiTakeshita{TAKESHITAHIDEKI}____ShingoYamamoto{YAMAMOTOSHINGO}|Lih-MingWong{WONGLIH-MING}____XinJiang{JIANGXIN}|TalyaBorkum{BORKUMTALYA}|SagiShprits{SHPRITSSAGI}|JosephBoen{BOENJOSEPH}|SofiaArshavsky-Graham{ARSHAVSKY-GRAHAMSOFIA}|BaruchRofman{ROFMANBARUCH}|MeravStrauss{STRAUSSMERAV}|RaulColodner{COLODNERRAUL}|JeremiasSulam{SULAMJEREMIAS}|HeidiLeonard{LEONARDHEIDI}|EsterSegal{SEGALESTER}|Chun-HsienWu{WUCHUN-HSIEN}|VictorC.Lin{LINVICTORC.}|KentoHokota{HOKOTAKENTO}|KahoHirose{HIROSEKAHO}|JunroYanai{YANAIJUNRO}|JunkiMorino{MORINOJUNKI}|YukiNagashima{NAGASHIMAYUKI}|AkikoNakajima{NAKAJIMAAKIKO}|NaoyaNagaya{NAGAYANAOYA}|ShigeoHorie{HORIESHIGEO}|KazuyoshiShigehara{SHIGEHARAKAZUYOSHI}|NaoakiSakatoku{SAKATOKUNAOAKI}|KotaroFukukawa{FUKUKAWAKOTARO}|ShingoTakada{TAKADASHINGO}|TomomiNakagawa{NAKAGAWATOMOMI}|YukiKato{KATOYUKI}|KazuhumiNakashima{NAKASHIMAKAZUHUMI}|ShoheiKawaguchi{KAWAGUCHISHOHEI}|TakahiroNohara{NOHARATAKAHIRO}|KojiIzumi{IZUMIKOJI}|ToruMiyagi{MIYAGITORU}|AtsushiMizokami{MIZOKAMIATSUSHI}|HiroshiAsanuma{ASANUMAHIROSHI}|MizukiIzawa{IZAWAMIZUKI}|ShunIwasa{IWASASHUN}|YotaYasumizu{YASUMIZUYOTA}|TaijuHyuga{HYUGATAIJU}|HiroyukiSatoh{SATOHHIROYUKI}|KimihikoMoriya{MORIYAKIMIHIKO}|HideoNakai{NAKAIHIDEO}|MototsuguOya{OYAMOTOTSUGU}|AyanoIshida{ISHIDAAYANO}|JunyaKawabata{KAWABATAJUNYA}|KojiroTachibana{TACHIBANAKOJIRO}|ShoichiNagamoto{NAGAMOTOSHOICHI}|SachiKitayama{KITAYAMASACHI}|YoheiOkada{OKADAYOHEI}|SatoruKawakami{KAWAKAMISATORU}|AkihiroYano{YANOAKIHIRO}____Selected Oral 8Infectious disease and pediatric urology____Accurate Prediction of Antimicrobial Susceptibility for Point-of-Care Testing of Urine in Less than 90 Minutes via iPRISM Cassettes|Comparative Efficacy of Early Minimally Invasive Interventions Versus Conservative Treatment for Prostate Abscess: A 15-Year Retrospective Study|Treatment chart of emphysematous nephritis from the experience of 30 cases|演題取り下げ|Retrospective study on postoperative infection prevention in robot-assisted radical cystectomy|Management of pregnancy and delivery in female patients after augmentation cystoplasty: The useful method considering pregnancy and delivery|Perioperative trimodal managements of testicular torsion for maximal testicular preservation: a prospective study

SO-8

Selected Oral 8
Infectious disease and pediatric urology

MasashiShiozaki{SHIOZAKIMASASHI}|KosukeIwatani{IWATANIKOSUKE}|TakahiroNohara{NOHARATAKAHIRO}|TomoyaYokoi{YOKOITOMOYA}|YongZhang{ZHANGYONG}|FumitoYamabe{YAMABEFUMITO}|ToruKanno{KANNOTORU}____MasakiShinbo{SHINBOMASAKI}____TomonoriMinagawa{MINAGAWATOMONORI}|NoriyukiOgawa{OGAWANORIYUKI}|HiroakiHara{HARAHIROAKI}|ManabuUeno{UENOMANABU}|YoshiyukiAkiyama{AKIYAMAYOSHIYUKI}|TakafumiYanagisawa{YANAGISAWATAKAFUMI}|AkihiroMatsukawa{MATSUKAWAAKIHIRO}|ShunSato{SATOSHUN}|TakahiroKimura{KIMURATAKAHIRO}|JunMiki{MIKIJUN}|HiroshiKano{KANOHIROSHI}|TomoyukiMakino{MAKINOTOMOYUKI}|RenatoNaito{NAITORENATO}|HiroakiIwamoto{IWAMOTOHIROAKI}|HiroshiYaegashi{YAEGASHIHIROSHI}|ShoheiKawaguchi{KAWAGUCHISHOHEI}|KazuyoshiShigehara{SHIGEHARAKAZUYOSHI}|KoujiIzumi{IZUMIKOUJI}|AtsushiMizokami{MIZOKAMIATSUSHI}|RinaOgawa{OGAWARINA}|ErikoTanaka{TANAKAERIKO}|MasanoriIto{ITOMASANORI}|HeisukeIijima{IIJIMAHEISUKE}|TakahiroTakahashi{TAKAHASHITAKAHIRO}|MasakatsuUeda{UEDAMASAKATSU}|YusukeShiraishi{SHIRAISHIYUSUKE}|KojiYoshimura{YOSHIMURAKOJI}|ShugoYajima{YAJIMASHUGO}|YulanZhang{ZHANGYULAN}|MizukiKasahara{KASAHARAMIZUKI}|HaruhisaOzawa{OZAWAHARUHISA}|MayukoTakeda{TAKEDAMAYUKO}|SinjiroTakeuchi{TAKEUCHISINJIRO}|MasatoUetani{UETANIMASATO}|MizuhoOkawa{OKAWAMIZUHO}|YozoMitsui{MITSUIYOZO}|HideyukiKobayashi{KOBAYASHIHIDEYUKI}|KoichiNakajima{NAKAJIMAKOICHI}|KeiSakurabayashi{SAKURABAYASHIKEI}|YoshihiroItabashi{ITABASHIYOSHIHIRO}|MasakiMuramatsu{MURAMATSUMASAKI}|TakeyukiWatanabe{WATANABETAKEYUKI}|NaokiHayata{HAYATANAOKI}|TakayoshiMiura{MIURATAKAYOSHI}|RyuichiroArakaki{ARAKAKIRYUICHIRO}|MutsukiMishina{MISHINAMUTSUKI}____一般ビデオ1膀胱____Initial experience with transurethral resection of en-bloc TURBT using a basket forceps tumor traction technique|Accurate Pathological Diagnosis through initial and repeat En Bloc TURBT in Bladder Cancer|Can robotic radical cystectomy using the hinotori surgical robot system be performed safely? ~from initial experience in our institution~|Robotic-assisted radical cystectomy and intracorporeal neobladder construction using the Hood technique|Robot - Assisted Laparoscopic Radical Cystectomy and ileal Conduit Surgery ( Xing's Technique)|A case of robot-assisted radical cystectomy for a third kidney transplant recipient|Application of Indocyanine Green in Robot-assisted Urinary Tract Reconstruction

VP-01

一般ビデオ1
膀胱

YusukeNoda{NODAYUSUKE}|TaikiKato{KATOTAIKI}|ShuNakasuka{NAKASUKASHU}|YuOzawa{OZAWAYU}|TomoyoshiOhashi{OHASHITOMOYOSHI}|YongZhang{ZHANGYONG}____JunMiki{MIKIJUN}____TakuNaiki{NAIKITAKU}|GensukeOkazaki{OKAZAKIGENSUKE}|TatsuyaHattori{HATTORITATSUYA}|YuyaOta{OTAYUYA}|HideyukiKamisawa{KAMISAWAHIDEYUKI}|SatoshiKurokawa{KUROKAWASATOSHI}|TakahiroYasui{YASUITAKAHIRO}|TakashiHamakawa{HAMAKAWATAKASHI}|YasueKubota{KUBOTAYASUE}|YosiyukiKawano{KAWANOYOSIYUKI}|MasatakaSano{SANOMASATAKA}|KiitiHagiwara{HAGIWARAKIITI}|TosihiroSimizu{SIMIZUTOSIHIRO}|NoboruSakamoto{SAKAMOTONOBORU}|HumioTukuda{TUKUDAHUMIO}|YutakaHoriguti{HORIGUTIYUTAKA}|SyoujiKoga{KOGASYOUJI}|MarcioCovasMoschovas{COVASMOSCHOVASMARCIO}|AhmedGamal{GAMALAHMED}|RohanSharma{SHARMAROHAN}|ShadySaikali{SAIKALISHADY}|TravisRogers{ROGERSTRAVIS}|VipulPatel{PATELVIPUL}|RogersTravis{TRAVISROGERS}|YujiroHosono{HOSONOYUJIRO}|YurikoNagasaka{NAGASAKAYURIKO}|HirokoMorikami{MORIKAMIHIROKO}|HidekiMizuno{MIZUNOHIDEKI}|HiroshiYamada{YAMADAHIROSHI}|ToshinoriNishikimi{NISHIKIMITOSHINORI}|NianzengXing{XINGNIANZENG}|DongChen{CHENDONG}____一般ビデオ2前立腺____The beak technique for transurethral enucleation of the prostate: invention and experience with its implementation|Techniques of TURS and TURP shorten the operation time of aquablation therapy: initial experience of robotic-assisted surgical treatment for LUTS with BPH|Experience in safely acquiring CVP surgical techniques using a step-by-step method|Anatomical changes in salvage robot-assisted radical prostatectomy: a video series from a US referral center|Robot-assisted radical prostatectomy for 500 cc huge prostate with median lobe enlargement; technique for bladder neck dissection|A case of RARP using fluorescent ureteral catheter to prevent ureteral injury after kidney transplantation|Modified Retzius-sparing robot-assisted radical prostatectomy and "Sandwich" technique of total urethral reconstruction

VP-02

一般ビデオ2
前立腺

MasanoriNomiya{NOMIYAMASANORI}|TomokoKuwata{KUWATATOMOKO}|TokumasaHayashi{HAYASHITOKUMASA}|NaotoKaburaki{KABURAKINAOTO}____ManamiKinjo{KINJOMANAMI}____HisaeNishii{NISHIIHISAE}|NoritoshiShamoto{SHAMOTONORITOSHI}|MasakiYoshida{YOSHIDAMASAKI}|YukikoDoi{DOIYUKIKO}|KazunobuYagi{YAGIKAZUNOBU}|HiromiKashihara{KASHIHARAHIROMI}|ChikakoKato{KATOCHIKAKO}|MasamiTakeyama{TAKEYAMAMASAMI}|MasayoshiNomura{NOMURAMASAYOSHI}|ShinoTokiwa{TOKIWASHINO}|MikaNagae{NAGAEMIKA}|HisaoKaneko{KANEKOHISAO}|TetsuyaKubota{KUBOTATETSUYA}____一般口演014尿失禁①____Association between urinary incontinence and frailty in elderly hospitalized patients: A 6-month follow-up study|2-Year Outcomes After Mid-urethral Sling Surgery at Our Hospital|Laparoscopic repair of vesico-vaginal fistula, case series study|First experience of intravesical botulinum toxin for oveactive bladder

OP-014

一般口演014
尿失禁①

NobuhiroHaga{HAGANOBUHIRO}|－|AtsushiSengoku{SENGOKUATSUSHI}|MinoriNakatani{NAKATANIMINORI}____ChieMatsushita{MATSUSHITACHIE}____MikakoYoshida{YOSHIDAMIKAKO}|TakahikoMitsui{MITSUITAKAHIKO}|NoritoshiSekido{SEKIDONORITOSHI}|NaoyaMasumori{MASUMORINAOYA}|KenjiOmae{OMAEKENJI}|YasueKubota{KUBOTAYASUE}|MotoakiSaito{SAITOMOTOAKI}|RyujiSakakibara{SAKAKIBARARYUJI}|SatoruTakahashi{TAKAHASHISATORU}|MasashiNomi{NOMIMASASHI}|TakeshiSasaki{SASAKITAKESHI}|ChinatsuSawai{SAWAICHINATSU}|SoutaInaba{INABASOUTA}|ShunsukeOwa{OWASHUNSUKE}|TaketomoNishikawa{NISHIKAWATAKETOMO}|MomokoKato{KATOMOMOKO}|ShinichiroHigashi{HIGASHISHINICHIRO}|YusukeSugino{SUGINOYUSUKE}|KouheiNishikawa{NISHIKAWAKOUHEI}|TakahiroInoue{INOUETAKAHIRO}____一般口演015尿失禁②____Prevalence and Risk Factors of Stress Urinary Incontinence of Both Sexes in a Community Survey (Jacs2023)|演題取り下げ|The outcomes of artificial urinary sphincter implantation: a retrospective study in a rehabilitation hospital|Investigation of patient factors associated with the acquisition of urinary continence after RARP

OP-015

一般口演015
尿失禁②

YuIshizuya{ISHIZUYAYU}|KazuyoshiIzumi{IZUMIKAZUYOSHI}|AkikoFujisaki{FUJISAKIAKIKO}|JunAjiki{AJIKIJUN}|ToekiYanagi{YANAGITOEKI}|ShuuzouHamamoto{HAMAMOTOSHUUZOU}|KazuhiroIshizaka{ISHIZAKAKAZUHIRO}|YutaroSasaki{SASAKIYUTARO}|ShunTakai{TAKAISHUN}|YasuhiroKaku{KAKUYASUHIRO}____YukihiroKondo{KONDOYUKIHIRO}____AtsunariKawashima{KAWASHIMAATSUNARI}|YukiHoribe{HORIBEYUKI}|AkihiroYoshimura{YOSHIMURAAKIHIRO}|NorichikaUeda{UEDANORICHIKA}|ShigeakiNakazawa{NAKAZAWASHIGEAKI}|TakujiHayashi{HAYASHITAKUJI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|KentaroTakezawa{TAKEZAWAKENTARO}|TaigoKato{KATOTAIGO}|KojiHatano{HATANOKOJI}|YoichiKakuta{KAKUTAYOICHI}|NorioNonomura{NONOMURANORIO}|KatsuhitoHori{HORIKATSUHITO}|KokiTada{TADAKOKI}|YuOzaki{OZAKIYU}|TakeshiMiyake{MIYAKETAKESHI}|TakuyaTsujioka{TSUJIOKATAKUYA}|AtsukoFujiwara{FUJIWARAATSUKO}|YasuoKawanishi{KAWANISHIYASUO}|MasahitoYamanaka{YAMANAKAMASAHITO}|MakiSugimoto{SUGIMOTOMAKI}|KurenaiKinno{KINNOKURENAI}|YukikoHiramoto{HIRAMOTOYUKIKO}|ShukoHomda{HOMDASHUKO}|MisaShimoinaba{SHIMOINABAMISA}|YasukuniYoshimura{YOSHIMURAYASUKUNI}|YasuyukiNaitoh{NAITOHYASUYUKI}|AtsukoFujihara{FUJIHARAATSUKO}|FumiyaHongo{HONGOFUMIYA}|ShigeruMurata{MURATASHIGERU}|OsamuUkimura{UKIMURAOSAMU}|AkihiroKanematsu{KANEMATSUAKIHIRO}|KoichiOshima{OSHIMAKOICHI}|YusukeYamada{YAMADAYUSUKE}|ShingoYamamoto{YAMAMOTOSHINGO}|MeitaUchida{UCHIDAMEITA}|SousukeNiwa{NIWASOUSUKE}|KengoKawase{KAWASEKENGO}|ReiUnno{UNNOREI}|AtsushiOkada{OKADAATSUSHI}|TakahiroYasui{YASUITAKAHIRO}|RyuKato{KATORYU}|IbukiKobayashi{KOBAYASHIIBUKI}|TetsuyukiMatsutani{MATSUTANITETSUYUKI}|EiichiKanai{KANAIEIICHI}|TaisukeOkumura{OKUMURATAISUKE}|HiroyukiWakamatsu{WAKAMATSUHIROYUKI}|TetsutaSenoo{SENOOTETSUTA}|RenaKindaichi{KINDAICHIRENA}|MasayaMukai{MUKAIMASAYA}|TsunehiroNenohi{NENOHITSUNEHIRO}|MasayasuUrushibara{URUSHIBARAMASAYASU}|MinatoYokoyama{YOKOYAMAMINATO}|TetsuhiroYano{YANOTETSUHIRO}|MitsukiNishiyama{NISHIYAMAMITSUKI}|SakiKobayashi{KOBAYASHISAKI}|RyoeiMinato{MINATORYOEI}|KeiDaizumoto{DAIZUMOTOKEI}|RyotaroTomida{TOMIDARYOTARO}|YoshitoKusuhara{KUSUHARAYOSHITO}|TomoyaFukawa{FUKAWATOMOYA}|YasuyoYamamoto{YAMAMOTOYASUYO}|KunihisaYamaguchi{YAMAGUCHIKUNIHISA}|MasayukiTakahashi{TAKAHASHIMASAYUKI}|JunyaFurukawa{FURUKAWAJUNYA}|YoheiNoda{NODAYOHEI}|YutoOhara{OHARAYUTO}|KoyaMorishita{MORISHITAKOYA}|YuriYuguchi{YUGUCHIYURI}|YoshieMoriya{MORIYAYOSHIE}|ToruKimura{KIMURATORU}|YokoYoshikawa{YOSHIKAWAYOKO}|OsamuKamihira{KAMIHIRAOSAMU}|NaotoTanaka{TANAKANAOTO}|YosukeFukiishi{FUKIISHIYOSUKE}|MasaichiroFujita{FUJITAMASAICHIRO}|FukashiYamamichi{YAMAMICHIFUKASHI}|TakaakiInoue{INOUETAKAAKI}____総会賞ビデオ2副腎・腎・尿管・その他____Establishment of lymph node dissection procedure with both safety and diagnostic accuracy in retroperitoneal robot-assisted radical nephroureterectomy|Appropriate Tumor Resection Using Virtual Partial Nephrectomy Imaging in Robotic Partial Nephrectomy: Visualization of Renal Cortex, Medulla, and Sinus Fat|Hologram marker-assisted mixed reality for transvaginal surgery|Development of novel morphological uroflowmetry using two colored-laser-light sheets|Non-transecting EPA using intra-sphincteric dissection technique for bulbomembranous urethral stricture after BPH surgery|Robotic ureteral reconstruction with Buccal Mucosal Graft for complete ureteral avulsion caused by traffic injury|Laparoscopic urological operations in the porcine model supported by the three-fingered robotic forceps operated by the assistant|Vas guide: a novel medical device that safely and smoothly secures blood vessels in robot-assisted surgery|Strategies for robot-assisted radical nephrectomy with left renal vein tumor thrombus depending on thrombus level|Combined doublet technology with suctioning flexible & navigable ureteral access sheath and powdering using Moses technology in retrograde intrarenal surgery

AVP-02

総会賞ビデオ2
副腎・腎・尿管・その他

NobuhikoShimizu{SHIMIZUNOBUHIKO}|SayaIto-Ueda{ITO-UEDASAYA}|－|WeiChunHuang{HUANGWEICHUN}|TakujiHayashi{HAYASHITAKUJI}|SahyunPak{PAKSAHYUN}|HarshaDPutra{PUTRAHARSHAD}|Ting-YaoCheng{CHENGTING-YAO}|YoshimiTamura{TAMURAYOSHIMI}____KojiShiraishi{SHIRAISHIKOJI}|BannakijLojanapiwat{LOJANAPIWATBANNAKIJ}____TakuNaiki{NAIKITAKU}|MariaAoki{AOKIMARIA}|ToshiharuMorikawa{MORIKAWATOSHIHARU}|MasakazuGonda{GONDAMASAKAZU}|TakashiNagai{NAGAITAKASHI}|ToshikiEtani{ETANITOSHIKI}|NoriyasuKawai{KAWAINORIYASU}|TakahiroYasui{YASUITAKAHIRO}|MingWeiHsu{HSUMINGWEI}|ChiPingHuang{HUANGCHIPING}|ChiReiYang{YANGCHIREI}|WenChiChen{CHENWENCHI}|HisChinWu{WUHISCHIN}|AtsunariKawashima{KAWASHIMAATSUNARI}|YuIshizuya{ISHIZUYAYU}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|NorichikaUeda{UEDANORICHIKA}|ShigeakiNakazawa{NAKAZAWASHIGEAKI}|KentaroTakezawa{TAKEZAWAKENTARO}|TaigoKato{KATOTAIGO}|KojiHatano{HATANOKOJI}|YoichiKakuta{KAKUTAYOICHI}|NorioNonomura{NONOMURANORIO}|ParkSungGon{SUNGGONPARK}|KwonOhseong{OHSEONGKWON}|LeeSeongHo{SEONGHOLEE}|LeeYoungGoo{YOUNGGOOLEE}|ChoSungTae{SUNGTAECHO}|Tsu-FengLin{LINTSU-FENG}|AllenW.Chiu{CHIUALLENW.}|YoshinoriHori{HORIYOSHINORI}|MasanoriIshizeki{ISHIZEKIMASANORI}|TadatoshiYoshihara{YOSHIHARATADATOSHI}|TankanoriShimizu{SHIMIZUTANKANORI}|AzusaKanayama{KANAYAMAAZUSA}|AkioHoriguchi{HORIGUCHIAKIO}____Selected Oral 9Others____Evaluation of Lysine-specific demethylase 1 (LSD1) expression and antitumor effects of LSD1 inhibitors, NCL1 and NCD38, in testicular tumors|Studies on the mechanisms of testicular cancer development based on molecular biological approaches|Withdrawn|Case series: Robotic-Assisted Adrenalectomy for pheochromocytoma, a single center 7 years experiences|演題取り下げ|The efforts to alleviate the financial toxicity of robot-assisted adrenalectomy based on the cost taking into consideration surgical time|Deep learning model using single image input for diagnosis of acute scrotum|Comparison of Complications after Surgery between Buccal Mucosa Graft and Penile Skin Flap for Urethroplasty in Stricture Urethra Patients: A Systematic Review|Exploring Risk Factors of Moderate to Severe Acute Pain Following Total Extraperitoneal Inguinal Hernia Repair: A Retrospective Analysis of 691 Cases|Treatment results of urethroplasty at Shibukawa Medical Center

SO-9

Selected Oral 9
Others

JumpeiKatsuta{KATSUTAJUMPEI}|SadayoshiSuzuki{SUZUKISADAYOSHI}|NaokoMatsumoto{MATSUMOTONAOKO}|WataruKudo{KUDOWATARU}|MisakiAshiya{ASHIYAMISAKI}|AkitoIto{ITOAKITO}____KojiInoue{INOUEKOJI}____AkioHoriguchi{HORIGUCHIAKIO}|MasayukiShinchi{SHINCHIMASAYUKI}|KenichiroOjima{OJIMAKENICHIRO}|YusukeHirano{HIRANOYUSUKE}|KazukiTakekawa{TAKEKAWAKAZUKI}|YoshiyukiFurukawa{FURUKAWAYOSHIYUKI}|TakahiroMinami{MINAMITAKAHIRO}|SadayoshiSuzuki{SUZUKISADAYOSHI}|HakaruMasumoto{MASUMOTOHAKARU}|KeiichiIto{ITOKEIICHI}|YuheiSegawa{SEGAWAYUHEI}|JunichiAsakuma{ASAKUMAJUNICHI}|EijiTakahashi{TAKAHASHIEIJI}|HiromiEdo{EDOHIROMI}|HiroshiShinmoto{SHINMOTOHIROSHI}|JunpeiKatsuta{KATSUTAJUNPEI}|TakaakiYokoyama{YOKOYAMATAKAAKI}|TakehiroHanazawa{HANAZAWATAKEHIRO}|YuuheiSegawa{SEGAWAYUUHEI}|HiroakiKobayashi{KOBAYASHIHIROAKI}|YuujirouTsujita{TSUJITAYUUJIROU}|KenjiKuroda{KURODAKENJI}|AtsushiHamano{HAMANOATSUSHI}|SaikaKajitani{KAJITANISAIKA}|KeiichiItou{ITOUKEIICHI}|YasuhiroKaiho{KAIHOYASUHIRO}|KieSekiguchi{SEKIGUCHIKIE}|WataruObara{OBARAWATARU}____一般ビデオ3尿道____Experience with transurethral ventral inlay urethroplasty for fossa navicularis strictures: A novel approach preserving glans aesthetics and urinary function|Surgical Pearls for Excision and Primary Anastomosis in Traumatic Bulbar Urethral Strictures: Urethral Dissection Tips for Corpus Spongiosum Disruption|Penile Skin Tube Flap Urethroplasty: A Reliable Salvage Technique for Ischemic Bulbar Urethral Necrosis Following Failed Excision and Primary Anastomosis|Outcomes of two-stage repair of a proximal hypospadias using a glans tunnel : retrospective comparison with the Thiersch-Duplay Methods|Dorsal Onlay Urethroplasty Using Oral Mucosa Grafts for Female Urethral Stricture: A Single-Center Experience|Implementation experience of artificial urinary sphincter implantation in Iwate Prefecture using smart glasses

VP-03

一般ビデオ3
尿道

TakashiYoshida{YOSHIDATAKASHI}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|NaofumiTsutsumi{TSUTSUMINAOFUMI}|MasanaoShinohara{SHINOHARAMASANAO}|KiyotakaKawashima{KAWASHIMAKIYOTAKA}____KazuhideMakiyama{MAKIYAMAKAZUHIDE}____YusukeMotoki{MOTOKIYUSUKE}|TakahiroNakamoto{NAKAMOTOTAKAHIRO}|TadashiMatsuda{MATSUDATADASHI}|HidefumiKinoshita{KINOSHITAHIDEFUMI}|KeishiroFukumoto{FUKUMOTOKEISHIRO}|NobuyukiTanaka{TANAKANOBUYUKI}|ToshikazuTakeda{TAKEDATOSHIKAZU}|MototsuguOya{OYAMOTOTSUGU}|TakatsunaShimazaki{SHIMAZAKITAKATSUNA}|ShinyaAbe{ABESHINYA}|ToshihideHosomi{HOSOMITOSHIHIDE}|YuriNishikawa{NISHIKAWAYURI}|YukiKamiyama{KAMIYAMAYUKI}|YoichiroKajita{KAJITAYOICHIRO}|TakehikoSegawa{SEGAWATAKEHIKO}|KouheiInui{INUIKOUHEI}|ShingoMoriyama{MORIYAMASHINGO}|ShumonKato{KATOSHUMON}|HiromasaTanaka{TANAKAHIROMASA}|RisakoKabasawa{KABASAWARISAKO}|RisaFukuda{FUKUDARISA}|WataruHirata{HIRATAWATARU}|ReikaTanaka{TANAKAREIKA}|KazueOgawa{OGAWAKAZUE}|DaiziFuzimori{FUZIMORIDAIZI}|YouheiKawashima{KAWASHIMAYOUHEI}|SatoshiSato{SATOSATOSHI}|HirokiKitoh{KITOHHIROKI}|HirokiIchikawa{ICHIKAWAHIROKI}____一般ビデオ4腎・尿管・その他____Photodynamic diagnosis-guided ureteroscopic laser ablation of upper urinary tract urothelial carcinoma: phase 2, open-label, single-arm trial|Pure retroperitoneal robot-assisted radical nephroureterectomy (RANU) technique using the hinotori surgical robot system|Experience of transperitoneal approach surgery using Da Vinci SP for upper urinary tract tumors at our hospital|Early Experience of Robotic-Assisted Partial Nephrectomy and Nephrouretectomy via a Low Anterior Access Approach Using the da Vinci SP System|Convenient and minimally invasive bilateral epididymis-sparing orchiectomy under local anesthesia with VIO® 3 (BiClamp, preciseSECT)

VP-04

一般ビデオ4
腎・尿管・その他

TaigoKato{KATOTAIGO}|MizuhoOkawa{OKAWAMIZUHO}|KoujiNishizawa{NISHIZAWAKOUJI}|SeiichiSaitou{SAITOUSEIICHI}____TakashiMatsumoto{MATSUMOTOTAKASHI}____ShugoYajima{YAJIMASHUGO}|YoshiakiNakamura{NAKAMURAYOSHIAKI}|ShinKobayashi{KOBAYASHISHIN}|HideakiMiyake{MIYAKEHIDEAKI}|MioWakai{WAKAIMIO}|MidoriShuhara{SHUHARAMIDORI}|MayukoTakeda{TAKEDAMAYUKO}|OrieHoshino{HOSHINOORIE}|MasatoUetani{UETANIMASATO}|MizukiKasahara{KASAHARAMIZUKI}|FumitoYamabe{YAMABEFUMITO}|YozoMitsui{MITSUIYOZO}|NaobumiTochigi{TOCHIGINAOBUMI}|ShinjiUjiie{UJIIESHINJI}|YukikoKatagiri{KATAGIRIYUKIKO}|KoichiNakajima{NAKAJIMAKOICHI}|MatsushitaTomonori{TOMONORIMATSUSHITA}|NakagawaHiromichi{HIROMICHINAKAGAWA}|GotoShuhei{SHUHEIGOTO}|FukuzawaShigeki{SHIGEKIFUKUZAWA}____一般口演016泌尿器腫瘍①____Current status and future prospects of molecular residual disease tests in genitourinary cancers: JSCO position paper on appropriate clinical use of MRD testing|Updates on Cancer Genome Medicine -Patient Supports at the Urological Cancer Genome Outpatient Clinic (UCGOC) and Clinical Genetics Unit (CGU) in Our Hospital -|Examination of the treatment course of oligometastatic advanced urothelial carcinoma cases|Possible relationship between glycosphingolipids and lineage plasticity in cancer_a literature review

OP-016

一般口演016
泌尿器腫瘍①

HiroshiNagae{NAGAEHIROSHI}|FumiyaYoneyama{YONEYAMAFUMIYA}|－|KotaroSuzuki{SUZUKIKOTARO}____TomoyaFukawa{FUKAWATOMOYA}____NaomiMaehori{MAEHORINAOMI}|ShingoHatakeyama{HATAKEYAMASHINGO}|OsamuSoma{SOMAOSAMU}|YusukeOzaki{OZAKIYUSUKE}|TakumaNarita{NARITATAKUMA}|NaokiFujita{FUJITANAOKI}|TeppeiOkamoto{OKAMOTOTEPPEI}|HayatoYamamoto{YAMAMOTOHAYATO}|AtsushiImai{IMAIATSUSHI}|YuyaMaezawa{MAEZAWAYUYA}|KeizoKawano{KAWANOKEIZO}|YasuyukiSakai{SAKAIYASUYUKI}____一般口演017泌尿器腫瘍②____Comprehensive geriatric assessment (CGA) for 161 cases of urologic cancer|The relationship between frailty and instrumental activities of daily living and its impact on quality-of-life in patients with urological cancers|演題取り下げ|A case of dedifferentiated liposarcoma of the spermatic cord

OP-017

一般口演017
泌尿器腫瘍②

YutoBaba{BABAYUTO}|ArinobuFukunaga{FUKUNAGAARINOBU}|TomoakiTakai{TAKAITOMOAKI}|MasakiShiota{SHIOTAMASAKI}|ToshikiOka{OKATOSHIKI}|SaizoFujimoto{FUJIMOTOSAIZO}|GoshiKitano{KITANOGOSHI}|SanjiKanaoka{KANAOKASANJI}|KaiOzaki{OZAKIKAI}|ShuheiAoyama{AOYAMASHUHEI}____TsukasaIgawa{IGAWATSUKASA}____KosakaTakeo{TAKEOKOSAKA}|YotaYasumizu{YASUMIZUYOTA}|ShigehisaKitano{KITANOSHIGEHISA}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|HiroshiNishihara{NISHIHARAHIROSHI}|TakashiWatanabe{WATANABETAKASHI}|ToyonoriTuzuki{TUZUKITOYONORI}|ToshiroSato{SATOTOSHIRO}|MototsuguOya{OYAMOTOTSUGU}|TakayukiSumiyoshi{SUMIYOSHITAKAYUKI}|MakiFujiwara{FUJIWARAMAKI}|KensukeHikami{HIKAMIKENSUKE}|KeiMizuno{MIZUNOKEI}|TakayukiGoto{GOTOTAKAYUKI}|ShusukeAkamatsu{AKAMATSUSHUSUKE}|TakashiKobayashi{KOBAYASHITAKASHI}|TatsuoFukushima{FUKUSHIMATATSUO}|KoNakamura{NAKAMURAKO}|TakuyaTsujino{TSUJINOTAKUYA}|YukiYoshikawa{YOSHIKAWAYUKI}|TomohisaMatsunaga{MATSUNAGATOMOHISA}|KazumasaKomura{KOMURAKAZUMASA}|HayahitoNomi{NOMIHAYAHITO}|HaruhitoAzuma{AZUMAHARUHITO}|TokiyoshiTanegashima{TANEGASHIMATOKIYOSHI}|ShigehiroTsukahara{TSUKAHARASHIGEHIRO}|JunMutaguchi{MUTAGUCHIJUN}|ShunsukeGoto{GOTOSHUNSUKE}|SatoshiKobayashi{KOBAYASHISATOSHI}|TakashiMatumoto{MATUMOTOTAKASHI}|MasatoshiEto{ETOMASATOSHI}|KojiHatano{HATANOKOJI}|HiroakiHase{HASEHIROAKI}|YutongLiu{LIUYUTONG}|TomohiroKanaki{KANAKITOMOHIRO}|MasaruTani{TANIMASARU}|YuIshizuya{ISHIZUYAYU}|TakujiHayashi{HAYASHITAKUJI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|TaigoKato{KATOTAIGO}|AtsunariKawashima{KAWASHIMAATSUNARI}|KazutakeTsujikawa{TSUJIKAWAKAZUTAKE}|NorioNonomura{NONOMURANORIO}|EriBanno{BANNOERI}|MarcoAntonioDeVelasco{ANTONIODEVELASCOMARCO}|ToshikiOka{OKATOSHIKI}|JunyaHata{HATAJUNYA}|MakotoMatsushita{MATSUSHITAMAKOTO}|TetsuyaTakao{TAKAOTETSUYA}|ShingoTakada{TAKADASHINGO}|AkiraTsujimura{TSUJIMURAAKIRA}|WataruObara{OBARAWATARU}|KazutoshiFujita{FUJITAKAZUTOSHI}|RyotaIkadai{IKADAIRYOTA}|ManabuKato{KATOMANABU}|WakiHosoda{HOSODAWAKI}|ChitoseOneyama{ONEYAMACHITOSE}|AkihitoInoko{INOKOAKIHITO}|TakahiroKojima{KOJIMATAKAHIRO}|AtsushiOkabe{OKABEATSUSHI}|ManatoKanesaka{KANESAKAMANATO}|MasahiroSugiura{SUGIURAMASAHIRO}|TakayukiHoshii{HOSHIITAKAYUKI}|MasakiFukuyo{FUKUYOMASAKI}|RahmutullaBahityar{BAHITYARRAHMUTULLA}|TomokazuSazuka{SAZUKATOMOKAZU}|YusukeImamura{IMAMURAYUSUKE}|ShinichiSakamoto{SAKAMOTOSHINICHI}|AtsushiKaneda{KANEDAATSUSHI}|TomohikoIchikawa{ICHIKAWATOMOHIKO}|TohruYoneyama{YONEYAMATOHRU}|YukaKubota{KUBOTAYUKA}|MihokoYoneyama{YONEYAMAMIHOKO}|ChikaraOhyama{OHYAMACHIKARA}|ShingoHatakeyama{HATAKEYAMASHINGO}|KoujiIzumi{IZUMIKOUJI}|YoshikiKouketsu{KOUKETSUYOSHIKI}|RyunosukeNakagawa{NAKAGAWARYUNOSUKE}|RenToriumi{TORIUMIREN}|RieFukuda{FUKUDARIE}|HiroshiKano{KANOHIROSHI}|TomoyukiMakino{MAKINOTOMOYUKI}|RenatoNaito{NAITORENATO}|HiroakiIwamoto{IWAMOTOHIROAKI}|HiroshiYaegashi{YAEGASHIHIROSHI}|TakahiroNohara{NOHARATAKAHIRO}|AtsushiMizokami{MIZOKAMIATSUSHI}____総会賞ポスター08前立腺癌：基礎____Development of organoid models of treatment-resistant prostate cancer and their application for drug screening aiming for personalized treatment|Transcriptome of de novo metastatic castration-sensitive prostate cancer using long-read sequencing|Development of a novel PARP inhibitor combination therapy and identification of a PARP inhibitor resistance mechanism in prostate cancer|Quantitative proteomic analysis to elucidate the mechanisms of resistance to second-generation antiandrogens|Exercise inhibits prostate cancer progression by altering arginine metabolism in tumor microenvironment|Differences between the gut microbiota of hormone-sensitive prostate cancer and castration-resistant prostate cancer in Japanese men|Development of an individualized preclinical model using a long-term primary culture from prostate cancer needle biopsies|Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer|Tumor-vascular targeting chemotherapy for prostate cancer using annexin A1 targeted D-type peptide-MMAE complex|AR-induced miRNA124-3p.2 suppresses the metastasis-promoting factor CCL2

AOP-08

総会賞ポスター08
前立腺癌：基礎

ShojiKoga{KOGASHOJI}|KazushigeSakaguchi{SAKAGUCHIKAZUSHIGE}|KojiHatano{HATANOKOJI}|YukiKohada{KOHADAYUKI}|HiroakiKobayashi{KOBAYASHIHIROAKI}|MasashiTsujimoto{TSUJIMOTOMASASHI}|TakeshiSasaki{SASAKITAKESHI}|SeijiHoshi{HOSHISEIJI}|MasakiKobayashi{KOBAYASHIMASAKI}|YukiMiura{MIURAYUKI}____KazuhiroSuzuki{SUZUKIKAZUHIRO}____NaoyukiShono{SHONONAOYUKI}|YutakaHoriguchi{HORIGUCHIYUTAKA}|YukiSano{SANOYUKI}|ShuNakasuka{NAKASUKASHU}|KiichiHagiwara{HAGIWARAKIICHI}|ToshihiroShimizu{SHIMIZUTOSHIHIRO}|YoshiyukiKawano{KAWANOYOSHIYUKI}|NoboruSakamoto{SAKAMOTONOBORU}|FumioTukuda{TUKUDAFUMIO}|TaichiKin{KINTAICHI}|KeijyuHonma{HONMAKEIJYU}|SachieKatayama{KATAYAMASACHIE}|AsamiUsui{USUIASAMI}|KazukiHonda{HONDAKAZUKI}|MakotoTanaka{TANAKAMAKOTO}|MichikataHayashida{HAYASHIDAMICHIKATA}|SuguruOka{OKASUGURU}|ShinjiUrakami{URAKAMISHINJI}|ToshikiOka{OKATOSHIKI}|TakujiYamada{YAMADATAKUJI}|MakotoMatsushita{MATSUSHITAMAKOTO}|SaizoFujimoto{FUJIMOTOSAIZO}|JunyaHata{HATAJUNYA}|AkiraTsujimura{TSUJIMURAAKIRA}|WataruObara{OBARAWATARU}|ShingoTakada{TAKADASHINGO}|TetsuyaTakao{TAKAOTETSUYA}|ShinichiYachida{YACHIDASHINICHI}|NorioNonomura{NONOMURANORIO}|KazutoshiFujita{FUJITAKAZUTOSHI}|ShunsukeMiyamoto{MIYAMOTOSHUNSUKE}|YukikoHonda{HONDAYUKIKO}|AkiraIshikawa{ISHIKAWAAKIRA}|KoheiKobatake{KOBATAKEKOHEI}|YoheiSekino{SEKINOYOHEI}|HiroyukiKitano{KITANOHIROYUKI}|KeisukeGoto{GOTOKEISUKE}|AkihiroGoriki{GORIKIAKIHIRO}|KeisukeHieda{HIEDAKEISUKE}|NaoyukiKitamura{KITAMURANAOYUKI}|KazuoAwai{AWAIKAZUO}|NobuyukiHinata{HINATANOBUYUKI}|TakeoKosaka{KOSAKATAKEO}|KoheiNakamura{NAKAMURAKOHEI}|KosukeMiyai{MIYAIKOSUKE}|TokuhiroKimura{KIMURATOKUHIRO}|YoshinoriYanai{YANAIYOSHINORI}|KoetsuHamamoto{HAMAMOTOKOETSU}|YutoBaba{BABAYUTO}|HiroshiNishihara{NISHIHARAHIROSHI}|MototsuguOya{OYAMOTOTSUGU}|KeiichiIto{ITOKEIICHI}|YutaInoue{INOUEYUTA}|HidetoTaga{TAGAHIDETO}|YumikoSaito{SAITOYUMIKO}|MasatsuguMiyashita{MIYASHITAMASATSUGU}|TakashiUeda{UEDATAKASHI}|AtsukoFujihara{FUJIHARAATSUKO}|TakumiShiraishi{SHIRAISHITAKUMI}|MasayoshiOkumi{OKUMIMASAYOSHI}|FumiyaHongo{HONGOFUMIYA}|EiichiKonishi{KONISHIEIICHI}|KeiYamada{YAMADAKEI}|OsamuUkimura{UKIMURAOSAMU}|RemiSemba{SEMBAREMI}|IkuoKobayashi{KOBAYASHIIKUO}|KatsunoriUchida{UCHIDAKATSUNORI}|KouheiNishikawa{NISHIKAWAKOUHEI}|HiroshiMiyamoto{MIYAMOTOHIROSHI}|NaotoSassa{SASSANAOTO}|ToyonoriTsuzuki{TSUZUKITOYONORI}|MasatoshiWatanabe{WATANABEMASATOSHI}|TakahiroInoue{INOUETAKAHIRO}|TomokiTakeda{TAKEDATOMOKI}|ManabuKyan{KYANMANABU}|YuEndo{ENDOYU}|AkihisaHasegawa{HASEGAWAAKIHISA}|RyoTanji{TANJIRYO}|RurikoTakinami{TAKINAMIRURIKO}|YuichiSato{SATOYUICHI}|HidenoriAkaihata{AKAIHATAHIDENORI}|SoichiroOgawa{OGAWASOICHIRO}|MotohideUemura{UEMURAMOTOHIDE}|YoshiyukiKojima{KOJIMAYOSHIYUKI}|HirokiShimoda{SHIMODAHIROKI}|TsubasaIto{ITOTSUBASA}|ShunyaMatsumoto{MATSUMOTOSHUNYA}|YukiNakamura{NAKAMURAYUKI}|YudaiIshikawa{ISHIKAWAYUDAI}|ShoheiFukuda{FUKUDASHOHEI}|HiroshiFukushima{FUKUSHIMAHIROSHI}|YumaWaseda{WASEDAYUMA}|HajimeTanaka{TANAKAHAJIME}|SoichiroYoshida{YOSHIDASOICHIRO}|YasuhisaFujii{FUJIIYASUHISA}|TohruYoneyama{YONEYAMATOHRU}|HayatoYamamoto{YAMAMOTOHAYATO}|HiromuSuzuki{SUZUKIHIROMU}|TakumaOtsubo{OTSUBOTAKUMA}|ErikoFujita{FUJITAERIKO}|FumiyasuTsushima{TSUSHIMAFUMIYASU}|ShitaroGoto{GOTOSHITARO}|MasahiroIshiyama{ISHIYAMAMASAHIRO}|TadashiYoshizawa{YOSHIZAWATADASHI}|ShingoKakeda{KAKEDASHINGO}|ShingoHatakeyama{HATAKEYAMASHINGO}|ChikaraOhyama{OHYAMACHIKARA}____総会賞ポスター09前立腺癌：疫学・診断____Automatic segmentation of prostate cancer lesion into preoperative MRI Images by deep learning based on specimens of robotic-assisted radical prostatectomy|Low hemoglobin A1c level in type2 diabetic mellites is a risk factor of prostate cancer incidence: A large cohort study using Japanese claims database|Gut microbiota profile in Japanese patients with prostate cancer: PROMISE-JAPAN cohort analysis|Utility of tumor diameter-to-prostate volume ratio for predicting the outcome of magnetic resonance imaging/transrectal ultrasound fusion-targeted biopsy|Characteristics unique to Japanese patients derived from a genomic profile analysis of rare ductal adenocarcinoma of the prostate in the largest cohort in Asia|Magnetic resonance imaging-determined tumor contact area to predict pathological extra prostatic extension in clinical T2 prostate cancer|Regional discrepancy of the incidence and outcomes of intraductal carcinoma of the prostate (IDCP) based on RARP specimens between Japan and United States|Predictor of Rapidly Progressing Castration-Sensitive Prostate Cancer|Comparison of highest versus global Gleason grade groups on MRI/US fusion biopsy for predicting significant cancer in radical prostatectomy specimens|Comprehensive reagent performance and clinical relevance of S2,3PSA% test in mpMRI fusion targeted prostate biopsy cohort

AOP-09

総会賞ポスター09
前立腺癌：疫学・診断

KeiYaginuma{YAGINUMAKEI}|MasaruTani{TANIMASARU}|YoshiyukiMiyazawa{MIYAZAWAYOSHIYUKI}|YoshinoriYanai{YANAIYOSHINORI}|NobumichiTanaka{TANAKANOBUMICHI}|TaketoKawai{KAWAITAKETO}|NobuyoshiFukumitsu{FUKUMITSUNOBUYOSHI}|AtsuroSawada{SAWADAATSURO}|KeitaHayakawa{HAYAKAWAKEITA}|ShuntaroIuchi{IUCHISHUNTARO}____MikioSugimoto{SUGIMOTOMIKIO}____HoshiSeiji{SEIJIHOSHI}|TomohiroKawamata{KAWAMATATOMOHIRO}|TomokiTakeda{TAKEDATOMOKI}|YuEndo{ENDOYU}|SyuntaMakabe{MAKABESYUNTA}|HitomiImai{IMAIHITOMI}|HidenoriAkaihata{AKAIHATAHIDENORI}|SoichiroOgawa{OGAWASOICHIRO}|MotohideUemura{UEMURAMOTOHIDE}|TomoyaUehara{UEHARATOMOYA}|KazuhiroTakahashi{TAKAHASHIKAZUHIRO}|YoshiyukiKojima{KOJIMAYOSHIYUKI}|KojiHatano{HATANOKOJI}|YuIshizuya{ISHIZUYAYU}|KeisukeNimura{NIMURAKEISUKE}|TomohiroKanaki{KANAKITOMOHIRO}|YutongLiu{LIUYUTONG}|ToshikiOka{OKATOSHIKI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|TakujiHayashi{HAYASHITAKUJI}|TaigoKato{KATOTAIGO}|AtsunariKawashima{KAWASHIMAATSUNARI}|IwaoNonomura{NONOMURAIWAO}|KönikArda{KÖNIKARDA}|KeisukeOtani{OTANIKEISUKE}|YukakoOtani{OTANIYUKAKO}|RichardLee{LEERICHARD}|XinGao{GAOXIN}|BasharKako{KAKOBASHAR}|PedramHeidari{HEIDARIPEDRAM}|DejanJuric{JURICDEJAN}|MilesA.Miller{A.MILLERMILES}|LindaNieman{NIEMANLINDA}|ThomasS.c.Ng{NGTHOMASS.C.}|DavidTMiyamoto{MIYAMOTODAVIDT}|TakeoKosaka{KOSAKATAKEO}|ShujiMikami{MIKAMISHUJI}|MasashiArai{ARAIMASASHI}|YutoBaba{BABAYUTO}|KeitaroWatanabe{WATANABEKEITARO}|ToshikazuTakeda{TAKEDATOSHIKAZU}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|MakikoYamashita{YAMASHITAMAKIKO}|ShigehisaKitano{KITANOSHIGEHISA}|MototsuguOya{OYAMOTOTSUGU}|AtsunoriYorozu{YOROZUATSUNORI}|KazutoIto{ITOKAZUTO}|HiromichiIsiyama{ISIYAMAHIROMICHI}|TakefumiSatoh{SATOHTAKEFUMI}|KentaMiki{MIKIKENTA}|MitsuguKanehira{KANEHIRAMITSUGU}|YoshitoKusuhara{KUSUHARAYOSHITO}|ShigehiroTsukahara{TSUKAHARASHIGEHIRO}|KojiOkihara{OKIHARAKOJI}|ShinsukeKojima{KOJIMASHINSUKE}|TakashiKikuchi{KIKUCHITAKASHI}|ShiroSaito{SAITOSHIRO}|FumikoKiyonaga{KIYONAGAFUMIKO}|HirotakaShibata{SHIBATAHIROTAKA}|YusukeTanaka{TANAKAYUSUKE}|AtsushiSaito{SAITOATSUSHI}|KazumaIwashita{IWASHITAKAZUMA}|SungchulPark{PARKSUNGCHUL}|YusukeDemizu{DEMIZUYUSUKE}|YukariBandou{BANDOUYUKARI}|AkihisaYao{YAOAKIHISA}|KeiMatsushita{MATSUSHITAKEI}|HideakiMiyake{MIYAKEHIDEAKI}|SunaoTokumaru{TOKUMARUSUNAO}|KoushiroNishimoto{NISHIMOTOKOUSHIRO}|SyusukeAkamatsu{AKAMATSUSYUSUKE}|MasashiKubota{KUBOTAMASASHI}|TakayukiSumiyoshi{SUMIYOSHITAKAYUKI}|RyoichiSaioto{SAIOTORYOICHI}|RyomaKurahashi{KURAHASHIRYOMA}|YuyaSekine{SEKINEYUYA}|HiromitsuNegoro{NEGOROHIROMITSU}|KimihiroShimatani{SHIMATANIKIMIHIRO}|ToshiyukiKamoto{KAMOTOTOSHIYUKI}|TakashiKobayashi{KOBAYASHITAKASHI}|TakayukiGoto{GOTOTAKAYUKI}|TakashiUeda{UEDATAKASHI}|MurashitaJunki{JUNKIMURASHITA}|TakumiShiraishi{SHIRAISHITAKUMI}|SaizoFujimoto{FUJIMOTOSAIZO}|MasatsuguMiyashita{MIYASHITAMASATSUGU}|YumikoSaito{SAITOYUMIKO}|YusukeGabata{GABATAYUSUKE}|AtsukoFujihara{FUJIHARAATSUKO}|MasayoshiOkumi{OKUMIMASAYOSHI}|FumiyaHongo{HONGOFUMIYA}|KazutoshiFujita{FUJITAKAZUTOSHI}|OsamuUkimura{UKIMURAOSAMU}|ShinTakenaka{TAKENAKASHIN}|XueZhao{ZHAOXUE}|KodaiSato{SATOKODAI}|NobushigeTakesita{TAKESITANOBUSHIGE}|DaichiKitaguchi{KITAGUCHIDAICHI}|HirotakaYamada{YAMADAHIROTAKA}|TomokazuSazuka{SAZUKATOMOKAZU}|YusukeImamura{IMAMURAYUSUKE}|NobuyoshiTakeshita{TAKESHITANOBUYOSHI}|ShinichiSakamoto{SAKAMOTOSHINICHI}|TomohikoIchikawa{ICHIKAWATOMOHIKO}|MasaakiIto{ITOMASAAKI}____総会賞ポスター10前立腺癌：治療____Novel astatine (211At)-labelled PSMA ligand with neopentyl-glycol structure: Evaluation of stability, efficacy, and safety using prostate cancer xenograft model|Novel LIG1 inhibitor Enhances Efficacy of PARP Inhibitors in Prostate Cancer|Circulating tumor cell-based molecular biomarkers of 177Lu-PSMA-617 treatment efficacy in metastatic prostate cancer|Prognostic significance of tumor immune microenvironment dynamics in prostate cancer induced by androgen deprivation therapy|Long term survival and oncologic outcomes of Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) study|Treatment patterns in patients with metastatic castration-sensitive prostate cancer in Japan: Analysis of MDV large-scale claims database|Study of 200 Cases of moderate hypofractionated proton beam therapy with hydrogel spacer placement for prostate cancer: 2-year outcomes|Oncologic outcomes and effectiveness of extended lymph node dissection in robot-assisted radical prostatectomy|Screen for predictive factor of the efficacy of second-generation androgen receptor axis-targeted agents in high-risk mHSPC patients|Automatic recognition for suture ligation process based on deep learning models and research on surgical skill evaluation

AOP-10

総会賞ポスター10
前立腺癌：治療

KimiharuTakamatsu{TAKAMATSUKIMIHARU}|HidekazuNishizawa{NISHIZAWAHIDEKAZU}|RenpeiKato{KATORENPEI}|TomokazuSazuka{SAZUKATOMOKAZU}|HajimeTanaka{TANAKAHAJIME}|IchiroTsuboi{TSUBOIICHIRO}____TaigoKato{KATOTAIGO}____NobuyukiTanaka{TANAKANOBUYUKI}|TomohiroIwasawa{IWASAWATOMOHIRO}|AtsukoSato{SATOATSUKO}|KeishiroFukumoto{FUKUMOTOKEISHIRO}|YotaYasumizu{YASUMIZUYOTA}|ToshikazuTakeda{TAKEDATOSHIKAZU}|ShinyaMorita{MORITASHINYA}|KazuhiroMatsumoto{MATSUMOTOKAZUHIRO}|TakeoKosaka{KOSAKATAKEO}|RyuichiMizuno{MIZUNORYUICHI}|MototsuguOya{OYAMOTOTSUGU}|ShintaroFunasaki{FUNASAKISHINTARO}|ToshikiAnami{ANAMITOSHIKI}|RyomaKurahashi{KURAHASHIRYOMA}|TakanobuMotoshima{MOTOSHIMATAKANOBU}|YojiMurakami{MURAKAMIYOJI}|JunjiYatsuda{YATSUDAJUNJI}|MasayaBaba{BABAMASAYA}|TomomiKamba{KAMBATOMOMI}|DaikiIkarashi{IKARASHIDAIKI}|ShigekatsuMaekawa{MAEKAWASHIGEKATSU}|MitsuguKanehira{KANEHIRAMITSUGU}|YosukeMatsushita{MATSUSHITAYOSUKE}|TetsuroYoshimaru{YOSHIMARUTETSURO}|TomoyaFukawa{FUKAWATOMOYA}|ToyomasaKatagiri{KATAGIRITOYOMASA}|WataruObara{OBARAWATARU}|ManatoKanesaka{KANESAKAMANATO}|KeisukeAndo{ANDOKEISUKE}|ShimpeiSaito{SAITOSHIMPEI}|SangjonPae{PAESANGJON}|KosukeMikami{MIKAMIKOSUKE}|KodaiSato{SATOKODAI}|TakayukiArai{ARAITAKAYUKI}|HiroakiSato{SATOHIROAKI}|YusukeImamura{IMAMURAYUSUKE}|ShinichiSakamoto{SAKAMOTOSHINICHI}|YasuhiroShigeta{SHIGETAYASUHIRO}|TomohikoIchikawa{ICHIKAWATOMOHIKO}|YukiFukawa{FUKAWAYUKI}|KouheiYamamoto{YAMAMOTOKOUHEI}|ShunyaMatsumoto{MATSUMOTOSHUNYA}|MasakiKobayashi{KOBAYASHIMASAKI}|YukiNakamura{NAKAMURAYUKI}|YudaiIshikawa{ISHIKAWAYUDAI}|HiroshiFukushima{FUKUSHIMAHIROSHI}|ShoheiFukuda{FUKUDASHOHEI}|YumaWaseda{WASEDAYUMA}|SoichiroYoshida{YOSHIDASOICHIRO}|YasuhisaFujii{FUJIIYASUHISA}|AkihiroMatsukawa{MATSUKAWAAKIHIRO}|KoheiOgawa{OGAWAKOHEI}|HirochikaNakajima{NAKAJIMAHIROCHIKA}|TaichiNagami{NAGAMITAICHI}|TatsushiKawada{KAWADATATSUSHI}|SatoshiKatayama{KATAYAMASATOSHI}|TakehiroIwata{IWATATAKEHIRO}|KensukeBekku{BEKKUKENSUKE}|MotooAraki{ARAKIMOTOO}|KoichiroWada{WADAKOICHIRO}____一般口演018腎腫瘍／基礎・診断・マーカー____Unraveling TIGIT related tumor immune-genetic biology and clinical significance in renal cell carcinoma|Hypoxia response pathway controls metabolic shift and tumor development in Xp11.2 translocation renal cell carcinoma|Elucidating the role of mitochondrial phospholipid regulation and oxidative stress in renal carcinogenesis|Renal cell carcinoma recurrence patterns by histological type and need for regional collaboration on a follow-up system|Validation of the UICC 8th T Staging and Potential Refinement with Renal Parenchymal Infiltration or Micronodular Spread in Clear Cell Renal Cell Carcinoma|Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis

OP-018

一般口演018
腎腫瘍／基礎・診断・マーカー

MasahiroMatsuki{MATSUKIMASAHIRO}|KosukeUeda{UEDAKOSUKE}|HiroomiKanayama{KANAYAMAHIROOMI}|HiromichiSakurai{SAKURAIHIROMICHI}|KojiIinuma{IINUMAKOJI}____JunTeishima{TEISHIMAJUN}____ToshiakiTanaka{TANAKATOSHIAKI}|MasayaSenda{SENDAMASAYA}|TetsuyaShindo{SHINDOTETSUYA}|AtsushiTakahashi{TAKAHASHIATSUSHI}|YasuharuKunishima{KUNISHIMAYASUHARU}|FumimasaFukuta{FUKUTAFUMIMASA}|ShintaroMiyamoto{MIYAMOTOSHINTARO}|ManabuOkada{OKADAMANABU}|YukiKyoda{KYODAYUKI}|KoheiHashimoto{HASHIMOTOKOHEI}|KoKobayashi{KOBAYASHIKO}|NaoyaMasumori{MASUMORINAOYA}|RyoichiImamura{IMAMURARYOICHI}|TomomiKamba{KAMBATOMOMI}|AkinoriMinato{MINATOAKINORI}|ShunsukeGoto{GOTOSHUNSUKE}|JunichiInokuchi{INOKUCHIJUNICHI}|KeijiroKiyoshima{KIYOSHIMAKEIJIRO}|ToruInoue{INOUETORU}|HisajiKumagae{KUMAGAEHISAJI}|ShinichiroIrie{IRIESHINICHIRO}|NoguchiMitsuru{MITSURUNOGUCHI}|TsukasaIgawa{IGAWATSUKASA}|ShingoKuroda{KURODASHINGO}|TsuyoshiOsaka{OSAKATSUYOSHI}|MasatoshiEto{ETOMASATOSHI}|MasanobuShiga{SHIGAMASANOBU}|SyuyaKandori{KANDORISYUYA}|BunpeiIsoda{ISODABUNPEI}|YoshiyukiNagumo{NAGUMOYOSHIYUKI}|ToruShimazui{SHIMAZUITORU}|JunMiyazaki{MIYAZAKIJUN}|MasahiroIinuma{IINUMAMASAHIRO}|MasakazuTsutsumi{TSUTSUMIMASAKAZU}|KojiKikuchi{KIKUCHIKOJI}|HiroyukiNishiyama{NISHIYAMAHIROYUKI}|TomokiTaniguchi{TANIGUCHITOMOKI}|KoheiNishikawa{NISHIKAWAKOHEI}|YutaSano{SANOYUTA}|AikaMatsuyama{MATSUYAMAAIKA}|KojiKameyama{KAMEYAMAKOJI}|KosukeTochigi{TOCHIGIKOSUKE}|ToraiEnomoto{ENOMOTOTORAI}|MasatakaTamura{TAMURAMASATAKA}|YasuakiKubota{KUBOTAYASUAKI}|TakahiroInoue{INOUETAKAHIRO}|ShusukeAkamatsu{AKAMATSUSHUSUKE}|TakuyaKoie{KOIETAKUYA}|SatoruMaruyama{MARUYAMASATORU}|YasatomoNakai{NAKAIYASATOMO}|KojiIinuma{IINUMAKOJI}|SachiKitayama{KITAYAMASACHI}|DaisukeMotoyama{MOTOYAMADAISUKE}|TomokazuSazuka{SAZUKATOMOKAZU}|SunaoShoji{SHOJISUNAO}|TakahiroOsawa{OSAWATAKAHIRO}|YukiKono{KONOYUKI}|TakutoTokudome{TOKUDOMETAKUTO}|NobuoShinohara{SHINOHARANOBUO}|HirotsuguUemura{UEMURAHIROTSUGU}____一般口演019腎腫瘍／薬物療法①____Significance of cytoreductive nephrectomy for metastatic renal cell carcinoma in the immunotherapy era: a multicenter retrospective study|Real-world treatment outcomes of patients with advanced renal cell carcinoma undergoing hemodialysis in the Kyushu-Okinawa area|Post-marketing surveillance of cabozantinib in Japanese patients with advanced renal cell carcinoma (aRCC)|Multicenter Analysis of Efficacy and CRP in First-line Immune-Checkpoint Inhibitor Combinations for Metastatic Renal Cell Carcinoma|Multi-institutional retrospective study on the comparison of oncological outcomes in advanced clear cell renal cell carcinoma (RCC) and non-clear cell RCC|Patterns of treatment and outcomes evaluation in metastatic renal cell carcinoma patients in Japan (POEM-RCC Study): The 2nd interim analysis

OP-019

一般口演019
腎腫瘍／薬物療法①

YoshihikoTasaki{TASAKIYOSHIHIKO}|AkinoriNakayama{NAKAYAMAAKINORI}|－|NoboruNakaigawa{NAKAIGAWANOBORU}|KensukeBekku{BEKKUKENSUKE}____RyuichiMizuno{MIZUNORYUICHI}____ShuzoHamamoto{HAMAMOTOSHUZO}|ToshikiEtani{ETANITOSHIKI}|ShoichiroIwatsuki{IWATSUKISHOICHIRO}|ReiUnno{UNNOREI}|TomokiTakeda{TAKEDATOMOKI}|TomokiOkada{OKADATOMOKI}|YosukeSugiyama{SUGIYAMAYOSUKE}|YujiHotta{HOTTAYUJI}|TakuNaiki{NAIKITAKU}|AtsushiOkada{OKADAATSUSHI}|Furukawa-HibiYoko{YOKOFURUKAWA-HIBI}|TakahiroYasui{YASUITAKAHIRO}|ShoheiFukuda{FUKUDASHOHEI}|MasaharuInoue{INOUEMASAHARU}|MasayaIto{ITOMASAYA}|NoboruNumao{NUMAONOBORU}|HajimeTanaka{TANAKAHAJIME}|TakeshiYuasa{YUASATAKESHI}|FumitakaKoga{KOGAFUMITAKA}|JunjiYonese{YONESEJUNJI}|YukioKageyama{KAGEYAMAYUKIO}|KazutakaSaito{SAITOKAZUTAKA}|YasuhisaFujii{FUJIIYASUHISA}|MasatoKubo{KUBOMASATO}|MunehiroMatsumoto{MATSUMOTOMUNEHIRO}|TomohikoAigase{AIGASETOMOHIKO}|AtsutoSuzuki{SUZUKIATSUTO}|KimitsuguUsui{USUIKIMITSUGU}|TakeshiKishida{KISHIDATAKESHI}|ShotaInoue{INOUESHOTA}|KasumiYoshinaga{YOSHINAGAKASUMI}|TomoakiYamanoi{YAMANOITOMOAKI}|TatsushiKawada{KAWADATATSUSHI}|YusukeTominaga{TOMINAGAYUSUKE}|TakuyaSadahira{SADAHIRATAKUYA}|SatoshiKatayama{KATAYAMASATOSHI}|TakehiroIwata{IWATATAKEHIRO}|ShingoNishimura{NISHIMURASHINGO}|KoheiEdamura{EDAMURAKOHEI}|TomokoKobayashi{KOBAYASHITOMOKO}|MotooAraki{ARAKIMOTOO}____一般口演020腎腫瘍／薬物療法②____Tumor-infiltrated and peripheral blood-included eosinophil may predict efficacy and safety in patients with renal cell carcinoma with ipilimumab plus nivolumab|Identifying clear cell renal cell carcinoma patients who are unlikely to benefit from Ipilimumab-Nivolumab therapy|Withdrawn|Post-Therapy Treatment-Free Survival in advanced Renal Cell Carcinoma: Outcomes After IO-Combination Therapy|Correlation Between Body Mass Index and Oncological Outcomes in Advanced Renal Cell Carcinoma Patients Treated with Ipilimumab and Nivolumab Combination Therapy

OP-020

一般口演020
腎腫瘍／薬物療法②

ShimpeiYamashita{YAMASHITASHIMPEI}|YosukeSekii{SEKIIYOSUKE}|YutoNukariya{NUKARIYAYUTO}|TakashiBabasaki{BABASAKITAKASHI}|TaigoKato{KATOTAIGO}____SatoshiTamada{TAMADASATOSHI}____KazutomoKuwata{KUWATAKAZUTOMO}|YutaNabeshima{NABESHIMAYUTA}|RyusukeDeguchi{DEGUCHIRYUSUKE}|HarukaMiyai{MIYAIHARUKA}|MasatoshiHiguchi{HIGUCHIMASATOSHI}|TakashiIguchi{IGUCHITAKASHI}|NobuyukiMashima{MASHIMANOBUYUKI}|YuyaIwahashi{IWAHASHIYUYA}|SatoshiMuraoka{MURAOKASATOSHI}|TakahitoWakamiya{WAKAMIYATAKAHITO}|YasuoKohjimoto{KOHJIMOTOYASUO}|IsaoHara{HARAISAO}|MichihiroEnoki{ENOKIMICHIHIRO}|TetsuyaYamamoto{YAMAMOTOTETSUYA}|ToshichikaIwanishi{IWANISHITOSHICHIKA}|HitoshiTakayama{TAKAYAMAHITOSHI}|KojiroTashiro{TASHIROKOJIRO}|TomoyaAraki{ARAKITOMOYA}|AyaneNishioka{NISHIOKAAYANE}|YushiSuhara{SUHARAYUSHI}|MasakiHashimoto{HASHIMOTOMASAKI}|KentaroYoshihara{YOSHIHARAKENTARO}|MariaOkamoto{OKAMOTOMARIA}|YusukeTakahashi{TAKAHASHIYUSUKE}|SyuheiHara{HARASYUHEI}|AkiraHisakane{HISAKANEAKIRA}|HirokiYamada{YAMADAHIROKI}|TakahiroKimura{KIMURATAKAHIRO}|NatsukiUemura{UEMURANATSUKI}|YugoMatsubara{MATSUBARAYUGO}|MasayukiMuto{MUTOMASAYUKI}|KojiMita{MITAKOJI}|YasutomoNakai{NAKAIYASUTOMO}|MototakaSato{SATOMOTOTAKA}|HirokiOsaki{OSAKIHIROKI}|TomochikaIwanishi{IWANISHITOMOCHIKA}|KyosukeMatsuzaki{MATSUZAKIKYOSUKE}|ShingoToyoda{TOYODASHINGO}|AtsunariKawashima{KAWASHIMAATSUNARI}|KenichiKakimoto{KAKIMOTOKENICHI}|TetsuyaTakao{TAKAOTETSUYA}|YutakaOno{ONOYUTAKA}|MasaoTsujihata{TSUJIHATAMASAO}|NorioNonomura{NONOMURANORIO}____一般口演021腎腫瘍／薬物療法③____Clinical outcomes of pembrolizumab plus lenvatinib in patients with advanced or metastatic renal cell carcinoma: real-world data in Wakayama|Our experience with lenvatinib plus pembrolizumab for renal cell carcinoma|Combination therapy with lenvatinib and pembrolizumab in patients with metastatic renal cell carcinoma at single institute retrospective study|Retrospective Evaluation of Reduced-Dose Lenvatinib Combined with Pembrolizumab for Metastatic Renal Cell Carcinoma|Real world first line pembrolizumab plus lenvatinib therapy in metastatic renal cell carcinoma: multi nstitutional retrospective study

OP-021

一般口演021
腎腫瘍／薬物療法③

JunMorita{MORITAJUN}|YuyaSakai{SAKAIYUYA}|JunyaFurukawa{FURUKAWAJUNYA}|HirokiIshihara{ISHIHARAHIROKI}|GakuYamamichi{YAMAMICHIGAKU}____TakahiroOsawa{OSAWATAKAHIRO}____KeitaHamamoto{HAMAMOTOKEITA}|YokoKikuyama{KIKUYAMAYOKO}|YoojinChung{CHUNGYOOJIN}|YutaOgushi{OGUSHIYUTA}|KojiTanaka{TANAKAKOJI}|YukiIchimura{ICHIMURAYUKI}|HirooSugishita{SUGISHITAHIROO}|HideakiShimoyama{SHIMOYAMAHIDEAKI}|MichiyaOta{OTAMICHIYA}|HaruakiSasaki{SASAKIHARUAKI}|TakashiFukagai{FUKAGAITAKASHI}|KousukeUeda{UEDAKOUSUKE}|NaokiItou{ITOUNAOKI}|SatoshiOonishi{OONISHISATOSHI}|HirokiSuekane{SUEKANEHIROKI}|KatsuakiChikui{CHIKUIKATSUAKI}|KeiichirouUemura{UEMURAKEIICHIROU}|MakotoNakiri{NAKIRIMAKOTO}|KiyoakiNishihara{NISHIHARAKIYOAKI}|ShigetakaSuekane{SUEKANESHIGETAKA}|TsukasaIgawa{IGAWATSUKASA}|MototsuguOya{OYAMOTOTSUGU}|TaigoKato{KATOTAIGO}|ToshinariYamasaki{YAMASAKITOSHINARI}|KeisukeMonji{MONJIKEISUKE}|ToshiakiTanaka{TANAKATOSHIAKI}|NorihikoTsuchiya{TSUCHIYANORIHIKO}|TomoakiMiyagawa{MIYAGAWATOMOAKI}|HiroshiYaegashi{YAEGASHIHIROSHI}|TomoyasuSano{SANOTOMOYASU}|TakashiKarashima{KARASHIMATAKASHI}|KazutoshiFujita{FUJITAKAZUTOSHI}|Jun-IchiHori{HORIJUN-ICHI}|MasahiroKajita{KAJITAMASAHIRO}|HirotsuguUemura{UEMURAHIROTSUGU}|KenjiOmae{OMAEKENJI}|YukiNemoto{NEMOTOYUKI}|ShinsukeMizoguchi{MIZOGUCHISHINSUKE}|NanakaKatsurayama{KATSURAYAMANANAKA}|HironoriFukuda{FUKUDAHIRONORI}|KazuhikoYoshida{YOSHIDAKAZUHIKO}|HiroakiShimmura{SHIMMURAHIROAKI}|YasunobuHashimoto{HASHIMOTOYASUNOBU}|JunpeiIizuka{IIZUKAJUNPEI}|TsunenoriKondo{KONDOTSUNENORI}|ToshioTakagi{TAKAGITOSHIO}|AkihiroYoshimura{YOSHIMURAAKIHIRO}|YuIshizuya{ISHIZUYAYU}|TakujiHayashi{HAYASHITAKUJI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|KojiHatano{HATANOKOJI}|AtsunariKawashima{KAWASHIMAATSUNARI}|TetsuyaTakao{TAKAOTETSUYA}|KensakuNishimura{NISHIMURAKENSAKU}|ShingoTaktakada{TAKTAKADASHINGO}|MasaoTsujihata{TSUJIHATAMASAO}|NorioNonomura{NONOMURANORIO}____一般口演022腎腫瘍／薬物療法④____The efficacy and reasons of choice for IO-TKI combination therapy compared with IO-IO combination therapy in metastatic renal cell carcinoma|The study of eligible patients for avelumab plus axitinib for advanced renal cell carcinoma|Real-world outcomes with avelumab + axitinib by IMDC risk classification in patients with advanced renal cell carcinoma: subgroup analyses from J-DART2|Outcome comparison between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib for advanced renal cell carcinoma|The efficacy of second-line nivolumab versus tyrosine kinase inhibitors for renal cell carcinoma with bone metastasis: A multi-institutional retrospective study

OP-022

一般口演022
腎腫瘍／薬物療法④

YukiNemoto{NEMOTOYUKI}|RyoeiMinato{MINATORYOEI}|TomokiTaniguchi{TANIGUCHITOMOKI}|HiroakiMurata{MURATAHIROAKI}|RyousukeMatsushita{MATSUSHITARYOUSUKE}____NaotoSassa{SASSANAOTO}____HirokiIshihara{ISHIHARAHIROKI}|HironoriFukuda{FUKUDAHIRONORI}|YoshidaKazuhiko1{YOSHIDAKAZUHIKO1}|JunpeiIizuka{IIZUKAJUNPEI}|HiroakiShimmura{SHIMMURAHIROAKI}|TsunenoriKondo{KONDOTSUNENORI}|ToshioTakagi{TAKAGITOSHIO}|KeiDaizumoto{DAIZUMOTOKEI}|MitsukiNishiyama{NISHIYAMAMITSUKI}|TetsuhiroYano{YANOTETSUHIRO}|SakiKobayashi{KOBAYASHISAKI}|YutaroSasaki{SASAKIYUTARO}|RyotarouTomida{TOMIDARYOTAROU}|YoshitoKusuhara{KUSUHARAYOSHITO}|TomoyaFukawa{FUKAWATOMOYA}|YasuyoYamamoto{YAMAMOTOYASUYO}|KunihisaYamaguchi{YAMAGUCHIKUNIHISA}|MasayukiTakahashi{TAKAHASHIMASAYUKI}|JunyaFurukawa{FURUKAWAJUNYA}|KojiIinuma{IINUMAKOJI}|ToraiEnomoto{ENOMOTOTORAI}|MasayukiTomioka{TOMIOKAMASAYUKI}|MakotoKawase{KAWASEMAKOTO}|KotaKawase{KAWASEKOTA}|YukiTobisawa{TOBISAWAYUKI}|KeitaNakane{NAKANEKEITA}|KojiKameyama{KAMEYAMAKOJI}|MasahiroNakano{NAKANOMASAHIRO}|KimiakiTakagi{TAKAGIKIMIAKI}|ShingoNagai{NAGAISHINGO}|TakuyaKoie{KOIETAKUYA}|TakashiNagata{NAGATATAKASHI}|YasuoTuzaka{TUZAKAYASUO}|YutakaKasuya{KASUYAYUTAKA}|YusukeAkitomi{AKITOMIYUSUKE}|AsukaKitamura{KITAMURAASUKA}|KenichiroTaira{TAIRAKENICHIRO}|RyokoIhara{IHARARYOKO}|YasushiNishina{NISHINAYASUSHI}|AtushiIwata{IWATAATUSHI}|HarukiKume{KUMEHARUKI}|HirofumiYoshino{YOSHINOHIROFUMI}|YoichiOsako{OSAKOYOICHI}|TakashiSakaguchi{SAKAGUCHITAKASHI}|SatoshiInoguchi{INOGUCHISATOSHI}|AkihikoMitsuke{MITSUKEAKIHIKO}|JunyaArima{ARIMAJUNYA}|WakakoFuruyashiki{FURUYASHIKIWAKAKO}|SayuriYamamoto{YAMAMOTOSAYURI}|DaichiMiyauchi{MIYAUCHIDAICHI}|YasutoshiYamada{YAMADAYASUTOSHI}|SyuichiTatarano{TATARANOSYUICHI}|HidekiEnokida{ENOKIDAHIDEKI}____一般口演023腎腫瘍／薬物療法⑤____Details of adrenal insufficiency as an immune-related adverse events in combination immune checkpoint therapy for advanced renal cell carcinoma|Study of irAEs in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors and DPP4 inhibitors|Multi-institutional study of the association of oncological outcome with or without steroid use for adverse events after nivolumab and ipilimumab treatment|A case of myositis and myasthenia gravis requiring ventilator management due to irAE After initial administration of pembrolizumab for renal cancer|Two cases of renal cancer patients who developed irAEs myasthenia gravis and myositis after administration of immune checkpoint inhibitors

OP-023

一般口演023
腎腫瘍／薬物療法⑤

ShuheiSuzuki{SUZUKISHUHEI}|FumihikoUrabe{URABEFUMIHIKO}|HitomiImai{IMAIHITOMI}|ChihiroSuzuki{SUZUKICHIHIRO}|HirokiTakizawa{TAKIZAWAHIROKI}|YukiHarigane{HARIGANEYUKI}|AkihiroMaeda{MAEDAAKIHIRO}|TakahiroImanaka{IMANAKATAKAHIRO}____YoshiyukiKojima{KOJIMAYOSHIYUKI}____NegoroHiromitsu{HIROMITSUNEGORO}|HarunaNonaka{NONAKAHARUNA}|IchiroChihara{CHIHARAICHIRO}|YoshiyukiNagumo{NAGUMOYOSHIYUKI}|HiroyukiNishiyama{NISHIYAMAHIROYUKI}|AkiraFuruta{FURUTAAKIRA}|TaroIgrashi{IGRASHITARO}|JunNakayama{NAKAYAMAJUN}|YusukeYamamoto{YAMAMOTOYUSUKE}|TakahiroKimura{KIMURATAKAHIRO}|HidenoriAkaihata{AKAIHATAHIDENORI}|KanakoGunji{GUNJIKANAKO}|ManabuKyan{KYANMANABU}|YukiHarigane{HARIGANEYUKI}|AkifumiOnagi{ONAGIAKIFUMI}|RurikoTakinami{TAKINAMIRURIKO}|JunyaHata{HATAJUNYA}|YuichiSato{SATOYUICHI}|MasaoKataoka{KATAOKAMASAO}|SoichiroOgawa{OGAWASOICHIRO}|MotohideUemura{UEMURAMOTOHIDE}|YoshiyukiKojima{KOJIMAYOSHIYUKI}|TetsuyaImamura{IMAMURATETSUYA}|NoriyukiOgawa{OGAWANORIYUKI}|HiroakiHara{HARAHIROAKI}|MasahiroGoto{GOTOMASAHIRO}|MasashiShiozaki{SHIOZAKIMASASHI}|ManabuUeno{UENOMANABU}|TomonoriMinagawa{MINAGAWATOMONORI}|YoshiyukiAkiyama{AKIYAMAYOSHIYUKI}|HirokiIto{ITOHIROKI}|QingChang{CHANGQING}|TakumaNirei{NIREITAKUMA}|TakeshiFukasawa{FUKASAWATAKESHI}|RisaShinoki{SHINOKIRISA}|MariHioki{HIOKIMARI}|IkuKimura{KIMURAIKU}|KenjiTanaka{TANAKAKENJI}|KazuhideMakiyama{MAKIYAMAKAZUHIDE}|SyuntaMakabe{MAKABESYUNTA}|KeiYaginuma{YAGINUMAKEI}|AkihisaHasegawa{HASEGAWAAKIHISA}|RyojiFukabori{FUKABORIRYOJI}|KazutoKobayashi{KOBAYASHIKAZUTO}|MakiKawasaki{KAWASAKIMAKI}|HiroakiKakinoki{KAKINOKIHIROAKI}|KazumaUdo{UDOKAZUMA}|ShoheiTobu{TOBUSHOHEI}|FumiakiYoshida{YOSHIDAFUMIAKI}|MitsuruNoguchi{NOGUCHIMITSURU}|YumaKujime{KUJIMEYUMA}|HiroakiKitakaze{KITAKAZEHIROAKI}|GoTsujimura{TSUJIMURAGO}|NorichikaUeda{UEDANORICHIKA}|KentaroTakezawa{TAKEZAWAKENTARO}|ShinichiroFukuhara{FUKUHARASHINICHIRO}|NorioNonomura{NONOMURANORIO}____総会賞ポスター11排尿障害：基礎____Bladder capacity exhibits circadian variation independent of behavioral rhythms: study using conditional knockout mice lacking the central nervous clock gene|Elucidation of the pathophysiology of Hunner-type interstitial cystitis through single-cell expression analysis|Axon regeneration induced by elevated cAMP levels provides therapeutic effects for underactive bladder caused by pelvic nerve injury|Hybrid grafts organized with mesenchymal stem cell structures and fibroblast sheets regenerate functional bladders with reconstructed smooth muscle layers|Age-related functional changes in Barrington's nucleus may underlie lower urinary tract dysfunction|Identification of a novel brain pathway in overactive bladder associated with Parkinson's disease by retrograde gene transfer vectors|Optogenetic stimulation induces bladder detrusor muscle contractions in diabetic rats|Overcoming salt-Induced nocturnal polyuria: moderate-intensity exercise as a novel therapeutic strategy for salt-induced nocturnal polyuria in aging

AOP-11

総会賞ポスター11
排尿障害：基礎

ShinakoTakeda{TAKEDASHINAKO}|HitoshiOh-Oka{OH-OKAHITOSHI}|NorichikaUeda{UEDANORICHIKA}|GoAnan{ANANGO}|KazunoriHaga{HAGAKAZUNORI}|TakuyaIwaki{IWAKITAKUYA}|TadashiTabei{TABEITADASHI}|HiroshiKano{KANOHIROSHI}|JunyaHata{HATAJUNYA}|AsukaAshikari{ASHIKARIASUKA}____NaoyaMasumori{MASUMORINAOYA}____TsubasaShironomae{SHIRONOMAETSUBASA}|KeikoAinoya{AINOYAKEIKO}|KiyohideSakai{SAKAIKIYOHIDE}|TakashigeNamima{NAMIMATAKASHIGE}|NaokiKawamorita{KAWAMORITANAOKI}|YumaKujime{KUJIMEYUMA}|HiroakiKitakaze{KITAKAZEHIROAKI}|GoTsujimura{TSUJIMURAGO}|TakahiroImanaka{IMANAKATAKAHIRO}|KentaroTakezawa{TAKEZAWAKENTARO}|ShinichiroFukuhara{FUKUHARASHINICHIRO}|HiroshiAkasaka{AKASAKAHIROSHI}|NorioNonomura{NONOMURANORIO}|HideroMinami{MINAMIHIDERO}|YosukeFujishima{FUJISHIMAYOSUKE}|KanyaKaga{KAGAKANYA}|KeigoAkagashi{AKAGASHIKEIGO}|MusashiTobe{TOBEMUSASHI}|KosukeUchida{UCHIDAKOSUKE}|IchiyaHonma{HONMAICHIYA}|MegumiHirobe{HIROBEMEGUMI}|JunjiIshizaki{ISHIZAKIJUNJI}|TakashiShimizu{SHIMIZUTAKASHI}|KeitaroWatanabe{WATANABEKEITARO}|HisaoNakajima{NAKAJIMAHISAO}|SatoshiUrahama{URAHAMASATOSHI}|YoshikazuSato{SATOYOSHIKAZU}|YoshiyukiAkiyama{AKIYAMAYOSHIYUKI}|MakotoKurano{KURANOMAKOTO}|MasahikoSumitani{SUMITANIMASAHIKO}|AyaNiimi{NIIMIAYA}|HiroshiFukuhara{FUKUHARAHIROSHI}|YukioHomma{HOMMAYUKIO}|HarukiKume{KUMEHARUKI}|AkioHoriguchi{HORIGUCHIAKIO}|HibikiHirose{HIROSEHIBIKI}|YushiAraki{ARAKIYUSHI}|HidekiOhuchi{OHUCHIHIDEKI}|YoshifumiKadono{KADONOYOSHIFUMI}|RenatoNaito{NAITORENATO}|TomoyukiMakino{MAKINOTOMOYUKI}|HiroakiIwamoto{IWAMOTOHIROAKI}|HiroshiYaegashi{YAEGASHIHIROSHI}|ShoheiKawaguchi{KAWAGUCHISHOHEI}|TakahiroNohara{NOHARATAKAHIRO}|KazuyoshiShigehara{SHIGEHARAKAZUYOSHI}|KoujiIzumi{IZUMIKOUJI}|AtsushiMizokami{MIZOKAMIATSUSHI}|SaizoFujimoto{FUJIMOTOSAIZO}|ToshikiOka{OKATOSHIKI}|MakotoMatsushita{MATSUSHITAMAKOTO}|MitsuguKanehira{KANEHIRAMITSUGU}|KojiHatano{HATANOKOJI}|TakujiYamada{YAMADATAKUJI}|ShinichiYachida{YACHIDASHINICHI}|TetsuyaTakao{TAKAOTETSUYA}|AkiraTujimura{TUJIMURAAKIRA}|KazutoshiFujita{FUJITAKAZUTOSHI}|YoshiyukiKojima{KOJIMAYOSHIYUKI}|KatsumiKadekawa{KADEKAWAKATSUMI}|AkihiroTokushige{TOKUSHIGEAKIHIRO}|HiroyoshiIwata{IWATAHIROYOSHI}|SatokoNagamine{NAGAMINESATOKO}|NorikoMachida{MACHIDANORIKO}|YumiIkehara{IKEHARAYUMI}|KeikoMekaru{MEKARUKEIKO}|JunichiInokuchi{INOKUCHIJUNICHI}|KoshiNakamura{NAKAMURAKOSHI}|ShinichiroUeda{UEDASHINICHIRO}|MinoruMiyazato{MIYAZATOMINORU}____総会賞ポスター12排尿障害：臨床____Unformed conus medullaris and sacral dysplasia are risk factors for neurogenic lower urinary tract dysfunction in children with spinal lipoma|Factors contributing to transient urinary retention after Contact laser Vaporization of the Prostate|Frailty, especially decreased daily activity, is associated with nocturnal polyuria|What are the goals of endoscopic views after prostatic urethral lift for benign prostatic hyperplasia? - a prospective single-center study|One hundred fifty cases of Rezum water vapor thermal therapy for Benign prostatic hyperplasia: real-world data at a single institution in Japan|Machine learning-driven urinary lipidomics analysis to develop diagnostic biomarkers for interstitial cystitis and bladder pain syndrome|Continence Outcomes After Urethroplasty for Proximal Bulbar Urethral Stricture Post-TURP|Elucidation of the mechanism of urinary continence during abdominal pressure in men: a dynamic MRI-based study|Exploration of new bacterial species contributing to the exacerbation of male lower urinary tract symptoms using human gut microbiome metagenomic analysis|Family history and acquired risk factors for pelvic organ prolapse A case-control study in Japan

AOP-12

総会賞ポスター12
排尿障害：臨床

YosukeYamashita{YAMASHITAYOSUKE}|TeppeiTakeshima{TAKESHIMATEPPEI}|YuheiSegawa{SEGAWAYUHEI}|YukiMuranishi{MURANISHIYUKI}|HideyukiKobayashi{KOBAYASHIHIDEYUKI}|HiroshiOkada{OKADAHIROSHI}|KunihisaNezu{NEZUKUNIHISA}|KeiDaizumoto{DAIZUMOTOKEI}|TetsuyaKawahara{KAWAHARATETSUYA}|KoutaFujimoto{FUJIMOTOKOUTA}____AkiraTsujimura{TSUJIMURAAKIRA}____ChanhyonKin{KINCHANHYON}|ShunKawamura{KAWAMURASHUN}|KatsuyaSato{SATOKATSUYA}|KeisukeOkada{OKADAKEISUKE}|KojiChiba{CHIBAKOJI}|MichiyoKoyanagi{KOYANAGIMICHIYO}|TakashiAoi{AOITAKASHI}|HideakiMiyake{MIYAKEHIDEAKI}|KotaShimokihara{SHIMOKIHARAKOTA}|ShinnosukeKuroda{KURODASHINNOSUKE}|KazuhideMakiyama{MAKIYAMAKAZUHIDE}|YasushiYumura{YUMURAYASUSHI}|AkioHoriguchi{HORIGUCHIAKIO}|MasayukiShinchi{SHINCHIMASAYUKI}|KenichiroOjima{OJIMAKENICHIRO}|HiromiEdo{EDOHIROMI}|HiroshiShinmoto{SHINMOTOHIROSHI}|KeiichiIto{ITOKEIICHI}|YoshitomoKobori{KOBORIYOSHITOMO}|YukoKatoh-Fukui{KATOH-FUKUIYUKO}|AkiyoshiOsaka{OSAKAAKIYOSHI}|HitoshiOkada{OKADAHITOSHI}|ToshiyukiIwahata{IWAHATATOSHIYUKI}|MakiFukami{FUKAMIMAKI}|MasafumiKon{KONMASAFUMI}|MasashiFujieda{FUJIEDAMASASHI}|ShinjiroTakeuchi{TAKEUCHISHINJIRO}|MasatoUetani{UETANIMASATO}|KoichiNakajima{NAKAJIMAKOICHI}|KoichiNagao{NAGAOKOICHI}|KazuhiroIshida{ISHIDAKAZUHIRO}|IoriNakaniwa{NAKANIWAIORI}|TakashiTanaka{TANAKATAKASHI}|HirokiTsujioka{TSUJIOKAHIROKI}|HintaroHasegawa{HASEGAWAHINTARO}|MihoSugie{SUGIEMIHO}|KazutakaSaito{SAITOKAZUTAKA}|KouheiSugimoto{SUGIMOTOKOUHEI}|ShinichiYamashita{YAMASHITASHINICHI}|JuntaroKoyama{KOYAMAJUNTARO}|TakuroGoto{GOTOTAKURO}|SuzukiYu{YUSUZUKI}|TakumaSato{SATOTAKUMA}|YoshihideKawasaki{KAWASAKIYOSHIHIDE}|NaokiKawamorita{KAWAMORITANAOKI}|AkihiroIto{ITOAKIHIRO}|RyoeiMinato{MINATORYOEI}|HiroyukiOi{OIHIROYUKI}|YoshitoKusuhara{KUSUHARAYOSHITO}|TakeshiIwasa{IWASATAKESHI}|JunyaFurukawa{FURUKAWAJUNYA}|RenatoNaito{NAITORENATO}|HiroshiKano{KANOHIROSHI}|TomoyukiMakino{MAKINOTOMOYUKI}|HiroakiIwamoto{IWAMOTOHIROAKI}|HiroshiYaegashi{YAEGASHIHIROSHI}|ShoheiKawaguchi{KAWAGUCHISHOHEI}|KazuyoshiShigehara{SHIGEHARAKAZUYOSHI}|TakahiroNohara{NOHARATAKAHIRO}|KoujiIzumi{IZUMIKOUJI}|AtsushiMizokami{MIZOKAMIATSUSHI}|DaikiHashimoto{HASHIMOTODAIKI}|BeomYongRho{RHOBEOMYONG}|YongSeungLee{LEEYONGSEUNG}|SangWoonKim{KIMSANGWOON}|GenYamada{YAMADAGEN}____総会賞ポスター13アンドロロジー・不妊・性機能____Generation of Human iPS Cell-Derived Leydig Cells Independent of Exogenous NR5A1 Forced Expression|Development of a segmentation model for intraoperative structure recognition in microsurgical varicocelectomy|Erectile Function in Patients with Pelvic Fracture Urethral Injury: What Are the Predictors of Persistent Severe Erectile Dysfunction After Urethroplasty?|Molecular basis of isolated non-obstructive azoospermia: Systematic molecular analysis for 115 karyotypically normal patients|Development of a web-based male infertility screening system using hormonal analysis, that does not rely on semen analysis|Is the sperm DNA fragmentation index a good indicator for treatment selection in the era of modern assisted reproductive technology?|Imipramine attenuated ejaculatory dysfunction in a rat model of hypogastric nerve injury|Development of male infertility treatment using LEDs|Experience with Testosterone Replacement Therapy after Radiation Therapy for Prostate Cancer|Novel erectile analyses revealed inducible penile Lyve-1, the lymphatic marker, expression

AOP-13

総会賞ポスター13
アンドロロジー・不妊・性機能

－|YousukeIkegami{IKEGAMIYOUSUKE}|ShunsukeInoguchi{INOGUCHISHUNSUKE}|RyotaroOkazaki{OKAZAKIRYOTARO}|YoshitakaSaito{SAITOYOSHITAKA}____RyoichiSaito{SAITORYOICHI}____NayukaMatsuyama{MATSUYAMANAYUKA}|SatoshiYoshida{YOSHIDASATOSHI}|MasatoWatanabe{WATANABEMASATO}|AtsukoOkumura{OKUMURAATSUKO}|AkihisaTakeda{TAKEDAAKIHISA}|AkinaruYamamoto{YAMAMOTOAKINARU}|AtsunariKawashima{KAWASHIMAATSUNARI}|NesrineSacci{SACCINESRINE}|YukiHoribe{HORIBEYUKI}|ToshihikoUemura{UEMURATOSHIHIKO}|YuIshizuya{ISHIZUYAYU}|TakujiHayashi{HAYASHITAKUJI}|YoshiyukiYamamoto{YAMAMOTOYOSHIYUKI}|TaigoKato{KATOTAIGO}|KojiHatano{HATANOKOJI}|YoichiKakuta{KAKUTAYOICHI}|NorioNonomura{NONOMURANORIO}|AtsushiIkeda{IKEDAATSUSHI}|WonjikKim{KIMWONJIK}|HirokazuNosato{NOSATOHIROKAZU}|HiroyukiNishiyama{NISHIYAMAHIROYUKI}|ShogoAdomi{ADOMISHOGO}|KazukoSakai{SAKAIKAZUKO}|KenFukiage{FUKIAGEKEN}|HiroyukiKita{KITAHIROYUKI}|SaizoFujimoto{FUJIMOTOSAIZO}|ShingoToyoda{TOYODASHINGO}|MamoruHashimoto{HASHIMOTOMAMORU}|KoichiSugimoto{SUGIMOTOKOICHI}|TakahumiMinami{MINAMITAKAHUMI}|KazuhiroYoshimura{YOSHIMURAKAZUHIRO}|KazutoNishio{NISHIOKAZUTO}|KazutoshiFujita{FUJITAKAZUTOSHI}____一般口演024尿路上皮腫瘍／基礎・診断・マーカー①____Withdrawn|Development of a novel photodynamic therapy against bladder cancer cells using glycoconjugated fullerene and ultraviolet A-1 irradiation|Serum D-asparagine concentration adjusted for eGFR could become a novel screening tool for urothelial carcinoma|A Novel Approach for Accurate Detection of Bladder Tumor Using Foundation Model|Evaluation of TERT promoter mutation in 5-ALA false positive sites in non-muscle invasive bladder cancer

OP-024

一般口演024
尿路上皮腫瘍／基礎・診断・マーカー①

KenShibata{SHIBATAKEN}|SoichiroYoshida{YOSHIDASOICHIRO}|YuusukeYoneoka{YONEOKAYUUSUKE}|HiroyukiHonda{HONDAHIROYUKI}|RyotaIkadai{IKADAIRYOTA}____NobuyukiTanaka{TANAKANOBUYUKI}____FumihikoUrabe{URABEFUMIHIKO}|KosukeIwatani{IWATANIKOSUKE}|YuImai{IMAIYU}|KentaroYoshihara{YOSHIHARAKENTARO}|KoujiroTashiro{TASHIROKOUJIRO}|SyunsukeTsuzuki{TSUZUKISYUNSUKE}|YusukeKoike{KOIKEYUSUKE}|TatsuyaShimomura{SHIMOMURATATSUYA}|HirokiYamada{YAMADAHIROKI}|AkiraFuruta{FURUTAAKIRA}|JunMiki{MIKIJUN}|TakahiroKimura{KIMURATAKAHIRO}|KeitaIzumi{IZUMIKEITA}|MotohiroFujiwara{FUJIWARAMOTOHIRO}|MasahiroToide{TOIDEMASAHIRO}|TakanobuYamamoto{YAMAMOTOTAKANOBU}|ShoUehar{UEHARSHO}|SaoriAraki{ARAKISAORI}|MasaharuInoue{INOUEMASAHARU}|RyojiTakazawa{TAKAZAWARYOJI}|NoboruNumao{NUMAONOBORU}|YukihiroOhtsuka{OHTSUKAYUKIHIRO}|HajimeTanaka{TANAKAHAJIME}|YasuhisaFujii{FUJIIYASUHISA}|RyoFujiwara{FUJIWARARYO}|AkiraHasegawa{HASEGAWAAKIRA}|YusukeAida{AIDAYUSUKE}|YukiSimozawa{SIMOZAWAYUKI}|KousukeTakemura{TAKEMURAKOUSUKE}|YosukeYasuda{YASUDAYOSUKE}|TomohikoOguchi{OGUCHITOMOHIKO}|TakeshiYuasa{YUASATAKESHI}|JunjiYonese{YONESEJUNJI}|TomohiroMatsuo{MATSUOTOMOHIRO}|SyotaKakita{KAKITASYOTA}|ShintaroMori{MORISHINTARO}|KyoheiAraki{ARAKIKYOHEI}|KensukeMitsunari{MITSUNARIKENSUKE}|KojiroOhba{OHBAKOJIRO}|YasushiMochizuki{MOCHIZUKIYASUSHI}|RyoichiImamura{IMAMURARYOICHI}|GoshiKitano{KITANOGOSHI}|ManabuKato{KATOMANABU}|TakashiKinoshita{KINOSHITATAKASHI}|ShiroSuzuki{SUZUKISHIRO}|WakiHosoda{HOSODAWAKI}|NobueTakaiso{TAKAISONOBUE}|IsseiImoto{IMOTOISSEI}|TakahiroKojima{KOJIMATAKAHIRO}____一般口演025尿路上皮腫瘍／基礎・診断・マーカー②____Preoperative lung immune prognostic index as a predictor of outcomes in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma|Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases|Impact of Geriatric Nutritional Risk Index as the prognostic factor in patients with locally advanced bladder cancer|The Prognostic Nutritional Index is useful for predicting the efficacy of Enfortumab Vedotin in metastatic urothelial carcinoma|Characteristics of patients with upper tract urothelial carcinoma in suspected lynch syndrome identified by immunohistochemical universal tumor screening

OP-025

一般口演025
尿路上皮腫瘍／基礎・診断・マーカー②

HiroshiYamane{YAMANEHIROSHI}|NoriyaYamaguchi{YAMAGUCHINORIYA}|NaokiUchida{UCHIDANAOKI}|TomoyaHatayama{HATAYAMATOMOYA}|ToshikiKenuka{KENUKATOSHIKI}____TakashigeAbe{ABETAKASHIGE}____ShuichiMorizane{MORIZANESHUICHI}|SumiyoToji{TOJISUMIYO}|MasashiHonda{HONDAMASASHI}|KuniyasuMuraoka{MURAOKAKUNIYASU}|HirofumiOono{OONOHIROFUMI}|TadahiroIsoyama{ISOYAMATADAHIRO}|KojiOno{ONOKOJI}|TakehiroSejima{SEJIMATAKEHIRO}|AtsushiTakenaka{TAKENAKAATSUSHI}|HiroshiYamane{YAMANEHIROSHI}|RyutaroShimizu{SHIMIZURYUTARO}|RyomaNishikawa{NISHIKAWARYOMA}|YusukeKimura{KIMURAYUSUKE}|KatsuyaHikita{HIKITAKATSUYA}|ShunSaito{SAITOSHUN}|HidetuguTakahashi{TAKAHASHIHIDETUGU}|YujiYata{YATAYUJI}|ShuheiHara{HARASHUHEI}|KousukeIwatani{IWATANIKOUSUKE}|KeijiYasue{YASUEKEIJI}|HirokiYamada{YAMADAHIROKI}|JunMiki{MIKIJUN}|TakahiroKimura{KIMURATAKAHIRO}|FumihikoUrabe{URABEFUMIHIKO}|YukiKohada{KOHADAYUKI}|KesukeGoto{GOTOKESUKE}|KosukeAkiyama{AKIYAMAKOSUKE}|KensukeNishida{NISHIDAKENSUKE}|TomokiFurutani{FURUTANITOMOKI}|YoshimasaKurimura{KURIMURAYOSHIMASA}|TakeshiUeno{UENOTAKESHI}|KunihiroHashimoto{HASHIMOTOKUNIHIRO}|KosukeSadahide{SADAHIDEKOSUKE}|NobuyukiHinata{HINATANOBUYUKI}|TetsuyaShindo{SHINDOTETSUYA}|YoheiUeki{UEKIYOHEI}|GenkiKobayashi{KOBAYASHIGENKI}|ShintaroMiyamoto{MIYAMOTOSHINTARO}|YasuharuKunishima{KUNISHIMAYASUHARU}|ShunsukeSato{SATOSHUNSUKE}|ManabuOkada{OKADAMANABU}|YukiKyoda{KYODAYUKI}|KoKobayashi{KOBAYASHIKO}|KoheiHashimoto{HASHIMOTOKOHEI}|ToshiakiTanaka{TANAKATOSHIAKI}|NaoyaMasumori{MASUMORINAOYA}____一般口演026腎盂・尿管腫瘍①____Development of preoperative risk stratification models to predict prognosis after radical nephroureterectomy for upper tract urothelial carcinoma|Lung immune prognostic index as a prognosis predictor following radical nephroureterectomy for upper urinary tract urothelial cancer|Associations Between Early Neutrophil-to-Lymphocyte Ratio Changes and Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma|The impact of the Advanced Lung Cancer Inflammation Index on prognosis for patients underwent radical nephroureterectomy for upper tract urothelial carcinoma|The impact of variant histology on prognosis of patients who underwent radical nephroureterectomy for upper urinary tract carcinoma

OP-026

一般口演026
腎盂・尿管腫瘍①

MoetoShimoda{SHIMODAMOETO}|TakahideNoro{NOROTAKAHIDE}|TetsuyaShindo{SHINDOTETSUYA}|RyotaroYamaguchi{YAMAGUCHIRYOTARO}|RyuujiTabata{TABATARYUUJI}____KazumasaMatsumoto{MATSUMOTOKAZUMASA}____HirokiIto{ITOHIROKI}|TakuSasaki{SASAKITAKU}|TetsuyaAoki{AOKITETSUYA}|JuriiKaribe{KARIBEJURII}|YousukeShibata{SHIBATAYOUSUKE}|MasashiImano{IMANOMASASHI}|MasahiroInoue{INOUEMASAHIRO}|ShinjiOhtake{OHTAKESHINJI}|KazukiKobayashi{KOBAYASHIKAZUKI}|NaotoKamiya{KAMIYANAOTO}|MioInui{INUIMIO}|TaroOkazaki{OKAZAKITARO}|NaokiIshitsuka{ISHITSUKANAOKI}|YutaSuzuki{SUZUKIYUTA}|SyoutaIijima{IIJIMASYOUTA}|YukaSugisaki{SUGISAKIYUKA}|TakatoshiSoumoto{SOUMOTOTAKATOSHI}|RyoOka{OKARYO}|TakumiEndo{ENDOTAKUMI}|TakanobuUtsumi{UTSUMITAKANOBU}|HiroyoshiSuzuki{SUZUKIHIROYOSHI}|YoheiUeki{UEKIYOHEI}|GenkiKobayashi{KOBAYASHIGENKI}|ShintaroMiyamoto{MIYAMOTOSHINTARO}|YasuharuKunishima{KUNISHIMAYASUHARU}|ShunsukeSato{SATOSHUNSUKE}|ManabuOkada{OKADAMANABU}|FumimasaFukuta{FUKUTAFUMIMASA}|KyodaYuki{YUKIKYODA}|HashimotoKohei{KOHEIHASHIMOTO}|KoKobayashi{KOBAYASHIKO}|ToshiakiTanaka{TANAKATOSHIAKI}|MasumoriNaoya{NAOYAMASUMORI}|FumihikoUrabe{URABEFUMIHIKO}|HirokazuKagawa{KAGAWAHIROKAZU}|KentaroYoshihara{YOSHIHARAKENTARO}|ShutaroYamamoto{YAMAMOTOSHUTARO}|ShuheiHara{HARASHUHEI}|YukiEnei{ENEIYUKI}|ShunsukeTsuzuki{TSUZUKISHUNSUKE}|GenIshii{ISHIIGEN}|TakahiroHiguchi{HIGUCHITAKAHIRO}|ShunSato{SATOSHUN}|TakahiroKimura{KIMURATAKAHIRO}|JunMiki{MIKIJUN}|ShinsukeKurokawa{KUROKAWASHINSUKE}|MasahiroYamazaki{YAMAZAKIMASAHIRO}|MaikoKomatsubara{KOMATSUBARAMAIKO}____一般口演027腎盂・尿管腫瘍②____Analysis of Cases of Patients Initially Diagnosed with Non-Muscle-Invasive Bladder Cancer Who Later Required Nephroureterectomy: A 10-Year Observational Study|Recurrence and prognostic studies of patients undergoing nephroureterectomy for upper tract urothelial carcinoma|Prognostic impact and risk factors of patients not receiving any systemic therapy at the time of recurrence after radical nephroureterectomy|Preoperative Predictors of Pathological Upstaging in Upper Tract Urothelial Carcinoma: Insights from a Multicenter Cohort|Devices to avoid position changes and undocking in robotic-assisted laparoscopic radical nephroureterectomy

OP-027

一般口演027
腎盂・尿管腫瘍②

TomonoriKanagawa{KANAGAWATOMONORI}|－|RyojiTakazawa{TAKAZAWARYOJI}|ShinKobayashi{KOBAYASHISHIN}|IppeiMuranaka{MURANAKAIPPEI}|ShotaOshima{OSHIMASHOTA}____AtsunariKawashima{KAWASHIMAATSUNARI}____YumaWaseda{WASEDAYUMA}|KokiMitani{MITANIKOKI}|TakehiroNakamura{NAKAMURATAKEHIRO}|TaichiroIshimaru{ISHIMARUTAICHIRO}|TsubasaHatakeyama{HATAKEYAMATSUBASA}|RyokenTsunekawa{TSUNEKAWARYOKEN}|NaokiWada{WADANAOKI}|JunichiHori{HORIJUNICHI}|HiromichiIuchi{IUCHIHIROMICHI}|YujiSaga{SAGAYUJI}|TakeyaKitta{KITTATAKEYA}|TetsuyaShindo{SHINDOTETSUYA}|YoheiUeki{UEKIYOHEI}|GenkiKobayashi{KOBAYASHIGENKI}|ShintaroMiyamoto{MIYAMOTOSHINTARO}|YasuharuKunishima{KUNISHIMAYASUHARU}|ShunsukeSato{SATOSHUNSUKE}|ManabuOkada{OKADAMANABU}|YukiKyoda{KYODAYUKI}|KoKobayashi{KOBAYASHIKO}|KoheiHashimoto{HASHIMOTOKOHEI}|ToshiakiTanaka{TANAKATOSHIAKI}|NaoyaMasumori{MASUMORINAOYA}|ShinjiKono{KONOSHINJI}|YukiSakaue{SAKAUEYUKI}|GenTanaka{TANAKAGEN}|KazutakaMitani{MITANIKAZUTAKA}|TakafumiHara{HARATAKAFUMI}|YusukeKobayashi{KOBAYASHIYUSUKE}|IchiroTsuboi{TSUBOIICHIRO}|HirochikaNakajima{NAKAJIMAHIROCHIKA}|TaichiNagami{NAGAMITAICHI}|KoheiOgawa{OGAWAKOHEI}|ChiakiKoike{KOIKECHIAKI}|KoichiroWada{WADAKOICHIRO}____一般口演028腎盂・尿管腫瘍③____Impact of random bladder biopsy on intravesical recurrence in upper tract urothelial carcinoma patients undergoing radical nephroureterectomy|演題取り下げ|Laser ablation treatment for UTUC: A single-center 12-year experience|Clinical study of the usefulness of MMC intravesical infusion therapy soonafter nephroureterectomy in patients with urothelial carcinoma of upperurinary tract|Risk factors for early intravesical recurrence after radical nephroureterectomy for upper urinary tract carcinoma with or without history of bladder cancer|Initial experience of hybrid thulium: YAG laser ablation as a kidney-sparing surgery for upper tract urothelial carcinoma

OP-028

一般口演028
腎盂・尿管腫瘍③

AtsushiYamamoto{YAMAMOTOATSUSHI}|YukiNishio{NISHIOYUKI}|MasafumiMaruo{MARUOMASAFUMI}|KoheiTakei{TAKEIKOHEI}|HironobuWakeda{WAKEDAHIRONOBU}____SusumuKageyama{KAGEYAMASUSUMU}____HiroshiYamane{YAMANEHIROSHI}|ShuichiMorizane{MORIZANESHUICHI}|MasashiHonda{HONDAMASASHI}|SumiyoToji{TOJISUMIYO}|KuniyasuMuraoka{MURAOKAKUNIYASU}|HirofumiOhno{OHNOHIROFUMI}|TadahiroIsoyama{ISOYAMATADAHIRO}|KojiOno{ONOKOJI}|TakehiroSejima{SEJIMATAKEHIRO}|AtsushiTakenaka{TAKENAKAATSUSHI}|TetsuyaShindo{SHINDOTETSUYA}|YoheiUeki{UEKIYOHEI}|ShintaroMiyamoto{MIYAMOTOSHINTARO}|MasahiroMatsuki{MATSUKIMASAHIRO}|YasuharuKunishima{KUNISHIMAYASUHARU}|ShunsukeSato{SATOSHUNSUKE}|FumimasaFukuta{FUKUTAFUMIMASA}|ManabuOkada{OKADAMANABU}|AkioTakayanagi{TAKAYANAGIAKIO}|KoheiHashimoto{HASHIMOTOKOHEI}|ToshiakiTanaka{TANAKATOSHIAKI}|NaoyaMasumori{MASUMORINAOYA}|MotoharuTanaka{TANAKAMOTOHARU}|MasayaZenntou{ZENNTOUMASAYA}|HirokiShibata{SHIBATAHIROKI}|AyumiFujimoto{FUJIMOTOAYUMI}|MotohiroNakamura{NAKAMURAMOTOHIRO}|KunioEtou{ETOUKUNIO}|KenseiMiyamoto{MIYAMOTOKENSEI}|YusukeImamura{IMAMURAYUSUKE}|ShinichiSakamoto{SAKAMOTOSHINICHI}|NobuyukiSekita{SEKITANOBUYUKI}|TomohikoIchikawa{ICHIKAWATOMOHIKO}|TosihkiKijima{KIJIMATOSIHKI}|HarukaKubota{KUBOTAHARUKA}|SakiInaba{INABASAKI}|MotokiFujita{FUJITAMOTOKI}|MarikoKotono{KOTONOMARIKO}|AkihitoOkazaki{OKAZAKIAKIHITO}|NaoyaOkubo{OKUBONAOYA}|RyoKurashina{KURASHINARYO}|HidetoshiKokubun{KOKUBUNHIDETOSHI}|ToshitakaUematsu{UEMATSUTOSHITAKA}|MasahiroYashi{YASHIMASAHIRO}|TakaoKamai{KAMAITAKAO}|MasahiroTateishi{TATEISHIMASAHIRO}____一般口演029腎盂・尿管腫瘍④____A multicenter study of the independent prognostic factors for non-urothelial tract recurrence-free survival in upper urothelial carcinoma|The impact of lymphovascular invasion according to pathological stages in patients with upper urinary tract carcinoma|A case of metastatic renal pelvis cancer responded to EV, with removal of the primary tumor and disease control, and a study by anti-Nectin 4 antibody staining|Association between second-line pembrolizumab therapy outcomes and Inflammatory biomarkers in metastatic urothelial carcinoma patients|Long-term survival of a patient with metastatic renal pelvic carcinoma after pulmonary metastasectomy and pembrolizumab administration

OP-029

一般口演029
腎盂・尿管腫瘍④

井上貴昭{いのうえたかあきINOUETAKAAKI}____－________ミートザエキスパート1結石治療____fTULの真髄とさらなる進歩

MTE1

ミートザエキスパート1
結石治療

猪口淳一{いのくちじゅんいちINOKUCHIJUNICHI}____－________ミートザエキスパート2UCの薬物療法____尿路上皮癌に対する薬物療法

MTE2

ミートザエキスパート2
UCの薬物療法

川喜田睦司{かわきたむつしKAWAKITAMUTSUSHI}____－________ミートザエキスパート3ロボット手術____ロボット手術

MTE3

ミートザエキスパート3
ロボット手術

堀口明男{ほりぐちあきおHORIGUCHIAKIO}____－________ミートザエキスパート4尿道狭窄____教えて！尿道形成術―あなたの疑問に答えます―

MTE4

ミートザエキスパート4
尿道狭窄

髙橋悟{たかはしさとるTAKAHASHISATORU}____－________ミートザエキスパート5前立腺肥大症____前立腺肥大症

MTE5

ミートザエキスパート5
前立腺肥大症

松本一宏{まつもとかずひろMATSUMOTOKAZUHIRO}|田岡利宜也{たおかりきやTAOKARIKIYA}____藤本清秀{ふじもときよひでFUJIMOTOKIYOHIDE}________ランチョンセミナー1日常診療におけるバベンチオ維持療法の真価転移性尿路上皮癌治療:最新のReal World Dataに基づく治療戦略の考察____日常診療におけるバベンチオ維持療法の真価|転移性尿路上皮癌治療:最新のReal World Dataに基づく治療戦略の考察

LS01

ランチョンセミナー1
日常診療におけるバベンチオ維持療法の真価
転移性尿路上皮癌治療:最新のReal World Dataに基づく治療戦略の考察

【共催：メルクバイオファーマ株式会社】

演者：松本 一宏

演者：田岡 利宜也

浮村理{うきむらおさむUKIMURAOSAMU}|岡田充生{おかだみつをOKADAMITSUO}____大野芳正{おおのよしおONOYOSHIO}________ランチョンセミナー2マイクロ超音波による前立腺イメージング____29MHz経直腸的前立腺超音波断層法はmp-MRIを凌駕するか?|マイクロ超音波イメージングによるターゲット生検

LS02

ランチョンセミナー2
マイクロ超音波による前立腺イメージング

【共催：エダップテクノメド株式会社】

演者：浮村 理

演者：岡田 充生

大澤崇宏{おおさわたかひろOSAWATAKAHIRO}|本郷文弥{ほんごうふみやHONGOFUMIYA}____小原航{おばらわたるOBARAWATARU}________ランチョンセミナー3腎細胞がん治療を多角的に考える____転移性腎癌治療におけるCabo＋Nivoの実力　～安全性とQOLの視点から探るその真価～|複雑化する進行性腎細胞癌の一次治療　～Nivo+Caboをどう活かすか～

LS03

ランチョンセミナー3
腎細胞がん治療を多角的に考える

【共催：武田薬品工業株式会社】

演者：大澤 崇宏

演者：本郷 文弥

Jean-ChristopheBernhard{BERNHARDJEAN-CHRISTOPHE}____大家基嗣{おおやもとつぐOYAMOTOTSUGU}________ランチョンセミナー4Kidney cancer : dealing with the risk of disease recurrence as a urologist____－

LS04

ランチョンセミナー4
Kidney cancer : dealing with the risk of disease recurrence as a urologist

【共催：MSD株式会社】

演者：Jean-Christophe Bernhard

TombalBertrand{BERTRANDTOMBAL}____鈴木啓悦{すずきひろよしSUZUKIHIROYOSHI}________ランチョンセミナー5Radium223 after PEACE-3 Revisiting the benefits and the positioning____－

LS05

ランチョンセミナー5
Radium223 after PEACE-3 Revisiting the benefits and the positioning

【共催：バイエル薬品株式会社】

演者：Tombal Bertrand

MartinGleave{GLEAVEMARTIN}____舛森直哉{ますもりなおやMASUMORINAOYA}________ランチョンセミナー6Sequencing Therapies in Advanced Prostate Cancer - Evolving Towards Precision Medicine____－

LS06

ランチョンセミナー6
Sequencing Therapies in Advanced Prostate Cancer - Evolving Towards Precision Medicine

【共催：アストラゼネカ株式会社】

演者：Martin Gleave

石田勝{いしだまさるISHIDAMASARU}|西川晃平{にしかわこうへいNISHIKAWAKOHEI}____清川岳彦{せがわたけひこSEGAWATAKEHIKO}________ランチョンセミナー7Da Vinci SPを用いたロボット手術のコツとピットフォール____前立腺から始めるda Vinci SP腹膜外手術 ～低侵襲の極みへ～|上部尿路疾患に対するda Vinci SPの使いどころ ～当院での初期経験を踏まえて～

LS07

ランチョンセミナー7
Da Vinci SPを用いたロボット手術のコツとピットフォール

【共催：インテュイティブサージカル合同会社】

演者：石田 勝

演者：西川 晃平

田畑健一{たばたけんいちTABATAKENICHI}|森實修一{もりざねしゅういちMORIZANESYUICHI}____雑賀隆史{さいがたかしSAIGATAKASHI}________ランチョンセミナー8Hugo™を使用した最適な治療の探求____中規模病院、Hugo™1台体制における泌尿器科手術の実践と教育|Hugo™によるレトロアプローチ　最適化を目指した取り組みと結果

LS08

ランチョンセミナー8
Hugo™を使用した最適な治療の探求

【共催：コヴィディエンジャパン株式会社】

演者：田畑 健一

演者：森實 修一

藤田雅一郎{ふじたまさいちろうFUJITAMASAICHIRO}|志賀直樹{しがなおきSHIGANAOKI}____井上貴昭{いのうえたかあきINOETAKAAKI}________ランチョンセミナー9我々はTULデバイスを駆使できているか？ －軟性尿管鏡と自動灌流装置－____自動灌流装置の役割を再考する －FANS時代の到来に向けて－|長く使おう！リユース軟性尿管鏡 －シングルユース時代における価値を再考する－

LS09

ランチョンセミナー9
我々はTULデバイスを駆使できているか？ －軟性尿管鏡と自動灌流装置－

【共催：カールストルツ・エンドスコピー・ジャパン株式会社／エム・シー・メディカル株式会社】

演者：藤田 雅一郎

演者：志賀 直樹

戸山友香{とやまゆうかTOYAMAYUKA}____井川掌{いがわつかさIGAWATSUKASA}________ランチョンセミナー10こんな時こそ漢方！FLUTS症例を通じて考える東西両輪の処方選択術____－

LS10

ランチョンセミナー10
こんな時こそ漢方！FLUTS症例を通じて考える東西両輪の処方選択術

【共催：株式会社ツムラ】

演者：戸山 友香

－____－________ランチョンセミナー11※本セミナーは中止になりました____－

LS11

ランチョンセミナー11
※本セミナーは中止になりました

塩田真己{しおたまさきSHIOTAMASAKI}____赤松秀輔{あかまつしゅうすけAKAMATSUSYUSUKE}________ランチョンセミナー12泌尿器腫瘍におけるCGP検査の意義について____－

LS12

ランチョンセミナー12
泌尿器腫瘍におけるCGP検査の意義について

【共催：中外製薬株式会社】

演者：塩田 真己

安部崇重{あべたかしげABETAKASHIGE}____西山博之{にしやまひろゆきNISHIYAMAHIROYUKI}________ランチョンセミナー13la/mUC治療におけるFGFR阻害剤の位置づけと治療展望____－

LS13

ランチョンセミナー13
la/mUC治療におけるFGFR阻害剤の位置づけと治療展望

【共催：ヤンセンファーマ株式会社】

演者：安部 崇重

金城真実{きんじょうまなみKINJOMANAMI}|松尾朋博{まつおともひろMATSUOTOMOHIRO}____髙橋悟{たかはしさとるTAKAHASHISATORU}________ランチョンセミナー14過活動膀胱治療の最新動向____女性OAB診療のコツ|研究の最前線から読み解くOAB治療の将来像

LS14

ランチョンセミナー14
過活動膀胱治療の最新動向

【共催：アステラス製薬株式会社】

演者：金城 真実

演者：松尾 朋博

阿南剛{あなんごうANANGO}|副田雄也{そえだゆうやSOEDAYUYA}____舛森直哉{ますもりなおやMASUMORINAOYA}________ハンズオンセミナー1エキスパートから学ぶ！UroLift™のコツ____－

HS1

ハンズオンセミナー1
エキスパートから学ぶ！UroLift™のコツ

【共催：テレフレックスメディカルジャパン株式会社】

演者：阿南 剛

演者：副田 雄也

三浦裕司{みうらゆうじMIURAYUJI}|三宅牧人{みやけまきとMIYAKEMAKITO}____榎田英樹{えのきだひできENOKIDAHIDEKI}________イブニングセミナー1進行性尿路上皮癌に対する薬物療法____新時代を迎えた進行性尿路上皮癌薬物療法のAEマネジメントについて考える～実臨床の経験も踏まえて～|進行性尿路上皮癌に対する複合免疫療法の利活用～実臨床から肌身で学ぶ～

ES01

イブニングセミナー1
進行性尿路上皮癌に対する薬物療法

【共催：MSD株式会社】

演者：三浦 裕司

演者：三宅 牧人

杉本康弘{すぎもとやすひろSUGIMOTOYASUHIRO}|藤田雅一郎{ふじたまさいちろうFUJITAMASAICHIRO}____井上貴昭{いのうえたかあきINOETAKAAKI}________イブニングセミナー2結石治療に於けるMOSES™モードのTipsとピットホール____レーザ結石破砕治療に於けるレーザ照射条件の効果とその周囲への影響|MOSES™活用術～尿管から腎結石まで～

ES02

イブニングセミナー2
結石治療に於けるMOSES™モードのTipsとピットホール

【共催：ボストン・サイエンティフィックジャパン株式会社】

演者：杉本 康弘

演者：藤田 雅一郎

内藤整{ないとうせいNAITOSEI}|高木敏男{たかぎとしおTAKAGITOSHIO}____中井川昇{なかいがわのぼるNAKAIGAWANOBORU}________イブニングセミナー3腎癌治療におけるFGFR阻害の臨床的意義____腎癌におけるFGFRの役割|RCC治療を集学的に考える上でのFGFR阻害

ES03

イブニングセミナー3
腎癌治療におけるFGFR阻害の臨床的意義

【共催：エーザイ株式会社／MSD株式会社】

演者：内藤 整

演者：高木 敏男

小林知子{こばやしともこKOBAYASHITOMOKO}|三木健太{みきけんたMIKIKENTA}____三井貴彦{みついたかひこMITSUITAKAHIKO}________イブニングセミナー4泌尿器科における技術継承____膀胱尿管逆流症に対するDeflux治療|前立腺癌の密封小線源療法

ES04

イブニングセミナー4
泌尿器科における技術継承

【共催：テレフレックスメディカルジャパン株式会社】

演者：小林 知子

演者：三木 健太

鈴木和浩{すずきかずひろSUZUKIKAZUHIRO}____三宅秀明{みやけひであきMIYAKEHIDEAKI}________イブニングセミナー5nmCRPC治療におけるダロルタミドの役割____－

ES05

イブニングセミナー5
nmCRPC治療におけるダロルタミドの役割

【共催：バイエル薬品株式会社】

演者：鈴木 和浩

西野和美{にしのかずみNISHINOKAZUMI}|田岡利宜也{たおかりきやTAOKARIKIYA}____野々村祝夫{ののむらのりおNONOMURANORIO}________イブニングセミナー6尿路上皮がんにおける遺伝子検査の現状と今後の展望____マルチプレックス遺伝子検査に基づく肺癌診療の今～ Nothing seek, nothing find ～|次の100年に向けた実践：遺伝子検査を介した新たな尿路上皮癌治療戦略の構築

ES06

イブニングセミナー6
尿路上皮がんにおける遺伝子検査の現状と今後の展望

【共催：ヤンセンファーマ株式会社】

演者：西野 和美

演者：田岡 利宜也

塩田真己{しおたまさきSHIOTAMASAKI}____－________卒後教育プログラム1前立腺がん薬物療法 up to date____前立腺がん薬物療法 up to date

RPG01

卒後教育プログラム1
前立腺がん薬物療法 up to date

演者：塩田 真己

藤田和利{ふじたかずとしFUJITAKAZUTOSHI}____－________卒後教育プログラム2マイクロバイオーム研究の基礎と実践____マイクロバイオーム研究の基礎と実践

RPG02

卒後教育プログラム2
マイクロバイオーム研究の基礎と実践

演者：藤田 和利

伊藤一人{いとうかずとITOKAZUTO}____－________卒後教育プログラム3前立腺がん検診のすべて____前立腺がん検診のすべて

RPG03

卒後教育プログラム3
前立腺がん検診のすべて

演者：伊藤 一人

重村克巳{しげむらかつみSHIGEMURAKATSUMI}____－________卒後教育プログラム4「薬剤耐性（AMR）」ってなんだろう？____「薬剤耐性（AMR）」ってなんだろう？

RPG04

卒後教育プログラム4
「薬剤耐性（AMR）」ってなんだろう？

演者：重村 克巳

後信{うしろしんUSHIROSHIN}____雑賀隆史{さいかたかしSAIKATAKASHI}________卒後教育プログラム5医療安全の国際潮流について____医療安全の国際潮流について

RPG05

卒後教育プログラム5
医療安全の国際潮流について

演者：後 信

橘田岳也{きったたけやKITTATAKEYA}____－________卒後教育プログラム6泌尿器科専門医として知っておくべき排尿生理の最前線____泌尿器科専門医として知っておくべき排尿生理の最前線

RPG06

卒後教育プログラム6
泌尿器科専門医として知っておくべき排尿生理の最前線

演者：橘田 岳也

大日方大亮{おびなただいすけOBINATADAISUKE}____－________卒後教育プログラム7高齢泌尿器がんの実臨床：対策とピットフォール____高齢泌尿器がんの実臨床：対策とピットフォール

RPG07

卒後教育プログラム7
高齢泌尿器がんの実臨床：対策とピットフォール

演者：大日方 大亮

－____－________開会式____－

NO01

開会式